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ABSTRACT 
 
 Multidrug resistant bacterial infections are of a global concern due to the rapidly 
increasing incidence over the past three decades and alarmingly few new antimicrobial 
pharmaceuticals currently under development. Nonetheless, simply designing new 
antibiotics may not be sufficient due to the vast genetic diversity of bacteria and their 
alarming efficient ability to acquire new and diverse resistance mechanisms. Instead, it has 
become necessary to understand the virulence and resistance mechanisms by which 
bacteria infect and persist in their host. Biofilm formation is one type of resistance 
mechanism of particular concern in pulmonary diseases such as cystic fibrosis and 
pneumonia. Opportunistic pathogens such as Pseudomonas aeruginosa and 
Stenotrophomonas maltophilia colonize the lungs of cystic fibrosis patients and secrete an 
extracellular matrix of protein, DNA, and polysaccharides which acts as a diffusion barrier 
against dehydration, phagocytosis, and antibiotic treatment. The polysaccharides of many 
biofilms contain uronic acids. Polysaccharide lyases catalyze the depolymerization of 
uronic acid-containing polysaccharides via a β-elimination mechanism and play important 
roles in microbial biofilm formation and tissue invasion. Furthermore, polysaccharide 
lyases have pharmaceutical applications in the treatment of biofilm-associated infections 
and preparation of therapeutic oligosaccharides, as well as industrial applications in biofuel 
production. 
In an effort to understand the potential role that two putative alginate lyases 
(Smlt1473 and Smlt2602) from S. maltophilia may play in bacterial virulence, each 
enzyme was heterologously expressed in Escherichia coli, purified in a one-step fashion 
via affinity chromatography, and assayed for catalytic activity as well as substrate 
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specificity for a range of polysaccharides. Interestingly, Smlt1473 catalyzed the endolytic 
degradation of not only alginate, but poly-β-D-glucuronic acid and hyaluronic acid as well. 
Furthermore, the pH optimum for enzymatic activity was substrate-dependent, with 
optimal hyaluronic acid degradation at pH 5, poly-β-D-glucuronic acid degradation at pH 
7, and alginate degradation at pH 9. Homology modeling allowed for the selection of 
residues located in the active site, but not directly involved in the β-elimination mechanism. 
These residues were predicted to bind and optimally align the substrate in the active site 
for catalysis. Mutation of the substrate-binding residues resulted in the significant 
modification of Smlt1473 substrate specificity. The same nonrandom selection of residues 
responsible for substrate specificity was applied to Smlt2602, which catalyzed the exolytic 
degradation of alginate-based substrates. The result was the successful engineering of a 
completely unique mutant lyase that was exolytically active against both alginate and poly-
β-D-glucuronic acid. 
Little is known regarding the specific virulence mechanisms employed by S. 
maltophlia to infect and invade its host. Therefore we identified and characterized a 
secreted ankyrin-repeat containing protein (Smlt3054) from S. maltophilia that bound F-
actin in vitro and disrupted actin cytoskeletal structure in transfected mammalian cells. 
Altogether, this work furthers our understanding of S. maltophlia, an emergent, multidrug 
resistant opportunistic pathogen that is increasingly associated with chronic lung 
infections, and describes two unique polysaccharide lyases that could be utilized as 
platforms for the design of highly active enzymes who substrate specificity has been fine-
tuned for the problem at hand.  
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CHAPTER 1 
INTRODUCTION 
 
 Carbohydrates are an extensive class of molecules essential for cellular function in 
all living organisms. Despite being comprised of relatively simple building blocks of 
carbon, hydrogen and oxygen, their abundance of chiral centers, ability to undergo 
numerous specific modifications, including acetylation, methylation, oxidation and 
sulfation, and varying degrees of polymerization and branching allows for an immense 
library of chemically and structurally unique oligo- and polysaccharides (1,2). Frequently 
associated with energy storage for cell respiration, as well as providing mechanical support 
in biostructures such as the cell wall and extracellular matrix, carbohydrates in fact play a 
much more comprehensive role in biology, including functions in cell signaling, the 
immune system, cancer progression and bacterial pathogenesis (2-4). For example, (i) 
lectins recognize specific oligosaccharides attached to glycoproteins and glycolipids on the 
cell surface, signaling a variety of biological processes such as cell adhesion, cell 
differentiation and apoptosis (5); (ii) sulfated polysaccharides located on the cell surface 
and extracellular matrix interact with immune cells to both stimulate and inhibit the 
immune response, dependent on the structure of the polysaccharide (6); (iii) uronic acid-
containing polysaccharides are major components of bacterial biofilms and capsules, both 
virulence factors which protect the microbe from engulfment by macrophages and act as a 
diffusion barrier towards antibiotics, contributing to the problem of multidrug resistance 
(MDR) in microorganisms (7,8). 
Antibiotics have been revolutionary in the treatment of bacterial infections and are 
responsible for an overall decrease in morbidity and mortality over the past seventy years. 
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However, the increasing incidence of MDR in bacteria has modern healthcare professionals 
concerned our current antibacterial armamentarium may be insufficient (9). Drug 
resistance in bacteria is by no means a modern problem. As early as the 1960s the 
emergence of resistant bacteria forced researchers to make synthetic modifications to 
existing antibiotics in an effort to reconstitute their potency (10). Although these semi-
synthetic compounds proved more potent and less susceptible to inactivating enzymes, 
resistance in Gram-negative bacteria continued to increase. The discovery of 
fluoroquinolones in the 1980s proved effective as well, however the development of novel 
analogs to combat resistance has suffered from diminishing returns in recent years (9). 
Despite the fact that MDR in bacteria is increasing now more than ever (57.1% of 
Staphylococcus aureus, 27.5% of Enterococcus faecium, and 32.8% of Pseudomonas 
aeruginosa nosocomial infections are resistant to the drugs that 25 years ago effectively 
neutralized >90% of infections), startlingly few new antimicrobial drugs are under 
development (10). As seen in Figure 1.1 the number of new antibiotics that have been FDA 
approved decreased from 16 between 1983 and 1987 to 5 between 2003 and 2007 (10). 
The problem of MDR extends to opportunistic pathogens as well, including 
Stenotrophomonas maltophilia, a ubiquitous Gram-negative bacterium responsible for 
approximately 1% of all hospital-acquired bacteraemias, with an attributed mortality rate 
of about 28% (11). S. maltophilia is an environmental bacterium found in soil and water, 
which has also been isolated from a wide range of hospital locations and equipment, 
including contaminated disinfectant solutions, showerheads, hospital water, indwelling 
catheters, ventilators, and stents (12). As an opportunistic pathogen, S. maltophilia is 
considered to have relatively limited pathogenicity except with the immunocompromised, 
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in which the rate of isolation is thought to be increasing (13). Risk factors for infection 
include prolonged hospitalization, admittance into the intensive care unit, central venous 
catheterization, mechanical ventilation, and prior treatment with antibiotics (12). 
Controlled use of antibiotics has been identified as pivotal in the prevention of resistant S. 
maltophilia nosocomial infections (13). Treatment is complicated by the fact that the 
organism is heavily guarded by multiple antimicrobial and heavy metal resistance 
mechanisms, has an exceptional ability to adhere to inert surfaces including stainless steel 
and plastics used in medical equipment, is remarkably genetically diverse and capable of 
acquiring mobile DNA elements, and forms polymicrobial biofilms with more aggressive 
pathogens such as Pseudomonas and Neisseria (14).  
 
Figure 1.1: Number of new antibacterial agents approved by the FDA between 1983 and 2007. Data taken 
from Bad Bugs, No Drugs: No ESKAPE!, a report issued by the Infectious Diseases Society of America (2). 
 
 The development of new antimicrobials is complicated by the fact that many 
bacteria exhibit an alarmingly efficient ability to acquire new resistance mechanisms, 
rendering many drugs quickly ineffective. These mechanisms include, but are not limited 
to, enzymes which convert antibiotics into inactive forms, such as β-lactamases which 
hydrolyze the β-lactam ring found in penicillin and related antibiotics (Figure 1.2A) (15), 
and efflux pumps which recognize a wide array of antimicrobials and pump them across 
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the inner and outer bacterial membrane into the external medium (Figure 1.2B), such as 
the resistance-nodulation-division efflux pump AcrB of Escherichia coli which is capable 
of removing penicillins, cephalosporins, fluoroquinolones, and tetracyclines, as well as 
various detergents and organic solvents (16).  
 
 
Figure 1.2: Mechanisms of multidrug resistance. (A) Class of enzymes known as β-lactamases cleave the β-
lactam ring of penicillin and related antibiotics, rendering the antibiotic inactive. (B) Efflux pumps located 
in the bacterial membrane export a broad spectrum of antimicrobial compounds into the surrounding medium. 
 
Another mechanism of MDR is the formation of biofilms, which is increasingly 
recognized as an important bacterial virulence factor in a variety of diseases including 
cystic fibrosis (CF) and late-onset ventilator-associated pneumonia (LO-VAP) (17). A 
biofilm consists of an extracellular polymeric substance (EPS) matrix comprised mostly of 
polysaccharides, but also containing DNA and protein, which is secreted by certain bacteria 
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upon adherence to a surface. The EPS protects against external stresses such as dehydration 
and phagocytosis, allows for closer cell-to-cell contact, and creates a diffusion barrier 
against many antibiotics, resulting in biofilm-associated bacteria exhibiting up to 1,000 
times greater resistance to antibiotics than their free-swimming counterparts (Figure 1.3) 
(17,18). Biofilms can form on biological surfaces such as bronchial epithelial cells or inert 
surfaces such as medical-grade stainless steel, polystyrene, glass, and other materials used 
in many indwelling medical devices or found in industrial water system piping (17-19). 
 
Figure 1.3: Biofilm formation as a mechanism of multidrug resistance. Planktonic bacteria (dark brown) 
adhere to a surface in response to an external stress and switch to the mucoid phenotype (tan), secreting an 
extracellular polymeric substance (EPS) consisting mostly of polysaccharides, along with DNA and proteins. 
The EPS acts as a diffusion barrier towards antimicrobials (green) resulting in the survival and persistence 
of the mucoid bacteria upon treatment with antibiotic. 
  
As stated previously, biofilm formation has been associated with chronic multidrug 
resistant bacterial infections commonly found in the lungs of CF patients. Cystic fibrosis 
is a hereditary disease caused by a mutation in the cystic fibrosis transmembrane 
conductance regulator (CFTR) gene which results in the inability of pulmonary epithelial 
cells to transport chloride and thiocyanate ions across their plasma membrane. Ultimately 
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this results in an inability to transport water out of the epithelial cells and causes the 
dehydration and thickening of the mucus surrounding the respiratory tract. This in turn 
impairs the mucocilary apparatus, preventing the clearance of inhaled microorganisms 
from the bronchi and leaving CF patients vulnerable to infection (20). The most common 
bacteria isolated from the CF lung is P. aeruginosa, an opportunistic pathogen known to 
undergo a shift from planktonic (free-swimming) to mucoid (biofilm-producing) in 
response to oxidative stress caused by free radical release from macrophages. The switch 
to mucoidy allows P. aerugionsa to persist in the airways and results in severe damage to 
the lung due to a prolonged immune response (17,21-24). The major component of P. 
aeruginosa biofilm is the uronic acid-containing polysaccharide alginate (22,23,25,26).  
S. maltophilia has also been isolated from CF patients and shown to adhere to and 
form biofilm on bronchial cells, as well numerous indwelling medical devices. Biofilm-
producing strains of S. maltophilia have also exhibited greater resistance to antibiotics such 
as tobramycin (17). Analysis of the EPS of two S. maltophilia strains isolated from CF 
patients revealed a unique, highly negatively charged branched polysaccharide comprised 
of D-glucuronic acid (GlcA), D-galacturonic acid (GalA), and D-lactate. The greater 
negative charge density of the S. maltophilia EPS, as compared to alginate in P. 
aeruginosa, is thought to enhance adhesion to surfaces and inhibit cationic antimicrobial 
polypeptides such as polymyxins (27). 
Due to the correlation between biofilm-producing bacterial strains and enhanced 
antibiotic resistance, one proposed mechanism to combat multidrug resistant infections is 
to disrupt the structure of the biofilm via enzymatic degradation of its components, thereby 
exposing the protected bacterial cells to the surrounding environment and rendering them 
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once again sensitive to antibiotics (Figure 1.4) (28,29). Possible therapeutic candidates 
include enzymes which degrade polysaccharides, the major EPS macromolecule. Selection 
of the appropriate enzyme requires an innate knowledge of the chemical and structural 
composition of the polysaccharides found in biofilms. 
 
Figure 1.4: Schematic of the enzymatic degradation of biofilm as possible adjuvant to antibiotic treatments. 
Treatment with antibiotic alone is ineffective at killing the mucoid bacteria (tan) due to the protective barrier 
of the biofilm. Treatment with both antibiotic and enzyme results in the degradation of the biofilm and 
subsequent killing of the bacteria due to their exposure to the surrounding environment. 
 
The biofilms of both P. aeruginosa and S. maltophilia are known to contain uronic 
acids, whose hydroxyl group at the C6 position has been oxidized to carboxylic acid, 
resulting in an anionic polymer (Figure 1.5) (2). Polymers of uronic acids also play other 
critical roles in biology, including functions in the immune response, cell-cell signaling, 
inflammation, and cancer progression (30-33). Furthermore polyuronides have numerous 
industrial and pharmaceutical applications, including gelling and thickening agents, heavy 
metal sequestering, chromatography, wound dressing, drug delivery, and tissue 
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regeneration (34-38). Due to the importance of this class of carbohydrates, a review of the 
types of polyuronides is presented below. 
 
Figure 1.5: Uronic acids are oxidized at the C6 position, resulting in the formation of a carboxylic acid. 
 
There are four major groups of polyuronides: the alginates, the pectic acids, the 
glucuronans, and the glycosaminoglycans. Alginate is a linear copolymer comprised of D-
mannuronic acid (ManA) and its C5 epimer, L-guluronic acid (GulA), arranged in (1→4) 
O-linked blocks of repeating poly-β-ManA, poly--GulA, or alternating poly-MG (25). 
Each block type exhibits vastly different macromolecular properties due to the 
stereochemistry of the monomers which alters the polymer hydrogen bonding network and 
therefore the overall three dimensional shape (Figure 1.6A) (2,39). Poly-ManA blocks 
form an extended “ribbon” conformation (Figure 1.6A top) (25), which is more elastic and 
flexible than the other block types (39). The alginate in the P. aeruginosa biofilm is 
comprised predominantly of ManA which can be O-acetylated at the C2 and/or C3 position 
(40,41). The degree of acetylation is known to be important for adhesion and early biofilm 
development in P. aeruginosa (41). Poly-GulA blocks form a more rigid “buckled” 
conformation that readily binds calcium ions, cross-linking adjacent polymers and forming 
hydrogels via the egg-box model (Figure 1.6A middle) (25). Alginate hydrogels have 
applications in the pharmaceutical industry as thickening and stabilizing agents, drug 
delivery platforms, and components of wound dressings (42). The mechanical properties 
of the gel are dictated by the ratio of GulA to ManA present in the alginate polymer, with 
high percentages of GulA leading to strong, brittle gels, whereas high percentages of ManA 
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form more elastic gels (42). Lastly, alternating poly-MG blocks take on a sinusoidal 
conformation (Figure 1.6A bottom) (25). 
Pectic acids, otherwise known as poly-α-D-galacturonic acid (poly-GalA), 
comprise a second group of linear, (1→4) O-linked polyuronides. A major component of 
the cell wall in terrestrial plants, poly-GalA has a “buckled” structure similar to poly-GulA 
(Figure 1.6B) (43). The third group is poly-β-D-glucuronic acid (poly-GlcA), also known 
as glucuronan or celluronic acid.  Found in the cell wall of green algae as well as several 
microbial exopolysaccharides, including S. maltophilia, poly-GlcA has a “ribbon” 
structure similar to poly-ManA (Figure 1.6C) (44-46). 
Glycosaminoglycans (GAGs) comprise the fourth major group of uronic acid-
containing polysaccharides and include heparin, heparan sulfate, chondroitin sulfate, 
dermatan sulfate, and hyaluronic acid (HA). These long, linear polymers are comprised of 
repeating disaccharide units of an uronic acid, either GlcA or its C5 epimer, iduronic acid 
(IdoA), (1→3) O-linked to an amino sugar, either N-acetyl-D-glucosamine (GlcNAc) or 
N-acetyl-D-galactosamine (GalNAc), which in turn is (1→4) O-linked to the next uronic 
acid. The polymers are often attached to core proteins and heavily sulfated, with the 
exception of HA (2). Consisting of repeating units of strictly unsulfated GlcA and GlcNAc 
(Figure 1.6D), HA is ubiquitous in nearly all tissue of vertebrates and is a major component 
of the extracellular matrix (ECM). This giant molecule, usually consisting of 2000 to 
25,000 disaccharide units, play numerous roles in cell motility, inflammation, the immune 
system, and angiogenesis (47-49). In the context of bacterial infections, the highly viscous 
HA in the ECM acts as a barrier, preventing invading bacteria and secreted toxins from 
penetrating deeper into the tissue (50).  
12 
 
Figure 1.6: Structure of 
polyuronides. Hydrogen 
bonds are designated by 
red dashes. (A) Alginate 
block types. Poly-ManA 
forms a flexible extended 
ribbon shape. Poly-GulA 
forms a rigid buckled 
shape that contains a 
pocket which selectively 
binds calcium ions (blue), 
leading to crosslinking of 
adjacent polymers and 
formation of hydrogels. 
Poly-MG forms a semi-
flexible sinusoidal shape. 
(B) Poly-GalA has a 
buckled shape similar to 
poly-GulA. (C) Poly-
GlcA has an extended 
ribbon conformation 
similar to poly-ManA. 
(D) Glycosaminoglycans 
(GAGs) are comprised of 
repeating disaccharide 
units of an uronic acid 
and an amino sugar. 
Hyaluronic acid, the only 
unsulfated GAG, consists 
of GlcA and GlcNAc. 
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It is important to note that with the exception of the amino sugars found in GAGs, 
all the components of the above polyuronides are stereoisomers of one another (Figure 
1.7). For example, GlcA is the C2 epimer of ManA, which is the C5 epimer of GulA. These 
subtle variations in the monomers lead to significant differences in the three dimensional 
shape and properties of the resulting polymers (39). For instance, despite their being only 
C2 epimers of one another, poly-GlcA preferentially forms a 21 helix whereas poly-ManA 
forms a 32 helix (39,51). The implication of these differences and how they relate to 
structure of the enzymes which cleave these polymers is discussed further in Chapter 3. 
 
Figure 1.7: Stereochemistry of the uronic acid monomers found in nature. 
 
Polysaccharide lyases (PLs) are a broad family of polysaccharide-degrading 
enzymes which act on polyuronides, cleaving the glycosidic (1→4) O-linkages between 
sugar groups (25). Enzymatic activity is extremely dependent on the composition and 
stereochemistry of the polysaccharide substrate (2). Much of the research into utilizing 
14 
 
these enzymes as adjuvants for antibiotic treatment has been centered on alginate lyases, a 
subfamily of polysaccharide lyases which preferentially degrade either the ManA-ManA, 
GulA-GulA, ManA-GulA, or GulA-ManA bonds of alginate (25). AlgL, a periplasmic 
alginate lyase found in P. aeruginosa and responsible for regulating alginate chain length 
and concentration in the periplasm during EPS secretion, has been demonstrated to enhance 
antimicrobial killing efficiency when added to mucoid P. aeruginosa cultures in vitro and 
therefore has drawn much interest as a potential therapeutic (28). In contrast, little is known 
regarding the presence and activity of alginate lyases in clinical isolates of S. maltophilia. 
Unlike P. aeruginosa, there is no evidence to indicate that S. maltophilia produces alginate 
as part of its EPS and therefore would seemingly have no need to for an alginate lyase for 
EPS modification. However, the recently sequenced genome of S. maltophilia clinical 
isolate K279a (14) contains three predicted alginate lyases (Smlt1473, Smlt2601, 
Smlt2602), one of which (Smlt1473) shares greater than 90% sequence identity with 
putative alginate lyases found in the annotated genomes of a restricted subset of S. 
maltophilia clinical isolates (K279a, Ab55555, D457), yet is absent from environmental 
strains such as R551-3, implying a possible pathogenic role for the enzyme. Interestingly, 
Smlt1473 also shares greater than 60% sequence identity with predicted alginate lyases 
from two other opportunistic pathogens (Achromobacter insuavis AXX-A, Bordetella 
avium 197N) associated with upper respiratory disease (52).  
In order to gain a better understanding of the biological role and enzymatic 
properties of this putative alginate lyase specific to clinical strains of S. maltophilia and 
other related opportunistic pathogens, and potentially apply that knowledge to the 
development of therapeutics designed to combat biofilm-associated infections, we 
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underwent the molecular cloning, expression, purification and characterization of 
Smlt1473 (Chapters 2-3) (51,52). This study revealed that Smlt1473 exhibited a unique 
pH-sensitive substrate specificity, acting endolytically on alginate, poly-GlcA, and HA 
(Chapter 2) (52). We found that the substrate specificity of Smlt1473 could be significantly 
modified through the mutation of residues located in the active site cleft but not directly 
involved in the catalytic process. These residues were selected based on sequence 
alignment and homology modeling (Chapter 3) (51). The ability to engineer highly active 
and selective enzymes would be advantageous for the use of enzymes as adjuvants to 
antibiotics in the treatment of biofilm-associated infectious due to the diversity of EPS 
composition (27). Furthermore, given the wide-ranging bioactivity of carbohydrates, these 
enzymes could be utilized in the analysis and generation of highly specific glycans for 
therapeutic applications (30-33). These tailor-made lyases could also be applied in the 
saccharification of the abundant polyuronides found in macroalgae for the production of 
environmentally friendly biofuel (53). To this end, we characterized Smlt2602, the putative 
exolytic alginate lyase from S. maltophilia K279a and undertook a similar approach to that 
of Smlt1473 to create mutant lyases with novel substrate specificity. This study yielded the 
first characterized bacterial lyase to demonstrate exolytic activity towards both alginate-
based substrates and poly-GlcA (Chapter 4).  
Although the clinical important of S. maltophilia is clear, relatively few specific 
virulence factors have been identified (11-14). In an effort to better understand the 
mechanism by which S. maltophilia infects its host, we identified and characterized a 
putative ankyrin-repeat containing protein (Smlt3054) that was found to be secreted by S. 
maltophilia clinical isolates, bind F-actin in vitro, and disrupt actin cytoskeletal structure 
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in transfected mammalian cells (Chapter 5). Finally, the potential future of this research 
and related projects are discussed (Chapter 6).  
 
1.1 ABBREVIATIONS 
The abbreviations used in this chapter are as follows: MDR, multidrug resistant; CF, 
cystic fibrosis; LO-VAP, late-onset ventilator-associated pneumonia; EPS, extracellular 
polymeric substance; CFTR, cystic fibrosis transmembrane conductance regulator; GlcA, 
D-glucuronic acid; GAG, glycosaminoglycans; GalA, D-galacturonic acid; ManA, D-
mannuronic acid; GulA, L-guluronic acid; HA, hyaluronic acid; IdoA, iduronic acid; 
GlcNAc, N-acetyl-D-glucosamine; GalNAc, N-acetyl-D-galactosamine; ECM, 
extracellular matrix; PL, polysaccharide lyase. 
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CHAPTER 2 
A POLYSACCHARIDE LYASE FROM STENOTROPHOMONAS MALTOPHILIA 
WITH UNIQUE, PH-REGULATED SUBSTRATE SPECIFICITY 
 
The work described in this chapter has been published in “A 
Polysaccharide Lyase from Stenotrophomonas maltophilia 
with a Unique, pH-regulated Substrate Specificity” by 
Logan C. MacDonald and Bryan W. Berger, The Journal of 
Biological Chemistry (2014) 289 (1), 312-325. 
 
 
Polysaccharide lyases (PLs) catalyze the depolymerization of anionic 
polysaccharides via a β-elimination mechanism. PLs also play important roles in microbial 
pathogenesis, participating in bacterial invasion and toxin spread into the host tissue via 
degradation of the host extracellular matrix, or in microbial biofilm formation often 
associated with enhanced drug resistance. Stenotrophomonas maltophilia is a Gram-
negative bacterium that is among the emerging multidrug-resistant organisms associated 
with chronic lung infections as well as with cystic fibrosis patients. A putative alginate 
lyase (Smlt1473) from S. maltophilia was heterologously expressed in Escherichia coli, 
purified in a one-step fashion via affinity chromatography, and activity as well as 
specificity determined for a range of polysaccharides. Interestingly, Smlt1473 catalyzed 
the degradation of not only alginate, but poly-β-D-glucuronic acid and hyaluronic acid as 
well. Furthermore, the pH optimum for enzymatic activity is substrate-dependent, with 
optimal hyaluronic acid degradation at pH 5, poly-β-D-glucuronic acid degradation at pH 
7, and alginate degradation at pH 9. Analysis of the degradation products revealed that 
each substrate was cleaved endolytically into oligomers comprised predominantly of even 
numbers of sugar groups, with lower accumulation of trimers and pentamers. Collectively, 
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these results imply that Smlt1473 is a multifunctional PL that exhibits broad substrate 
specificity, but utilizes pH as a mechanism to achieve selectivity. 
 
2.1 INTRODUCTION 
Polysaccharides play critical structural and signaling roles in a diverse range of 
biological structures including plant and mammalian extracellular matrix as well as 
microbial biofilm. Many biologically important polysaccharides contain uronic acids, 
including hyaluronic acid (HA), a linear polysaccharide comprised of repeating 
disaccharide units of D-glucuronic acid (GlcA) and N-acetyl-D-glucosamine (GlcNAc) (1). 
HA is a major component of the extracellular matrix in eukaryotes and plays numerous 
roles in cell motility, inflammation, and angiogenesis (2, 3). Other polyuronides are major 
components of plant and algal cell walls, such as alginate in brown algae (4) and poly-β-
GlcA in green algae (5). Alginate is a linear copolymer comprised of D-mannuronic acid 
(ManA) and L-guluronic acid (GulA) arranged in repeating poly-β-ManA blocks, poly-α-
GulA blocks, or alternating poly-MG blocks (6). Bacteria such as Pseudomonas 
aeruginosa also synthesize and secrete alginate as a major component of microbial 
biofilms. In the case of pathogens such as P. aeruginosa, biofilm formation is often 
correlated with enhanced adhesion to mammalian cells or inert surfaces as well as increased 
resistance to antimicrobials (7). Thus, polysaccharides play several key roles in the 
organization and function of multicellular mammalian and microbial structures. 
Polysaccharide lyases (PLs) are a class of enzymes that degrade polyuronides via a 
β-elimination mechanism, resulting in the formation of unsaturated products containing 4-
deoxy-L-erythro-hex-4-enopyranosyluronic acid at the non-reducing end. The β-
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elimination mechanism proceeds in three major steps (Figure 2.1): (i) neutralization of the 
negative charge of the C6 carboxylate group of the +1 sugar ring, reducing the pKa of the 
C5 proton and thereby assisting in its abstraction, (ii) formation of enolate anion 
intermediate by removal of C5 proton by a Brønsted base, and (iii) concomitant formation 
of a double bond between C4 and C5 and cleavage of the C4-O-C1 glycosidic bond via 
electron transfer (8). Although several crystallographic and biochemical studies have 
confirmed the 3-step β-elimination mechanism, identifying which catalytic residues are 
responsible for each step is still an area of active research (9–12). In particular, whereas a 
conserved tyrosine and histidine present in numerous classes of PL are both known to play 
an important role in the catalytic mechanism, it is unclear whether the histidine acts as the 
proton donor and tyrosine as the proton acceptor, a mechanism proposed for the HA lyase 
of Streptococcus sp. (11, 12) or if tyrosine acts as proton donor and acceptor and histidine 
stabilizes an intermediate product, a mechanism proposed for A1-III alginate lyase of 
Sphingomonas sp. (9). Thus, defining the exact proton donor-acceptor pair for catalysis in 
PLs remains an area of active research. 
 
Figure 2.1: Schematic of β-elimination reaction mechanism. 
 
Biologically, microbial PLs play diverse roles in biofilm formation as well as in 
host-pathogen interactions. In particular, HA lyases secreted by Group A Streptococcus are 
thought to act as spreading factors, enabling bacteria and toxins to disseminate throughout 
the host by degrading the high molecular weight HA present in the extracellular matrix 
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(13). In Mycobacterium tuberculosis, secreted HA lyases generate low molecular weight 
sugars from HA that serve as carbon source for bacteria to replicate in deep tissue infections 
(14). In the case of P. aeruginosa biofilm formation, the periplasmic alginate lyase AlgL 
regulates the chain length and concentration of alginate in the periplasm during secretion 
(15). Loss of AlgL results in cell lysis for mucoid strains of P. aeruginosa due to alginate 
accumulation in the periplasm (16), and AlgL overexpression leads to truncation of alginate 
to short-chain polysaccharides unable to form extended extracellular aggregates. Addition 
of AlgL to mucoid P. aeruginosa in vitro has been demonstrated to enhance antimicrobial 
killing efficiency, and has attracted interest as a possible adjuvant for inhaled antimicrobial 
therapies (17). Thus, understanding the underlying structural basis for polysaccharide 
turnover by PLs is important not only in terms of resolving the basis of substrate specificity, 
but also in targeting microbial PLs that may contribute to pathogenicity. 
 To understand the role that PLs may play in microbial biofilm formation as well as 
virulence, we characterized a predicted alginate lyase (Smlt1473) from Stenotrophomonas 
maltophilia strain k279a. S. maltophilia is an emerging, multidrug-resistant organism often 
associated with chronic lung infections, especially in cystic fibrosis patients. Of particular 
note, the prevalence of biofilm-producing S. maltophilia strains isolated from the lungs of 
cystic fibrosis patients and from contaminated medical equipment has implicated biofilm 
formation as a mechanism contributing to S. maltophilia infection and multidrug resistance 
(18). We find that Smlt1473 is secreted when overexpressed in Escherichia coli, and 
secretion depends on a predicted lipoprotein secretion signal sequence. Strikingly, 
Smlt1473 is not only active against alginate, but also demonstrates significant activity 
toward poly-GlcA and HA in a pH-regulated manner; optimal enzymatic activity toward 
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HA is observed at pH 5, poly-GlcA at pH 7, and alginate at pH 9. The oligosaccharide 
products formed by Smlt1473 cleavage are comprised mainly of disaccharides, with odd 
numbered products such as trimers and pentamers produced in lower abundance. 
Collectively our results indicate Smlt1473 is a novel PL with broad, but pH-regulated, 
substrate specificity, which has implications for both biofilm formation and bacterial 
pathogenesis. 
 
2.2 MATERIALS AND METHODS 
2.2.1 Subcloning, Expression, and Purification 
Unless otherwise stated, standard molecular biology techniques were used for 
subcloning and site-directed mutagenesis (19). An E. coli codon-optimized nucleotide 
sequence of smlt1473 (corresponding to GenBankTM protein accession number 
CAQ45011) was subcloned into pET28a(+) (Invitrogen) as a BamHI-XhoI insert. 
Mutagenic primers were designed via PrimerX (bioinformatics.org/primerX) and point 
mutations were generated via the QuikChange II Site-directed Mutagenesis kit (Agilent 
Technologies). Nucleotide sequences containing point mutations were confirmed by DNA 
sequencing (GeneWiz). 
For expression, constructs were electroporated into E. coli BL21(DE3) cells and 
plated on LB agar plates containing 50 μg/ml of kanamycin. An individual colony was 
cultured in 5 ml of LB medium supplemented with 50 μg/ml of kanamycin for 16 h at 37°C, 
200 rpm. Then 2 ml of saturated culture was added to 200 ml of LB and incubated for 16 
h at 18°C, 200 rpm. The culture was then diluted to an A600 of 0.8 in 800 ml of LB and 
grown for 1 h at 18°C, 200 rpm. After 1 h, protein expression was induced by the addition 
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of 1 mM isopropyl 1-thio-β-D-galactopyranoside and the culture was incubated at 18°C, 
200 rpm, for another 16–20 h. 
For purification, cells were harvested at 8,000 × g for 15 min at 4°C, washed once 
in 20 ml of ice-cold PBS, resuspended in 15 ml of lysis buffer (100mM HEPES, 500mM 
NaCl, 10% w/v glycerol, 10mM imidazole), and sonicated at 15 watts, 50% duty, for 15 
min total processing time. The soluble cell lysate was clarified by centrifugation at 17,000 
× g for 20 min at 4°C and His6-tagged Smlt1473 was purified from the sample by 
immobilized metal ion affinity chromatography (IMAC). Cell lysate was passed over a 
column containing 15 ml of Ni2+-bound Chelating Sepharose Fast Flow resin (GE 
Healthcare) preequilibrated in IMAC Buffer A (20 mM HEPES, 500 mM NaCl, 10% (w/v) 
glycerol, 10 mM imidazole) at a flow rate of 1.8 ml/min via a BioLogic LP chromatography 
system (Bio-Rad) with a fraction collector. The column was washed for 70 min with IMAC 
Buffer A to remove any unbound proteins, before applying a gradient from 0 to 100% 
IMAC Buffer B (20 mM HEPES, 500 mM NaCl, 10% (w/v) glycerol, 500 mM imidazole) 
over the course of 200 min. Fractions were assayed for protein content via Bradford reagent 
(Bio-Rad) and samples containing purified Smlt1473 were pooled together and dialyzed 
against 4 liters of 20 mM sodium phosphate buffer (pH 8) for 40 h at 4°C with one buffer 
exchange. To confirm that recombinant Smlt1473 was responsible for the observed lyase 
activity and not a protein contaminant present in E. coli lysate, a control IMAC purification 
was run using BL21 cells transformed with the empty parent vector, pET28a(+). The lyase 
activity of fractions collected at low (~10 mM), medium (~85 mM), and high (~200mM) 
imidazole concentrations was tested by adding 2 μl of each fraction to 18 μl of 1 mg/ml of 
HA, poly-GlcA, or poly-ManA buffered at pH 5, 7, or 9, respectively. Reactions were 
30 
 
incubated for 10 min are room temperature before measuring the concentration of 4-deoxy-
L-erythro-hex-4-enopyranosyluronic acid via the thiobarbituric acid (TBA) method as 
described previously (20). 
Purity of Smlt1473 was also evaluated by SDS-PAGE, immunoblotting, size 
exclusion chromatography, and MALDI-TOF. For size exclusion chromatography, 500 μl 
of protein sample at 1 mg/ml was loaded onto a C 10/40 column (GE Healthcare) 
containing Bio-Gel P-100 (Bio-Rad) via a BioLogic LP chromatography system (Bio-Rad) 
in a mobile phase of 20 mM sodium phosphate (pH 7) and flowrate of 0.5 ml/min. Protein 
was detected by monitoring absorbance at 280 nm. For MALDI-TOF, 1 μl of protein 
sample was mixed with 1 μl of sinapinic acid matrix, spotted onto a MSP 96 target ground 
steel plate (Bruker), and allowed to air dry. Samples were then analyzed via a Microflex 
mass spectrometer (Bruker Daltonics). 
 
2.2.2 Preparation of Whole Cell Lysate and Subcellular Fractions 
Two 1-ml samples of cultures induced for 12 h were harvested by centrifugation at 
8,000 × g for 10 min at 4°C. One pellet was resuspended in 200 μl of 4 M urea and 
designated the whole cell lysate sample. The second pellet was resuspended in 200 μl of 
ice-cold sucrose buffer (20mM HEPES, 1mM EDTA, 20% (w/v) sucrose), incubated on 
ice for 15 min, centrifuged, resuspended in 200 μl of ice-cold 5 mM MgSO4, and incubated 
on ice for 15 min. The resulting supernatant containing the periplasmic proteins was 
collected by centrifugation at 17,000 × g for 10 min at 4 °C. 
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2.2.3 SDS-PAGE and Immunoblotting 
Protein samples (40 μl) were mixed with 10 μl of 5 × Lammeli sample buffer and 
heated for 5 min at 90°C before loading 25 μl onto a 4% stacking, 12% separating 
acrylamide gel with MES running buffer. Precision Plus Protein All Blue Standard (Bio-
Rad) was used as a molecular weight standard. Samples were run at 100 V and transferred 
to a nitrocellulose membrane (Amersham Biosciences Hybond ECL) for 90 min at 17 V at 
4°C. Transfer was confirmed by staining the membrane with 0.1% Ponceau S. The 
membrane was then blocked overnight at 4°C with 5% fat-free milk in TBST, washed once 
with TBST, incubated for 1 h at room temperature with mouse monoclonal anti-His6 tag 
primary antibody (Cell Signaling) diluted 3000-fold in 5% fat-free milk, washed five times 
with TBST, incubated for 1 h at room temperature with horseradish peroxidase-conjugated 
antimouse IgG secondary antibody (Cell Signaling) diluted 3000-fold in 5% fat-free milk, 
washed five times with TBST, and then twice with TBS. The membrane was developed 
with ECL plus Western blotting detection reagents (RPN2132, GE Healthcare), a 
chemiluminescent horseradish peroxidase substrate. 
 
2.2.4 Genetic screening for smlt1473 in S. maltophilia clinical isolates 
 Gene specific oligonucleotide primers were designed based on the nucleotide 
sequence of smlt1473 (NCBI GeneID 6395630). Genomic DNA was prepared from E. 
coli BL21(DE3), S. maltophilia environment isolate R551-3, S. maltophilia clinical 
isolate K279a, and 26 S. maltophilia clinical isolates collected from patients as part of an 
IRB-approved study with the Lehigh Valley Heath Network in Allentown, Pennsylvania. 
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The genomic DNA was used as a PCR template to screen for the presence of smlt1473 in 
each of these bacterial strains. 
 
2.2.5 Plate Assay to Detect Extracellular Lyase Activity 
S. maltophilia or induced E. coli cultures (5 μl) were spotted onto LB plates 
solidified with 1% agarose and supplemented with 50 μg/ml of kanamycin and 1 mg/ml of 
poly-ManA or poly-GlcA. Plates were incubated at room temperature for 12 h, gently 
flooded with 10% cetyl pyridinium chloride, and incubated at room temperature for 30 
min. A clearing zone surrounding the area treated with culture was indicative of 
extracellular lyase activity (21). 
 
2.2.6 Polysaccharide Sample Preparation 
Sodium alginate, medium viscosity, was obtained from MP Biomedicals. 
Hyaluronic acid potassium salt from human umbilical cord was a kind gift of Dr. 
Ellen Pure (The Wistar Institute). Poly-GlcA was prepared from Avicel PH-105 NF (FMC 
Biopolymer) by first converting the microcrystalline cellulose to regenerated amorphous 
cellulose by dissolution in 86.2% H3PO4 (22) and then converting the regenerated 
amorphous cellulose to poly-GlcA via 2,2,6,6-tetramethylpipelidine-1-oxyl radical-NaBr-
NaClO-mediated oxidation (23). Poly-GlcA samples were precipitated with ethanol, dried, 
resuspended in ddH2O, and dialyzed against 4 liters of ddH2O for 40 h at 4°C with one 
buffer exchange. Total carbohydrate concentration was measured via the phenol-sulfuric 
acid method (24) and uronic acid concentration was measured via the carbazole method 
(25). The percent oxidation of the poly-GlcA sample was determined by comparing the 
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total sugar concentration of the sample against the uronic acid concentration. D-Glucuronic 
acid (Acros Organics) was used to generate standard curves for each assay. 100% oxidation 
would correspond to an equal concentration of carbohydrates and uronic acids (i.e. all 
carbohydrate in the sample is oxidized to uronic acid). The poly-GlcA sample prepared 
from Avicel PH-150 NF was found to be 99.48 ± 4.64% oxidized (Figure 2.2A, B). The 
composition of the poly-GlcA sample was further confirmed by proton nuclear magnetic 
resonance (1H NMR) spectroscopy (Figure 2.2C). The 1H NMR spectrum matched 
spectrum obtained from other poly-GlcA samples, with two doublets at 4.42 and 3.75 ppm 
corresponding to H1 and H5 of the glucuronic ring and three triplets at 3.55, 3.50, and 3.25 
ppm corresponding to H4, H3, and H2, respectively (Figure 2.2C) (26). 
Poly-ManA, poly-GulA, and poly-MG block structures were prepared from sodium 
alginate by partial acid hydrolysis as described by previously (6). Each fraction was 
resuspended in ddH2O and dialyzed against 4 liters of ddH2O for 40 h at 4°C with one 
buffer exchange. The MG ratio of each alginate block was determined via 1H NMR 
according to the standard test method ASTM F2259 (27) (Figure 2.3A–C). Figure 2.3D 
depicts the molar fractions of monomers (FG and FM), dimers (FGG, FMM, FGM, and FMG), 
and trimers (FGGG, FMGM, FGGM, and FMGG) of each alginate block structure as well as the 
average degree of polymerization (DPn). Briefly, poly-ManA contained 83% ManA, poly-
GulA contained 7% ManA, and poly-MG contained 54% ManA. Additionally, 71% of the 
dimers in poly-ManA were ManA-ManA, 87% of the dimers in poly-GulA were GulA-
GulA, and 60% of the dimers in poly-MG were ManA-GulA or GulA-ManA (Figure 2.3D). 
 
34 
 
 
Figure 2.2: Chemical composition of poly-GlcA sample prepared from microcrystalline cellulose. (A) 
Uronic acid content and total carbohydrate of various concentrations of D-glucuronic acid were measured 
via the carbazole (25) and phenol-sulfuric acid (24) method, respectively. Standard curves were generated 
for each assay. (B) The percent oxidation of the poly-GlcA sample prepared from microcrystalline cellulose 
was determined by measuring its uronic acid and total carbohydrate content and comparing the two values, 
utilizing the ratio of the slopes of each standard curve determined in panel A (mcarbazole and mphenol) as a 
conversion factor. (C) 1H NMR spectrum of 10 mg/ml poly-GlcA sample in D2O. 
 
All 1H NMR measurements were carried out using a 500 MHz Bruker Avance II 
spectrometer (Bruker). Polysaccharide samples were lyophilized, resuspended in D2O, 
lyophilized again, and resuspended in D2O at a concentration of 10 mg/ml. 20 μl of 0.3 M 
3-(trimethylsilyl)propionate-2,2,3,3-d4 acid in D2O was added to the NMR sample tube as 
an internal standard. Data were collected at 80°C with sample spinning, proton spectral 
width, number of scans, relaxation delay, proton pulse angle, and acquisition time at 20 
Hz, -0.5→9.5 ppm, 64, 2 s, 90°, and 4.096 s, respectively. 
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Figure 2.3: Composition of alginate blocks. 1H NMR spectrum of poly-ManA (A), poly-GulA (B), and poly-
MG (C) at 10 mg/ml in D2O. Signals relevant to the determination of chemical structure are indicated with 
an arrow and labeled with the type of residue generating the signal. For dimer or trimer sequences the 
underlined residue contains the hydrogen responsible for the signal. Red-a and red-b correspond to α and β 
reducing ends, respectively, and were used to determine the average degree of polymerization. (D) The molar 
fractions of monomers (FG and FM), dimers (FGG, FMM, FMG, and FGM), and trimers (FGGG, FMGM, FGGM, and 
FMMG) in each substrate were calculated according to the standard test method ASTM F2259 (27). DPn 
indicates average degree of polymerization. 
 
2.2.7 Enzyme Activity Assays 
The β-elimination mechanism of PLs results in the formation of a double bond 
whose accumulation was monitored by measuring the change in absorbance at 235 nm 
(28). Absorbance measurements were made in 1-s intervals using an Ultrospec 3300 pro 
UV-visible spectrophotometer with a detection limit of 0.001 absorbance units at 235 
nm/min. One unit of enzyme activity was defined as an increase in absorbance at 235 nm 
of 1.0/min at 25 °C (1 unit = 1 ΔA235 nm min-1) (29–31). Purified Smlt1473 (17.5 μg) was 
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added to a final volume of 350 μl for reactions containing alginate, poly-ManA, poly-GulA, 
poly-MG, or HA. Due to the higher activity against poly-GlcA versus all other substrates, 
1.75 μg of protein was added to reactions containing poly-GlcA. The pH of all reactions 
was maintained by using a specific buffer for a given pH (acetate for pH 4–6, phosphate 
for pH 6–8, Tris for pH 6.5–9, and glycine for pH 9–10) at a total ionic strength of 30 mM. 
For the determination of optimal pH and buffer conditions, the enzyme was incubated in a 
given buffer without substrate for 10 min before being added to a solution containing a 
final polysaccharide concentration of 1 mg/ml in the same buffer. For the determination of 
Michaelis constant (Km) and maximum velocity (Vmax) for each substrate, the 
polysaccharide concentration (S) was varied from 0.0625 to 2 mg/ml and initial rates (vi) 
were fitted to the Michaelis-Menten equation, v = VmaxS/(Km + S), with a generalized 
reduced gradient (GRG2) nonlinear optimization program (32). For all substrates, R-
squared and correlation values were greater than 0.965 and 0.985, respectively. Lyase 
activity was also confirmed via the TBA method (20). 
HA activity was independently confirmed via a hyaluronan zymography as 
described previously (69). Purified protein samples (12 μg) were separated by native PAGE 
(20 mA, 4°C) on a 6% stacking/8% separating gel containing 0.25 mg/ml HA. Gel was 
incubated overnight in 20 mM Tris (pH 8), treated with 0.01 mg/ml pronase in 20 mM Tris 
(pH 8) for 4 hours, rinsed twice with ddH2O, and stained sequentially with 0.5% Alcian 
blue and 0.1% Coomassie blue R, each in 30% methonal:10% acetic acid. Gels were 
destained in 30% methanol:10% acetic acid until clearing bands of digested HA were 
visible (69). HA activity was further confirmed via PAGE as described previously (70). 
Briefly, purified Smlt1473 (4 μg/ml) was mixed with HA (3 mg/ml) in 30 mM sodium 
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acetate buffer (pH 5) in a total volume of 10 ml. Samples were taken at 0, 5, 10, 15, and 20 
min and boiled for 10 minutes to stop the enzymatic reaction. Boiled samples (60 μl) were 
mixed with 10 μl of 2 M sucrose in TBE and 1 μl of 1% bromophenol blue before loading 
30 μl onto a polyacrylamide gel containing 15% acrylamide, 0.5% N,N’-methylene 
bisacrylamide in TBE and run at 125 V, 4°C until dye front reached halfway down the gel. 
Gel was stained with 0.5% Alcian blue dissolved in 2% acetic acid for 2 hours and 
destained with 2% acetic acid until digested HA bands were visible (70). 
 
2.2.8 Circular Dichroism (CD) 
Proteins samples (300 μl) at 300 μg/ml in 20 mM sodium phosphate buffer (pH 8) 
were added to a 1-mm path length quartz cuvette (Starna) and ellipticity was measured 
from 190 to 260 nm in a J-815 circular dichroism spectrometer (JASCO). The scan speed 
was 200 nm/min with three accumulations per sample. 
 
2.2.9 Electrospray Ionization Mass Spectrometry (ESI-MS) of Oligosaccharide Products 
 Reaction mixtures containing 5 mg of digested oligosaccharides were desalted by 
size exclusion chromatography via a Bio-Gel P-2 column (1.5 cm by 45 cm) equilibrated 
with ddH2O (Bio-Rad). The flow rate was set to 0.1 ml/min and fractions containing uronic 
acids were pooled together, lyophilized, and resuspended in 1 ml of 1:1 (v/v) 
methanol:water. Oligosaccharide samples were delivered to a Thermo LTQ mass 
spectrometer with HESI-II probe (Thermo) by a syringe pump at a flow rate of 5 μl/min. 
MS was run in negative mode with a mass scan range of 150 to 2000 Da, capillary 
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temperature of 250°C, electrospray needle voltage of 3.5 kV, and nitrogen sheath gas at 8 
p.s.i. 
 
2.2.10 High-performance Liquid Chromatography (HPLC) of Oligosaccharide Products 
HPLC experiments were run on an Agilent 1100 series HPLC value system 
equipped with a 96-well autosampler and UV-visible detector. Smlt1473 at a final 
concentration of 50 μg/ml (5 μg/ml for poly-GlcA samples) was added to poly-ManA (3 
mg/ml, 30 mM Tris, pH 9), poly-GlcA (3 mg/ml, 30 mM Tris, pH 7), or HA (1 mg/ml, 30 
mM acetate, pH 5) at the final concentrations and buffers indicated in parentheses. The 
reaction mixture (15 μl) was injected after 24 h onto a TSKgel SuperOligoPW column 
(Tosoh) equipped with corresponding guard column. The mobile phase was 20 mM sodium 
phosphate buffer (pH 8) plus 250 mM NaCl and the flow rate was 0.275 ml/min. 
Unsaturated uronic acid products were detected by absorbance at 235 nm. A series of 
polyethylene glycol standards (molecular weight 200, 600, 1000, 1500, and 2000; Alfa 
Aesar) were used to generate a calibration curve. 
 
2.2.11 Sequence Alignment 
According to the Carbohydrate Active Enzymes (CAZy) database (33), Smlt1473 
belongs to polysaccharide lyase family 5 (PL-5). The amino acid sequences of PL-5 lyases 
from Achromobacter insuavis (formerly A. xylosoxidans) (Swiss-Prot F7SXN4), 
Bordetella avium (34), Cobetia marina (Swiss-Prot Q9ZNB7), P. aeruginosa (35), and 
Spingomonas sp. A1 (PDB 1QAZ) (36) were aligned with Smlt1473 using COBALT (37). 
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2.2.12 Homology Modeling 
 The alginate lyase A1-III (Protein Data Bank 1QAZ) from Sphingomonas sp. A1 
was chosen as a template for homology modeling based on having the highest sequence 
identity (30%) among polysaccharide lyases with solved crystal structures (36). Despite 
the low sequence identity between the two PLs (30%), which can limit the accuracy of 
homology models, comparative analysis of high-resolution PL crystal structures revealed 
similar folds in many cases despite having low overall sequence identity. Other groups 
have also noted alginate lyases share overall low sequence identity, even within specific 
structural subfamilies, but have been able to use highly conserved regions important for 
enzymatic activity to generate accurate homology models consistent with biochemical 
characterization. We used SWISS-MODEL to build a model for Smlt1473 based on Protein 
Data Bank code 1QAZ (38–40). All images based on the resultant model were generated 
using PyMOL (41). 
 
2.3 RESULTS 
2.3.1 Heterologous Expression and One-step Purification of Smlt1473 via IMAC 
An E. coli codon-optimized nucleotide sequence of smlt1473 was subcloned into 
pET28a(+) as a BamHI-XhoI insert without a stop codon, resulting in the recombinant 
lyase containing a C-terminal His6 tag. Expression was carried out at 18°C, 200 rpm, and 
soluble cell lysate was prepared via sonication. Smlt1473 was purified by passing the cell 
lysate over a Ni2+-bound chelating Sepharose column as described under 2.2.1 Subcloning, 
Expression, and Purification. At least 50 mg of enzyme was purified per liter of the induced 
culture. Purity was analyzed by size exclusion chromatography, resulting in a single peak 
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around 48 min (Figure 2.4A). The molecular mass of Smlt1473 without the signaling 
peptide was determined to be 35586.9 Da by MALDI-TOF, in close agreement with the 
predicted molecular mass of 35550.9 Da (Figure 2.4B).  
 
Figure 2.4: Purity of recombinant Smlt1473. (A) Low pressure size exclusion chromatography of purified 
recombinant Smlt1473. (B) Mass spectroscopy of purified Smlt1473. Molecular weight of purified Smlt1473 
without signaling peptide determined by MALDI-TOF mass spectroscopy. 
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A control purification experiment was performed with lysate prepared from BL21 
cells containing the pET28a vector alone. Figure 2.5A depicts a chromatogram of each 
purification experiment. Cell lysate was added at t = 0 min and the column was washed 
with buffer containing 10mM imidazole to remove unbound proteins. At t = 70 min an 
imidazole gradient was initiated, which increased the imidazole concentration by 2.5 mM 
per minute. At t = 100 min (~85 mM imidazole) nonspecifically bound proteins eluted from 
the column. At t = 145 min (~200 mM imidazole) recombinant Smlt1473 eluted from the 
column. Fractions collected at low (10 mM), mid (85 mM), and high (200 mM) imidazole 
concentrations were analyzed for lyase activity by mixing 2 μl of each fraction with 18 μl 
of 1 mg/ml of HA, poly-GlcA, or poly-ManA in 30 mM buffer at pH 5, 7, or 9, respectively. 
After 10 min the samples were analyzed for lyase activity by the TBA method (20) (Figure 
2.5B). Additionally each fraction was analyzed via SDS-PAGE (Figure 2.5C) and 
immunoblotting (Figure 2.5D). The high imidazole pET28a-smlt1473 fraction exhibited 
lyase activity against HA, poly-GlcA, and poly-ManA (Figure 2.5B) and contained a single 
protein with a molecular mass of ~35.5 kDa (Figure 2.5C), which appeared on an anti-His6 
tag immunoblot (Figure 2.5D). Conversely, the high imidazole pET28a fraction exhibited 
no lyase activity (Figure 2.5B), contained no proteins visible by SDS-PAGE (Figure 2.5C) 
nor anti-His6 tag immunoblot (Figure 2.5D). Therefore, recombinant Smlt1473 was 
purified in a one-step fashion via IMAC and was responsible for the lyase activity against 
each polysaccharide substrate. 
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Figure 2.5: Heterologous expression and one-step purification of Smlt1473 by immobilized metal ion 
affinity chromatography. (A) Chromatogram of IMAC purification. Cell lysates prepared from E. coli BL21 
cells transformed with pET28a-smlt1473 or pET28a vector and induced with 1 mM isopropyl 1-thio-β-D-
galactopyranoside at 18°C, 200 rpm, were added to Ni2+-bound chelating Sepharose column at t = 0 min and 
a flow rate of 1.8 ml/min. At t = 70 min a linear imidazole gradient was applied, increasing the imidazole 
concentration 2.5 mM per min. Low (~10mM), mid (~85mM), and high (~200mM) imidazole fractions were 
collected for both pET28a-smlt1473 and pET28a samples. (B) Fractions were analyzed for lyase activity by 
mixing 2 μl of sample with 18 μl of 1 mg/ml of HA, poly-GlcA, or poly-ManA in 30mM buffer at pH5, 7, or 
9, respectively. Oligosaccharide products formed via lyase enzymatic activity were detected by the TBA 
method (20). All reactions were performed in triplicate and error is reported as standard deviation. (C) SDS-
PAGE analysis of each fraction. WC corresponds to whole cell lysate prior to IMAC purification. (D) Anti-
His6 tag immunoblot of each fraction. 
 
2.3.2 Heterologous Secretion of Smlt1473 is Dependent on Predicted Lipoprotein Signal 
The primary sequence for Smlt1473 is predicted to contain a N-terminal signal 
peptide (SignalP) that includes an Ala-Ala-Cys motif at positions 21–23, which is 
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consistent with a consensus sequence for bacterial lipoprotein secretion (42). Secretion of 
lipoproteins requires the addition of a N-acyl-S-diacylglyceryl moiety to the cysteine 
residue in the +1 position (boxed in Figure 2.6A) (43). To determine whether Smlt1473 is 
a secreted lipoprotein when expressed heterologously in E. coli, we compared the 
subcellular distribution and lyase activity from BL21(DE3) cells expressing wild-type 
(WT) Smlt1473 and a mutant (C23F) where the predicted lipid-modified cysteine had been 
replaced with phenylalanine. Cultures expressing both WT and C23F were separated into 
whole cell lysate and periplasmic fractions, and immunoblotting revealed that although 
WT could traffic to the periplasmic space, C23F was completely retained in the cytosol 
(Figure 2.6B). Comparing purified Smlt1473 from the periplasmic fractions and whole cell 
lysates, both proteins migrate at their predicted molecular masses (35.5 kDa without 
signaling peptide, 41.2 kDa with signaling peptide, Figure 2.6B); this indicates that 
recognition and processing of Smlt1473 is dependent on the predicted lipoprotein secretion 
signal. Additionally, cell suspensions expressing WT and C23F were spotted onto LB-
agarose plates containing 1 mg/ml of poly-GlcA or poly-ManA and extracellular lyase 
activity was visualized by staining with 10% cetylpyridinium chloride. As indicated in 
Figure 2.6C, a clearing zone is present surrounding BL21(DE3) cells expressing WT, but 
not for C23F. Additionally, the C23F mutant was purified via IMAC and its activity was 
compared with WT Smlt1473. The C23F mutant retained between 40 and 50% of WT 
activity (Figure 2.6D), suggesting that signaling and secretion may play a role in activating 
Smlt1473. Thus, Smlt1473 is a secreted lipoprotein with extracellular activity when 
overexpressed in E. coli, and proper processing and secretion is dependent upon a predicted 
N-terminal lipoprotein secretion signal. 
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Figure 2.6: Trafficking of WT Smlt1473 and a C23F mutant. (A) Sequence of N-terminal signaling peptide 
of Smlt1473 highlighted in gray and the lipid modified cysteine 23 residue boxed. A C23F mutant was 
prepared via site-directed mutagenesis. (B) Anti-His6 tag immunoblot of E. coli BL21 cultures expressing 
Smlt1473 WT and C23F mutant separated into whole cell lysate and periplasmic fractions. (C) E. coli BL21 
cultures expressing Smlt1473 WT and C23F mutant dotted onto LB plates solidified with 1% agarose, and 
supplemented with 50 μg/ml of kanamycin and 1 mg/ml of poly-GlcA (top) or poly-ManA (bottom). After a 
12-h incubation at 25°C, the plates were treated with 10% cetylpyridinium chloride. Clearing zone indicates 
degradation of polysaccharide in surrounding media. (D) Activity of purified Smlt1473 WT and C23F. 
Enzyme activity was monitored by absorbance at 235 nm. All reactions were performed in triplicate and error 
is reported as standard deviation. 
 
2.3.3 Extracellular Lyase Activity Does Not Correlate with Genetic Prevalence of 
Smlt1473 in S. maltophilia Isolates 
 In the interest of determining if clinical and environmental isolates of S. maltophilia 
exhibited endogenous extracellular lyase activity and whether activity is correlated with 
the presence of the smlt1473 gene, various bacterial cultures were dotted onto a LB plate 
solidified with 1% agarose and supplemented with 1 mg/ml poly-ManA, and extracellular 
lyase activity was visualized by staining with 10% cetylpyridinium chloride (Figure 2.7 
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top). Furthermore, genomic DNA was extracted from each S. maltophilia clinical isolate 
and screened for the presence of the Smlt1473 gene product (Figure 2.7 bottom). As 
expected E. coli, E. coli transformed with pET28a, and E. coli transformed with pET28a-
smlt1473 C23F displayed no clearing zone, thus indicating no extracellular lyase activity. 
Conversely, E. coli transformed with pET28a-smlt1473 displayed significant extracellular 
lyase activity, as well as numerous S. maltophilia clinical isolates (Figure 2.7 top). Genetic 
screening of each S. maltophilia isolate revealed that 21 out of 26 strains contained 
smlt1473. Interestingly, strains which exhibited extracellular lyase activity did not correlate 
with strains that contained smlt1473. Likewise, strains that did not exhibit extracellular 
lyase activity did not correlate with strains that did not contain smlt1473 (Figure 2.7).  
Furthermore, both the S. maltophilia clinical isolate K279a, which contains smlt1473, and 
environmental isolate R551-3, which is known to not contain smlt1473, exhibited 
significant extracellular lyase activity (71) (Figure 2.7). Collectively, these results indicate 
smlt1473 is not ubiquitous in clinically relevant S. maltophilia isolates and extracellular 
lyase activity in these isolates is not solely due to Smlt1473. Genome analysis reveals that 
S. maltophilia K279a contains two other putative alginate lyases: (1) smlt2601 (NCBI 
GeneID 6393764), a PL-6 lyase whose homolog from S. maltophilia KJ-2 was recently 
characterized (49) and found preferentially cleave poly-MG blocks; (2) smlt2602 (NCBI 
GeneID 6393623), a PL-17 lyase which is the subject of Chapter 4 of this thesis. Homologs 
of smlt2601 and smlt2602 are found in numerous clinical and environmental S. maltophilia 
isolates. Thus, these two proteins, along with Smlt1473, are likely candidates for the 
extracellular lyase activity observed in Figure 2.7 top. 
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Figure 2.7: Extracellular lyase activity and genetic prevalence of smlt1473 in S. maltophilia isolates. (Top) 
Various bacterial cultures dotted onto LB plates solidified with 1% agarose, and supplemented and 1 mg/ml 
poly-ManA. After a 12-h incubation at 25°C, the plates were treated with 10% cetylpyridinium chloride. 
Clearing zone indicates degradation of polysaccharide in surrounding media. (Bottom) PCR products 
corresponding to smlt1473 from genetic screening of each S. maltophilia clinical isolate. 
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2.3.4 Substrate Specificity Analysis Revealed a pH-sensitive Mechanism 
 The enzymatic activity of purified Smlt1473 was tested against the following nine 
polyuronides: alginate (MP Biomedicals), poly-ManA, poly-GulA, poly-MG, poly-GlcA, 
poly-α-D-galacturonic acid (poly-GalA; Alfa Aesar), HA (MP Biomedicals), heparin 
(Sigma), and heparin sulfate (Sagent Pharmaceuticals). Of these substrates, significant 
activity in terms of increased absorbance at 235 nm was measured for poly-ManA, poly-
GlcA, and HA. This is illustrated in Table 2.1, in which the initial rates for each substrate 
(1 mg/ml) are given at their respective optimal pH values.  
Table 2.1: Substrate specificity of Smlt1473. 17.5 g of Smlt1473 was added to 1 mg/ml of each substrate 
in 30 mM buffer at various pH. Enzymatic activity was monitored by absorbance at 235 nm. One unit of 
activity was defined as an increase in absorbance at 235 nm of 1.0 per minute at 25oC. 
Substrate Source pH 
Specific Activity 
(units/mg) 
Alginate MP Biomedicals 9 20.4  0.7 
poly-ManA Prepared from Alginate 9 68.5  2.9 
poly-GulA Prepared from Alginate 9 2.1  0.2 
poly-MG Prepared from Alginate 9 12.8  0.4 
poly-GlcA Prepared from Avicel PH-105 NF 7 848.3  6.3 
poly-GalA Alfa Aesar 5,7,9 NDa 
Hyaluronan MP Biomedicals 5 42.3  1.3 
Heparin Sigma-Aldrich 5,7,9 ND 
Heparin Sulfate Sagent Pharmaceuticals 5,7,9 ND 
aNo detectable activity (detection limit: 0.001 absorbance units at 235 nm per minute). 
 
Of particular note, specific activities for each of the three most active substrates 
(HA, poly-GlcA, and poly-ManA) were found to be strongly dependent on pH with 
optimal activity for HA at pH 5, poly-GlcA at pH 7, and poly-ManA at pH 9 (Figure 2.8). 
The highest overall specific activity (848.3 ± 6.3 units/mg at pH 7) was for poly-GlcA 
(Figure 2.8A), which is among the highest reported for poly-GlcA specific lyases (30, 44, 
45). For poly-ManA the specific activity (68.5 ± 2.9 units/mg at pH 9) was also 
significant (Figure 2.8B) being within an order of magnitude to the reported values for 
poly-ManA-specific lyases (31, 46, 47). Likewise, whereas the specific activity for HA 
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(42.3 ± 1.3 units/mg at pH 5) was the lowest for the three major substrates (Figure 2.8C), 
it is within an order of magnitude of the reported values for bacterial hyaluronidases (48). 
Optimal pH values for each substrate were independently confirmed by the TBA method 
(Figure 2.8D). 
 
Figure 2.8: Optimal pH of Smlt1473 for poly-GlcA (A), alginate-based substrates (B), and HA (C). Enzyme 
activity was monitored by absorbance at 235 nm (A–C) and TBA method (D). Various buffer systems were 
utilized: acetate (pH 4 to 6), phosphate (pH 6 to 8), Tris (pH 6.5 to 9), and glycine (pH 9 to 10). (B) Various 
alginate block types were tested. Solid line, poly-ManA; dashed line, alginate; dotted line, poly-MG; dash 
dot, poly-GulA. (D) TBA confirmation of optimal pH for HA, poly-GlcA, and poly-ManA. 100% activity 
was taken as the activity at the optimal pH for a given substrate. All reactions were performed in triplicate 
and error is reported as standard deviation. 
 
Kinetic parameters for each of the three substrates were also determined according 
to the Michaelis-Menten equation (Table 2.2), with Vmax values similar in magnitude and 
trend to the specific activities for each of the three main substrates (poly-ManA, poly-GlcA, 
and HA); Vmax for poly-GlcA is ~10-fold greater versus poly-ManA or HA. The Km values 
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for the three substrates also follow a similar trend to Vmax and specific activity, with a 5-
fold larger Km for HA versus poly-GlcA (30, 47). Thus, based on the highest specific 
activity for poly-GlcA (Figure 2.8A), one could tentatively conclude that Smlt1473 is a 
poly-GlcAspecific lyase. However, the multiple pH optima exhibited by Smlt1473 for 
maximal HA, poly-GlcA, and poly-ManA cleavage (Figure 2.8), as well as comparable 
kinetic parameters and specific activities to published values for lyases specific to each of 
these substrates (Table 2.2), indicate that Smlt1473 is a multifunctional PL with potent 
activity against poly-ManA, poly-GlcA, and HA. 
Table 2.2: Kinetic parameters of Smlt1473. 
Substrate Buffer Km (mg ml-1) Vmax (ΔA235nm min-1 mg-1) 
poly-GlcA 30 mM Tris pH 7 0.14 940.0 
poly-ManA 30 mM Tris pH 9 0.26 91.6 
HA 30 mM Acetate pH 5 0.55 71.5 
 
 As stated previously, poly-ManA and poly-GlcA are homopolymers of uronic acids 
(4, 5), however HA is a glycosaminoglycan comprised of repeating disaccharide units of 
GlcA and GlcNAc, thus only half the monomers in HA are uronic acids (1). The β-
elimination mechanism of polysaccharide lyases requires that an uronic acid be positioned 
in the +1 subsite, therefore HA contains half as many cleavable bonds as poly-ManA and 
poly-GlcA (8). Given this uniqueness of HA and the fact that no other PL-5 lyase has been 
shown to cleave this substrate, the HA activity of Smlt1473 was independently confirmed 
via zymography and PAGE, as described previously (69, 70). Purified Smlt1473 WT and 
an HA-inactive mutant (W171A, see Chapter 3) were separated by native PAGE on a 
polyacrylamide gel containing HA. The gel was incubated in a reaction buffer to allow 
time for the enzymes to degrade the HA and then stained with Alcian blue, a dye which 
binds acidic polysaccharides. Degree of binding is dependent on chain length and Alcian 
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blue is incapable of binding HA oligomers comprised of less than 5 disaccharide repeating 
units (70). Thus, any degraded HA in the polyacrylamide gel will not be stained by the 
Alcian blue and will appear as a clearing zone on the zymogram. As seen in Figure 2.9A, 
the lane containing Smlt1473 WT exhibited a clearing zone, indicating the lyase degraded 
the HA in close proximity, whereas the HA-inactive mutant (W171A) displayed no such 
clearing zone.  
 
Figure 2.9: Confirmation of Smlt1473 HA activity. (A) Zymogram of Smlt1473 WT and an HA-inactive 
mutant (W171A) in a polyacrylamide gel containing 0.25 mg/ml HA. The clearing zone seen in the WT lane 
is indicative of Smlt1473 WT HA activity. (B) PAGE analysis of the oligosaccharide products formed by 
Smlt1473 degradation of HA. Purified Smlt1473 WT and HA were mixed and samples were taken at the 
indicated number of minutes. HA oligomers were visualized by Alcian blue staining (white signal). Each 
distinct band represents an oligomer of HA which differs in size from the band above and below by one 
disaccharide unit. 
 
Furthermore, the oligosaccharide products formed by Smlt1473 degradation of HA 
were visualized via a PAGE analysis (Figure 2.9B). Purified Smlt1473 WT (4 μg/ml) was 
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mixed with HA (3 mg/ml) in 30 mM sodium acetate buffer (pH 5). Samples were taken at 
0, 5, 10, 15, and 20 min and boiled for 10 minutes to stop the enzymatic reaction. The 
boiled samples were separated a polyacrylamide gel and HA oligomers were visualized by 
Alcian blue staining (Figure 2.9B, white signal). At t = 0 min, the HA remains undigested 
and the high-molecular weight polysaccharide is unable to enter the gel. As the reaction 
progresses, the HA is digested into smaller oligomers that travel further through the gel. 
Each distinct band represents an oligomer of HA which differs in size from the band above 
and below by one disaccharide unit (Figure 2.9B). Collectively these results confirm that 
Smlt1473 WT is indeed capable of digesting HA (Figure 2.9A) and the oligosaccharide 
products are initially high molecular weight species which are further digested into lower 
molecular weight species as the reaction progresses (Figure 2.9B).  
 
2.3.5 Mono- and Divalent Cations as Well as L-Ascorbic Acid 6-Hexadecanoate Inhibit 
Lyase Activity 
Several polysaccharide lyases are reported to have enhanced activity in response to 
addition of divalent cations such as calcium or magnesium as well as at elevated NaCl 
concentrations (31, 44, 49). In the case of Smlt1473, however, activity was significantly 
inhibited by the presence of both mono- and divalent cations (Table 2.3). At 50 mM NaCl, 
Smlt1473 is essentially inactive against HA activity, and retains ~30% of its optimal 
activity against poly-ManA and poly-GlcA; at 200 mM NaCl, activity is reduced to below 
10% optimal activity. For CaCl2 the inhibitory effects are even more pronounced; 2 mM 
CaCl2 reduces HA activity by nearly half, and reduces poly-ManA as well as poly-GlcA 
activity to nearly 30% of optimal activity. The monosaccharide derivative L-ascorbic acid 
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6-hexadecanoate (Vcpal), which has been shown previously to act as a specific inhibitor of 
bacterial hyaluronan lyases (50), also acts as a specific inhibitor for Smlt1473, with HA 
activity reduced by about 50% and poly-GlcA as well as poly-ManA activity reduced to 
30% of optimal activity at a concentration of 100 μM Vcpal (Table 2.3). 
Table 2.3: Effect of various chemicals on Smlt1743 lyase activity. Enzyme was incubated in 30 mM buffer 
containing NaCl, CaCl2, or Vcpal at the indicated concentration for 10 minutes before adding 17.5 g (for 
poly-ManA and HA) or 1.75 g (for poly-GlcA) to 1 mg/ml substrate in 30 mM buffer with the equivalent 
concentration of chemical. Enzyme activity was monitored by change in absorbance at 235 nm. Activity in 
the absence of any chemicals was taken to be 100%.  
Chemical 
Conc. 
(mM) 
Relative Activity (%)
 
polyGlcA (pH 7) polyManA (pH 9) HA (pH 5) 
None  100 ± 0.7 100 ± 4.2 100 ± 3.2 
NaCl 10 79.9 ± 5.6 104.0 ± 2.0 75.6 ± 0.2 
50 29.6 ± 1.4 26.5 ± 1.0 0.5 ± 0.2 
200 9.0 ± 0.5 3.2 ± 0.3 NDa
 
CaCl2 1 68.5 ± 0.6 70.7 ± 8.8 73.5 ± 3.0 
2 32.9 ± 0.8 27.1 ± 4.9 58.9 ± 2.3 
Vcpal 0.05 59.1 ± 3.7 64.5 ± 1.5 72.7 ± 5.0 
0.1 29.9 ± 2.1 31.4 ± 1.1 45.6 ± 3.1 
aNo detectable activity (detection limit: 0.001 absorbance units at 235 nm per minute). 
 
2.3.6 Identification of Conserved, Catalytic Residues Determining Lyase Activity 
 
As stated previously, the β-elimination mechanism of PLs requires a neutralizing 
group, proton acceptor, and protein donor (8). Despite diverse substrate specificity, 
secondary structure content, and tertiary folds, the residues responsible for each of the 
aforementioned roles appears to be highly conserved across many polysaccharide lyase 
families and fall into two general categories: (i) lyases that require a divalent cation 
(usually Ca2+) for activity due to its role as the neutralizing group, with lysine or arginine 
acting as the base and water as the acid, and (ii) lyases that do not require a divalent cation 
and instead neutralize the C6 carboxylate group via interactions with nearby arginine, 
asparagine, or glutamine residues, with tyrosine or histidine acting as the base and tyrosine 
as the acid (51). For example, the crystal structure of Streptococcus pneumoniae 
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hyaluronate lyase in complex with substrate revealed that the amide group of Asn329 acts 
as the neutralizing group by interacting directly with the C6 carboxylate in a bidentate 
fashion, with Tyr408/His399 acting as the acid/base pair (12). Similarly, the crystal structure 
of Sphingomonas sp. A1-III alginate lyase in complex with substrate revealed that in 
addition to Asn191, the guanidinium group of Arg239 interacts with the C6 carboxylate, with 
Tyr246 acting as both acid and base (47). Due to the fact that Smlt1473 activity is strongly 
inhibited by Ca2+ (Table 2.3), we focused on the Arg/Asn-Tyr/His neutralization-acid/base 
mechanism. As stated previously, Smlt1473 belongs to PL-5 CAZy family. A multiple 
sequence alignment of Smlt1473 with four other PL-5 lyases, including A1-III alginate 
lyase from Sphingomonas sp. (47), was performed with COBALT (Figure 2.10) (37). 
 
Figure 2.10: Sequence alignment of Smlt1473 with polysaccharide lyases belonging to PL-5. Identical 
residues are highlighted in gray. Residues predicted to participate in the catalytic mechanism of Smlt1473 
are marked by asterisks. 
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Based on this alignment, four conserved, putative active-site residues in Smlt1473 
were identified (Asn167, His168, Arg215, and Tyr222) and predicted inactivating mutants 
(N167L, H168A, R215L, and Y222F) were expressed, purified, and characterized. 
Enzymatic activity of each mutant was observed directly from a plate assay with poly-
GlcA and poly-ManA as the substrates (Figure 2.11A), and quantified in terms of the 
change in absorbance at 235 nm (Figure 2.11B) and the TBA method (Figure 2.11C).  
 
Figure 2.11: Mutagenesis of predicted catalytic residues. (A) E. coli BL21 cultures expressing Smlt1473 
WT, N167L, H168A, R215L, and Y222F were dotted onto LB plates solidified with 1% agarose and 
supplemented with 50 μg/ml of kanamycin and 1 mg/ml of poly-GlcA (left) or poly-ManA (right). A clearing 
zone is indicative of lyase activity. (B) Specific activity of Smlt1473 WT and catalytic mutants against HA, 
poly-GlcA, and poly-ManA at their respective optimal pH values. Enzyme activity was monitored by 
absorbance at 235 nm. (C) TBA confirmation of activity of Smlt1473 WT and putative catalytic mutants 
against HA, poly-GlcA, and poly-ManA at their respective optimal pH values. 100% activity was taken as 
the activity of WT against each substrate. All reactions were performed in triplicate and error is reported as 
standard deviation. 
 
All four mutations (N167L, H168A, R215L, and Y222F) were found to 
significantly diminish activity (less than 0.5% of WT) against all three substrates (poly-
GlcA, poly-ManA, and HA) with the exception of H168A, which retained low activity 
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(10% of WT) against poly-GlcA at pH 7. Interestingly, whereas the H168A mutant retained 
~10% of WT activity against poly-GlcA, its specific activity (59.9 ± 1.8 units/mg at pH 7) 
was comparable with optimal, WT Smlt1473 activity against poly-ManA (68.5 ± 2.9 
units/mg at pH 9) and HA (42.3 ± 1.3 units/mg at pH 5) (Table 2.1 and Figure 2.8). To 
confirm that the mutant lyases retained secondary structure equivalent to wild-type, CD 
spectra were collected for wildtype and each mutant (N167L, H168A, R215L, and Y222F). 
For WT and mutant Smlt1473, a predominantly α-helical secondary structure was observed 
in terms of specific minima at 208 and 222 nm. The calculated percent helicity for WT was 
48.3% (52), with less than 5% change in percent helicity for each mutant, indicating the 
overall secondary structure was not perturbed significantly by the mutations (Figure 2.12). 
Therefore, the catalytic mechanism of Smlt1473 appears to be dependent on four highly 
conserved residues (Asn167, His168, Arg215, and Tyr222) that are consistent with an Asn/Arg-
Tyr/His neutralization-acid/base mechanism. 
 
Figure 2.12: Circular dichroism spectrum of Smlt1473 and inactivating mutants. All proteins were measured 
at 300 µg/ml in 20 mM sodium phosphate buffer pH 8. 
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2.3.7 Analysis of Oligosaccharides Products formed by Smlt1473 
To gain further insight into the mechanism by which unsaturated products are 
generated by Smlt1473, enzymatic cleavage products of HA, poly-GlcA, and poly-ManA 
were monitored by ESI-MS and HPLC. In general, for all three substrates, the products 
observed by ESI-MS after 24 h are low molecular weight polysaccharides spanning from 
dimers to octamers (Figure 2.13A–C). For poly-GlcA, which is the substrate with the 
highest Vmax (Table 2.2), the products are dimer, trimer, and tetramer, whereas for poly-
ManA and HA, products include dimers through octamers. Using HPLC to determine the 
relative abundance of each of these products for a given substrate, the major product 
formed from poly-GlcA degradation after 24 h was dimer (Figure 2.13D), whereas poly-
ManA and HA yielded dimers, tetramers, hexamers, and octamers as the major products 
(Figure 2.13E, F). The presence of multiple higher order oligomers implies Smlt1473 
cleaves its substrates in an endolytic manner with the highest conversion to dimer, the 
terminal product, observed for the substrate with the highest specific activity (poly-GlcA). 
The predominance of dimers and tetramers as end products, with small amounts of trimer 
and pentamer, is consistent with cleavage patterns observed for other polysaccharide lyases 
that process substrates in an endolytic manner (44, 53). 
57 
 
 
Figure 2.13: Analysis of oligosaccharide products formed by Smlt1473 digestion. (A-C), ESI-MS of 
oligosaccharide products formed by Smlt1473 enzymatic cleavage of HA at pH 5 (A), poly-GlcA at pH 7 
(B), and poly-ManA at pH 9 (C). Each relevant peak is labeled with a mass and oligosaccharide sequence. 
“Δ” designates 4-deoxy-L-erythro-hex-4-enopyranosyluronic acid, the unsaturated residue at the non-
reducing end. (D-F) HPLC chromatogram of products formed after 24 h for HA (D), poly-GlcA (E), and 
poly-ManA (F). Numbers near peaks indicate the degree of polymerization for each major product. Gray 
dashed lines indicate the elution time of polyethylene glycol standards (2000, 1500, 1000, 600, and 200 
daltons from left to right). 
 
2.4 DISCUSSION 
The catalytically important residues for Smlt1473 were identified through site-
directed mutagenesis as Asn167, His168, Arg215, and Tyr222, with inactivating mutations for 
each of these residues resulting in nearly complete loss of Smlt1473 activity toward each 
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of the three most active substrates (poly-GlcA, poly-ManA, HA) (Table 2.1 and Figure 
2.8). Thus, our results are most consistent with a mechanism in which (i) the C6 carboxylate 
group is neutralized by arginine and asparagine and (ii) tyrosine or histidine acts as the 
base and tyrosine as the acid. This is illustrated further in the homology model generated 
for Smlt1473 (Figure 2.14) based on A1-III alginate lyase from Sphingomonas sp. A1-III 
alginate lyase (PDB 1QAZ) (36).  
 
Figure 2.14: Homology model of Smlt1473. Homology model built using SWISS-MODEL and Protein Data 
Bank file 1QAZ as a template. Images were generated in PyMOL. (A) Surface model of Smlt1473. Black 
arrow indicates location of the putative catalytic residues in evident enzymatic cleft. (B) Tentative catalytic 
residues Asn167, His168, Arg215, and Tyr222 were found to be located in close proximity to each other. 
 
In the model, Asn167 and Arg215 cluster in a deep cleft along with putative acid/base 
catalytic residues His168 and Tyr222, with their overall proximity within the putative active 
site consistent with their ability to neutralize the C6 carboxylate of the substrate. 
Inactivating mutants (N167L, R215L) also diminished activity to below 0.5% of WT 
independent of substrate type (Figure 2.11). Corresponding asparagine and arginine 
residues have been shown to be important in the catalytic mechanism of alginate lyases 
(47), hyaluronate lyases (12), xanthan lyases (10), and chondroitin AC lyases (54). As 
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stated previously, crystal structures of S. pneumoniae hyaluronate lyase and Sphingomonas 
sp. A1-III alginate lyase in complex with substrates have shown that the corresponding 
arginine and asparagine residues are within bonding distance (~3 Å) of the C6 carboxylate 
of the +1 sugar ring (9, 12, 47). Thus, our results point to Asn167 and Arg215 likely acting 
to neutralize the negative charge of the C6 carboxylate, thereby reducing the pKa of C5 
hydrogen on the +1 sugar and enabling its abstraction. 
In terms of the key residues responsible for general acid/base catalysis for 
Smlt1473, the unique pH optima for each of the key substrates suggests multiple, substrate-
dependent mechanisms may occur (Table 2.1 and Figure 2.8). Evidence for two general 
mechanisms exist (9–12, 55, 56), in which (i) tyrosine acts as both the base and acid and 
(ii) histidine acts as the base and tyrosine acts as the acid. Tyrosine is proposed to act as 
both proton acceptor (base) and donor (acid) in A1-II (56) and A1-III (9) alginate lyase 
from Sphingomonas sp. A1, as well as xanthan lyase from Bacillis sp. (10) and chondroitin 
AC lyase from Arthrobacter aurescens (57), based on crystal structures in complex with 
the corresponding substrate and the distance of the conserved catalytic histidine from the 
C5 hydrogen of the +1 sugar. The authors also propose that the histidine, rather than acting 
as a proton donor or acceptor, instead plays a role in either neutralizing the negative charge 
of the C6 carboxylate, stabilizing the enolate intermediate formed between proton 
abstraction and donation by tyrosine, or assisting in the deprotonation of the hydroxyl 
group of the catalytic tyrosine, enabling the tyrosine to act as the base. In contrast, histidine 
is proposed to act as the proton acceptor and tyrosine as the proton donor in the alginate 
lyase Atu3025 from Agrobacterium tumefaciens (55), as well as the HA lyases of 
Streptococcus sp. (11, 12), again based on their positioning relative to the C5 hydrogen on 
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the +1 sugar. Given the optimal activity against HA at acidic pH 5 versus poly-GlcA at pH 
7 and poly-ManA at pH 9 (Table 2.1 and Figure 2.8), our results are most consistent with 
a model in which His168 plays the role of proton acceptor at acidic pH for optimal HA 
activity, similar to the bacterial HA lyases of Streptococcus sp., which have optimal 
activity at acidic pH (11, 12), and His168 or Tyr222 plays the role of the proton acceptor at 
neutral or basic pH for optimal poly-GlcA and poly-ManA activity, similar to the alginate 
lyases of Sphingomonas sp., which have optimal activity at neutral or basic pH (9, 56). 
To provide further insight into the possible mechanisms by which multiple, 
divergent substrates could be processed by Smlt1473 (Figure 2.8), we estimated pKa values 
for each of the active site residues using PROPKA 3.1 (58–61). Based on the homology 
model of Smlt1473 (Figure 2.14), the predicted pKa of His
168 was shifted to 2.6, consistent 
with the measured HA activity at acidic pH 5, whereas Tyr222 was predicted to have a pKa 
of 9.8, thus unlikely to act as a proton acceptor at acidic pH. At neutral or basic pH, 
however, the roles of His168 and Tyr222 become less clear, with the possibility of His168 
acting as the proton acceptor and Tyr222 acting as the donor, or Tyr222 acting as both. It is 
interesting to note that the H168A mutant retains 10% activity against poly-GlcA at pH 7 
(Figure 2.11), implying that it is not absolutely necessary for catalysis. Although poly-
GlcA activity was significantly diminished by the H168A mutation, the specific rate of 
H168A against poly-GlcA was comparable with the rate of WT Smlt1473 against poly-
ManA and HA at their respective optimal pH values. Given that Smlt1473 activity toward 
poly-ManA and HA is comparable with other lyases specific to these substrates (47, 48), 
the residual activity of H168A is significant and suggests the possibility of Tyr222 acting as 
both proton acceptor and donor. Based on the homology model for Smlt1473 (Figure 2.14) 
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and PROPKA calculations, no other residues present within the predicted active site are 
likely to act as a replacement to His168 as putative proton donors or acceptors, consistent 
with the idea that Tyr222 acts as proton donor and acceptor at pH 7 for poly-GlcA. Thus, 
our overall results are most consistent with a model in which His168 acts as a specific proton 
acceptor at acidic pH to selectively cleave HA, based on predicted pKa values of His168 
and Tyr222, whereas at neutral (poly-GlcA) or basic (poly-ManA) pH Tyr222 acts as both 
proton acceptor and donor. It is also interesting to consider the pH-regulated substrate 
cleavage for Smlt1473 in the context mechanisms proposed for other polysaccharide 
eliminases. In particular, Shaya et al. (62) proposed a mechanism for heparinase II in which 
His202 acted as proton acceptor in the cleavage of heparin and Tyr257 acted as proton 
acceptor in the cleavage of heparan sulfate. Heparin contains mostly GlcNAc and GlcA, 
whereas heparin sulfate contains N-sulfoglucosamine (GlcNS) and iduronic acid, the C5 
epimer of GlcA. The heparin activity of His202 was attributed to the fact that the H5 proton 
of GlcA (found in heparin) points in the opposite direction of Tyr257, therefore preventing 
Tyr257 from acting as a proton acceptor in GlcA containing substrates. Conversely the H5 
proton of iduronic acid (found in heparan sulfate) points toward Tyr257, allowing the 
tyrosine to act as both proton acceptor and donor (62). In the case of Smlt1473, all three of 
the most active substrates contain GlcA (poly-GlcA and HA) or its C2 epimer ManA (poly-
ManA), however, only HA contains GlcNAc. GlcNAc contains a C2 acetylamino group 
and lacks the negatively charged C6 carboxyl indicative of uronic acids. Additionally, only 
HA contains both (1,4) and (1,3) O-glycosidic bonds, resulting in a distinct 
macromolecular conformation. The aromatic and polar residues surrounding the active site 
of PLs have been shown to interact with the -2, -1, +1, and +2 sugar residues of the substrate 
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via hydrogen bonding and π-stacking interactions (4). Therefore the structural and 
chemical differences between HA and poly-GlcA/poly-ManA could result in a unique 
binding site for HA in the active site cleft of Smlt1473 and thus a unique positioning of 
His168 and Tyr222 with respect to H5 proton of the +1 GlcA residue in HA. Chapter 3 of this 
thesis describes the effort to identify potential substrate binding residues that assist in the 
docking and positioning of all three substrates. 
PLs can act on polysaccharides endolytically, exolytically, or a combination of 
both. Endolytic enzymes bind to an internal site on the polysaccharide, cleave one 
glycosidic bond, and detach from the substrate, resulting in the simultaneous accumulation 
of multiple unsaturated products of various sizes (44, 45, 63, 64). Exolytic enzymes bind 
to the non-reducing end of the polysaccharide and removes mono-, di-, or trisaccharides 
from the end until the entire macromolecule has been processed, resulting in the 
accumulation of predominantly one unsaturated product, with little to no accumulation of 
differently sized oligosaccharides (46, 64–66). The HA lyases of Streptococcus sp. exhibit 
a hybrid mechanism, in which HA is digested via an initial random endolytic cleavage and 
subsequent exolytic processing into disaccharides (12). Analysis of the unsaturated 
polysaccharide products formed by Smlt1473 cleavage revealed the enzyme digested the 
substrates into oligomers of various sizes. The major products consisted of multiples of a 
disaccharide repeat, with residual trimers and pentamers present as well (Figure 2.13). The 
reduction in higher order oligomers also correlates with the specific activity for a given 
substrate (Table 2.1 and Figure 2.8); the predominant end product is a dimer for poly-GlcA, 
whereas a broad mixture of monomer, dimer, and higher-order oligomers are observed for 
poly-ManA and HA. The rapid production of multiple higher order unsaturated products 
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suggests an endolytic digestion of each substrate (Figure 2.9B and 2.13), similar to the 
endolytic alginate lyases A1-I, A1-II, and A1-III of Sphingomonas sp. (63), as well as the 
endolytic poly-GulA-specific lyases of Sinorhizobium meliloti M5N1CS (45) and 
Trichoderma reesei (44). Each of the aforementioned endolytic lyases produce products 
that vary in size by one sugar ring, including dimers, trimers, tetramers, and pentamers, 
which is indicative of a random endolytic mechanism in which the enzyme exhibits no bias 
for the initial size of the substrate, assuming it is larger than the minimum substrate size 
(64, 67). The ability of Smlt1473 to process substrates with divergent chemical structures 
such as HA and poly-ManA is also unique among bacterial lyases; most reported bacterial 
HA lyases show activity toward related substrates such as chondroitin (3), but to our 
knowledge no reported bacterial lyase is capable of processing both non-acetylglucosamine 
containing polysaccharides such as poly-ManA as well as acetylglucosamine containing 
heteropolysaccharides such as HA. 
 
2.5 CONCLUSION 
 Overall, it is interesting to consider the possible biological roles Smlt1473 may play 
in S. maltophilia physiology as well as possible uses in polysaccharide processing. Our 
results demonstrate that Smlt1473 is secreted when overexpressed heterologously in E. 
coli, and secretion depends on a predicted lipoprotein signaling sequence (Figure 2.6). 
Genetic screening for smlt1473 and analysis of endogenous extracellular lyase activity in 
S. maltophilia clinical isolates revealed that extracellular activity did not correlate with the 
presence of smlt1473, nor did the presence of smlt1473 correlate with extracellular activity 
(Figure 2.7). These results and the fact that Smlt1473 is absent from environmental isolates 
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of S. maltophilia (71) implies that the protein may serve an auxiliary purpose outside of 
carbohydrate metabolism and contribute to the virulence of certain S. maltophilia isolates. 
As mentioned before, secreted bacterial hyaluronan lyases have been shown to act 
as spreading factors to enhance invasion through degrading the host extracellular matrix as 
well as act as metabolic enzymes capable of generating sugars from host HA to promote 
bacterial growth during deep tissue infections (14). Alternatively, one recent study of the 
biofilm composition of two mucoid S. maltophilia strains isolated from cystic fibrosis 
patients identified a unique structure comprised of D-lactate-substituted, O-acetylated 
GalA and GlcA blocks (68). Given high Smlt1473 activity against both HA and poly-GlcA 
(Table 2.1 and Figure 2.8), it is possible that Smlt1473 participates in biofilm formation 
similar to AlgL in P. aeruginosa, acts as a spreading factor similar to other bacterial 
hyaluronidases, or potentially both (13, 15). 
 
2.6 ABBREVIATIONS 
The abbreviations used in this chapter are as follows: HA, hyaluronic acid; GlcA, 
D-glucuronic acid; GlcNAc, N-acetyl-D-glucosamine; ManA, D-mannuronic acid; GulA, 
L-guluronic acid; PL, polysaccharide lyase; MDR, multidrug resistance; CF, cystic 
fibrosis; IMAC, immobilized metal ion affinity chromatography; TBA, thiobarbituric acid; 
TEMPO, 2,2,6,6-tetramethylpipelidine-1-oxyl radical; 1H-NMR, proton nuclear magnetic 
resonance; DPn, degree of polymerization; TSP, 3-(trimethylsilyl)propionate-2,2,3,3-d4 
acid; CD, circular dichroism; HPLC, high-performance liquid chromatography; ESI-MS, 
electrospray ionization mass spectrometry; PL-5, CAZy polysaccharie lyase family 5; 
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GalA, D-galacturonic acid; Vcpal, L-Ascorbic acid 6-hexadecanoate; IdoA, L-iduronic 
acid. 
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CHAPTER 3 
INSIGHT INTO THE ROLE OF SUBSTRATE-BINDING RESIDUES IN 
CONFERRING SUBSTRATE SPECIFICITY FOR THE MULTIFUNCTIONAL 
POLYSACCHARIDE LYASE SMLT1473 
 
The work described in this chapter has been published in 
“Insight into the Role of Substrate-Binding Residues in 
Conferring Substrate Specificity for the Multifunctional 
Polysaccharide Lyase Smlt1473” by Logan C. MacDonald 
and Bryan W. Berger, The Journal of Biological Chemistry 
(2014) 289 (26), 18022-32. 
 
 Anionic polysaccharides are of growing interest in the biotechnology industry due 
to their potential pharmaceutical applications in drug delivery and wound treatment. 
Chemical composition and polymer length strongly influence the physical and biological 
properties of the polysaccharide and thus its potential industrial and medical applications. 
One promising approach to determining monomer composition and controlling the degree 
of polymerization involves the use of polysaccharide lyases, which catalyze the 
depolymerization of anionic polysaccharides via a β-elimination mechanism. Utilization 
of these enzymes for the production of custom-made oligosaccharides requires a high 
degree of control over substrate specificity. Previously, we characterized a polysaccharide 
lyase (Smlt1473) from Stenotrophomonas maltophilia K279a, which exhibited significant 
activity against hyaluronan (HA), poly-β-D-glucuronic acid (poly-GlcUA), and poly-β-D-
mannuronic acid (poly-ManA) in a pH-regulated manner. Here, we utilize a sequence 
structure guided approach based on a homology model of Smlt1473 to identify nine 
putative substrate-binding residues and examine their effect on substrate specificity via site 
directed mutagenesis. Interestingly, single point mutations H221F and R312L resulted in 
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increased activity and specificity toward poly-ManA and poly-GlcUA, respectively. 
Furthermore, a W171A mutant nearly eliminated HA activity, while increasing poly-ManA 
and poly-GlcUA activity by at least 35%. The effect of these mutations was analyzed by 
comparison with the high resolution structure of Sphingomonas sp. A1-III alginate lyase 
in complex with poly-ManA tetrasaccharide and by taking into account the structural 
differences between HA, poly-GlcUA, and poly-ManA. Overall, our results demonstrate 
that even minor changes in active site architecture have a significant effect on the substrate 
specificity of Smlt1473, whose structural plasticity could be applied to the design of highly 
active and specific polysaccharide lyases. 
 
3.1 INTRODUCTION 
Polysaccharide lyases (PLs) are a class of carbohydrate modifying enzymes that 
catalyze the degradation of polyuronides via a β-elimination mechanism, cleaving the 
glycosidic bond between two adjacent sugar residues and generating an unsaturated 
hexenuronic acid at the nonreducing end of the oligosaccharide product (1). Three chemical 
steps occur during the β-elimination mechanism as follows: (i) neutralization of the 
negatively charged C6 carboxylate group on the +1 sugar ring, reducing the pKa of the C5 
proton; (ii) abstraction of the C5 proton by a Brønsted base; and (iii) electron transfer 
resulting in double bond formation between C4 and C5 of the +1 sugar ring and donation 
of a proton by a Brønsted acid to the glycosidic oxygen resulting in the cleavage of the C4-
O-1 glycosidic bond (1). Despite diverse substrate specificity, secondary structure content, 
and tertiary folds, this three-step mechanism is highly conserved across the 23 different 
polysaccharide lyase families (PL-1 to PL-23) (2, 3) and can be divided into two general 
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categories as follows: metal ion-assisted and metal ion-independent lyases, the latter of 
which utilize nearby arginine, asparagine, or glutamine residues for substrate neutralization 
with a highly conserved tyrosine or histidine acting as the base and tyrosine as the acid (3). 
A consensus has not been met regarding the specific roles of the catalytic histidine and 
tyrosine, namely whether tyrosine acts as proton acceptor and donor with histidine 
stabilizing an intermediate, the mechanism proposed for alginate lyases (4) and xanthan 
lyases (5), or whether histidine acts as the proton acceptor and tyrosine as the proton donor, 
the mechanism proposed for hyaluronan lyases (6, 7). Furthermore, Shaya et al. (8) 
proposed a third mechanism for heparinase II in which the residue responsible for accepting 
the C5 proton is dependent on the structure of the substrate itself. Thus, while the 
catalytically active residues of PLs are highly conserved, delineating the individual roles 
of each residue in the mechanism of catalysis remains an area of active research. Additional 
studies suggest that variations in the polysaccharide structure itself and interactions 
between the substrate and other non-catalytic active site residues are important in the 
precise positioning of the cleavable glycosidic bond with respect to the catalytic tyrosine 
and histidine and therefore may dictate what role each plays (8-10).  
The crystal structures of PLs reveal that despite different secondary structure and 
tertiary folds, the lyases contain a long deep cleft to accommodate at least five sugar rings 
of the polysaccharide substrate (4, 8, 10-14). Furthermore, the residues along this cleft form 
hydrogen bonds, salt bridges, and van der Waals contacts with not only the +1 and -1 sugar 
residues between which cleavage takes place, but also the sugar rings located two or three 
residues away from the site of cleavage (3). Instead of participating directly in catalysis, 
these substrate-binding residues are thought to initially attract and then precisely orient the 
78 
 
substrate in a geometry which facilitates catalysis (10,15). Therefore substrate specificity 
is derived from shaping the active site cleft to precisely fit a given polysaccharide structure 
and form the appropriate bonds with the various substituents of the sugar rings. Given that 
all PLs utilize the β-elimination mechanism and yet lyases from different families exhibit 
vastly different substrate specificity, understanding how the substrate binding residues 
dictate specificity would allow for engineering of highly specialized lyases with numerous 
industrial and medical applications. These applications include polysaccharide sequence 
determination by cleavage with a set of well-characterized lyases and subsequent analysis 
of oligosaccharide products (16), saccharification of alginic acid and poly-β-D-glucuronic 
acid (polyGlcUA) found abundantly in brown and green algae for use in biofuels (17,18), 
and utilization of enzymes highly active against polysaccharides secreted by bacteria 
during biofilm formation as an adjuvant in the treatment of chronic bacterial infection (19). 
Previously we characterized a putative alginate lyase (Smlt1473) from the 
opportunistic pathogen Stenotrophomonas maltophilia strain K279a (9). Smlt1473 
exhibited broad, yet pH-regulated substrate specificity towards both bacterial and 
mammalian substrates, including poly-β-D-mannuronic acid (polyManA), polyGlcUA, 
and hyaluronan (HA), with optimal polyManA activity observed at pH 9, polyGlcUA at 
pH 7, and HA at pH 5. To understand the basis for pH regulated substrate specificity of 
Smlt1473 and determine roles for non-catalytic residues in substrate specificity, we 
identified nine putative substrate binding residues (Lys42, Tyr115, Lys162, Arg163, Trp171, 
Arg218, His221, Tyr225, Arg312) and expressed, purified and characterized nine single mutants 
(K42L, Y115F, K162L, R163L, W171A, R218L, H221F, Y225F, R312L). In particular, 
we find several of these mutations play key roles in altering, and in some cases, increasing 
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both substrate specificity and overall activity. For example, H221F increases the 
polyManA activity 2-fold and shifts the ratio of polyManA/polyGlcUA turnover from 0.1 
to 2.0. Conversely, R312L increases polyGlcUA activity 2.5-fold and shifts the ratio of 
polyGlcUA/polyManA turnover from 9.6 to 340.8. Calculation of enzyme efficiency 
(kcat/Km) revealed that mutants H221F and Y225F exhibited a 2.4-fold higher efficiency 
towards polyManA cleavage compared to wild-type Smlt1473. Collectively our results 
indicate that the non-covalent interactions between non-catalytic residues and substrate are 
critical for not only overall enzymatic activity, but also substrate specificity and optimal 
reaction conditions such as pH, and can be grouped into categories based on their 
positioning within the active site cleft. Furthermore, the apparent structural plasticity of 
Smlt1473 offers possibilities for selection of lyases with enhanced specificity towards a 
particular polysaccharide substrate (9).  
  
3.2 MATERIALS AND METHODS 
3.2.1 Subcloning and Site-directed Mutagenesis 
 Unless otherwise stated, standard molecular biology techniques were used for 
subcloning and site-directed mutagenesis (20). An Escherichia coli codon-optimized 
nucleotide sequence of smlt1473 (corresponding to GenBankTM accession number 
CAQ45011) was subcloned into pET28a(+) (Invitrogen) as an NcoI-XhoI insert with no 
stop codon, resulting in a C-terminal His6 tag. Mutagenic primers were designed via 
PrimerX, and amino acid substitutions were generated via the QuikChange II site-directed 
mutagenesis kit (Agilent Technologies). Nucleotide sequences containing mutations were 
confirmed by DNA sequencing (GeneWiz). 
80 
 
3.2.2 Expression and Purification 
For expression and purification, methods similar to those described previously (9) were 
used with the following modifications. Soluble cell lysate was passed over a column 
containing 15 ml of Ni2+-bound chelating Sepharose Fast Flow resin (GE Healthcare) pre-
equilibrated in IMAC Buffer A (20 mM HEPES, 500 mM NaCl, 10% v/v glycerol, 10 mM 
imidazole) at a flow rate of 2 ml/min via a BioLogic LP chromatography system (Bio-Rad) 
with fraction collector. The column was washed for 70 min with IMAC Buffer A to remove 
any unbound proteins before applying a gradient from 0 to 30% IMAC Buffer B (20 mM 
HEPES, 500 mM NaCl, 10% v/v glycerol, 500 mM imidazole) over the course of 80 min 
to wash away any nonspecifically bound proteins, and finally Smlt1473 was eluted from 
the column by running IMAC Buffer B for 20 min. Fractions were assayed for protein 
content via Bradford reagent (Bio-Rad), and samples containing purified Smlt1473 were 
pooled together and dialyzed against 4 liters of 20 mM HEPES, 100 mM NaCl, 5% v/v 
glycerol, 20 mM imidazole for 20 h at 4°C and then 25 mM sodium phosphate buffer, pH 
8, for 40 h at 4°C with one buffer exchange. Protein concentration was determined via 
absorbance measurements at 280 nm, and molar extinction coefficients were estimated 
from primary amino acid sequences (21). 
 
3.2.3 Polysaccharide Substrates 
Sodium alginate, medium viscosity, and hyaluronic acid, potassium salt from 
human umbilical cord, were obtained from MP Biomedicals. Chondroitin sulfate and poly-
α-D-galacturonic acid (poly-GalA) were obtained from Alfa Aesar. Heparin and heparan 
sulfate were obtained from Sigma and Sagent Pharmaceuticals, respectively. Poly-GlcUA 
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was prepared from Avicel PH-105 NF (FMC Biopolymer), and its structure was confirmed 
by 1H NMR as described previously (9). Poly-ManA, poly-GulA, and poly-MG block 
structures were prepared from sodium alginate by partial acid hydrolysis, and its structure 
was confirmed by 1H NMR as described previously (9). Poly-GlcUA, poly-ManA, poly-
GulA, and poly-MG samples were dialyzed against 4 liters of double distilled H2O for 40 
h at 4°C with one buffer exchange and then lyophilized. The resulting powders were stored 
at 4°C until needed. 
 
3.2.4 Enzyme Activity Assays 
The β-elimination mechanism employed by polysaccharide lyases generates a 
double bond between C4 and C5 of the sugar ring at the newly formed nonreducing end 
that can be monitored as a change in absorbance at 235 nm (22). Absorbance 
measurements were taken in 1-s intervals over the course of at least 5 min via an 
Ultrospec 3300 pro UV-visible spectrophotometer with a detection limit of 0.001 
absorbance units at 235 nm/min. One unit of enzyme activity was defined as an increase 
in absorbance at 235 nm of 1.0/min at 25°C (1 unit = 1 ΔA235 nm min-1) (9, 16). In general, 
14 μg of purified wild-type and mutant Smlt1473 was added to a solution containing 1 
mg/ml substrate in a final volume of 350 μl, with the exception of poly-GlcUA, in which 
1.4 μg of enzyme was added to each reaction due to higher activity against poly-GlcUA. 
The pH of all reactions was maintained via specific buffers for a given pH range at a total 
ionic strength of 30 mM (acetate for pH 4–6, phosphate for pH 5–8, Tris for pH 
6–9, and glycine forpH 9–10). Additionally, the Michaelis constant (Km) and turnover 
number (kcat) of wild-type and mutant Smlt1473 against poly-GlcUA and poly-ManA 
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were determined by varying polysaccharide concentrations. An extinction coefficient of 
6150 M-1 cm-1 at 235 nm was used to convert absorbance to product concentration (23). 
Initial rates (vi) were fit to the Michaelis-Menten equation, v = kcatE0S/(Km + S), via the 
generalized reduced gradient (GRG2) nonlinear optimization program (24). The R2 and 
correlation values for each substrate were greater than 0.943 and 0.944, respectively. All 
reactions were carried out in triplicate, and error is reported as standard deviation. 
 Lyase activity was independently determined via a thiobarbituric acid assay in 
which the unsaturated product is converted to a pre-chromogen by oxidation with 
periodic acid and then reacted with thiobarbituric acid to form a pink chromogen with an 
absorbance maximum of 550 nm (25). For these experiments, 4 μg of purified enzyme 
(0.4 μg for poly-GlcUA) was mixed to solutions containing 1 mg/ml substrate in a total 
reaction volume of 100 μl. Reactions were allowed to proceed for 5 min before heating 
the samples at 100°C for 10 min to degrade the enzyme and stop the reaction. 
 
3.2.5 Sequence Alignment 
According to the Carbohydrate Active Enzymes (CAZy) database, Smlt1473 
belongs to polysaccharide lyase family 5 (PL-5), which currently contains a total of 105 
lyases (2). The primary amino acid sequence of each PL-5 lyase was downloaded and 
parsed to remove any entry that shared a greater than 95% pairwise sequence identity 
with another entry in an effort to reduce redundancy in the database. The remaining 
50 lyases, including Spingomonas sp. A1 (PDB code 1QAZ) (11), were aligned with 
Smlt1473 using Clustal Omega (26). 
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3.2.6 Homology Modeling 
A homology model of Smlt1473 was constructed using Swiss-Model (27–29) 
based on the alginate lyase A1-III (PDB code 1QAZ) from Spingomonas sp. (11), as 
described previously (9). All images of the resultant model were generated via PyMOL 
(30). 
 
3.3 RESULTS 
3.3.1 Identification of Putative Substrate-binding Residues in Smlt1473 via Homology 
Modeling and Sequence Alignment 
 As stated previously, high resolution structures of various PLs have indicated that 
residues located inside the active site cleft yet not directly involved in the β-elimination 
mechanism form numerous noncovalent bonds with the substrate, including hydrogen 
bonds, salt bridges, and van der Waals contacts (4, 8, 10–14). The types of residues fall 
into three general categories as follows: (i) positively charged residues such as arginine or 
lysine that facilitate substrate binding and positioning by forming salt bridges with the 
negatively charged carboxylic acid groups present in the substrate (4, 14). Additionally, 
HA lyases from Streptococcus pneumoniae and Streptococcus agalactiae contain positive 
patches at the entrance of the cleft thought to assist in drawing the substrate into the cleft 
(6, 31). (ii) Aromatic residues such as tryptophan and phenylalanine undergo C–H/π 
interactions with the sugar rings of the substrate (32), thus optimizing its position with 
respect to the catalytically active residues to promote enzymatic activity (10). (iii) Polar 
residues such as tyrosine and asparagine form hydrogen bonds with various substituents on 
the substrate, further assisting in binding and positioning (4, 12, 14). In an effort to identify 
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putative residues that participate in substrate binding, a homology model for Smlt1473 was 
constructed with Swiss-Model using alginate lyase A1-III (PDB code 1QAZ) from 
Spingomonas sp. (11). In addition to sharing the greatest sequence identity with Smlt1473 
among all solved lyase crystal structures (30%), A1-III lyase is the only PL-5 member 
whose high resolution structure has been determined (2). From the Smlt1473 model, the 
predicted catalytic residues (Asn167, His168, Arg215, and Tyr222), highlighted in white in 
Figure 3.1A, are clustered in a deep trench-like cleft (9). A cluster of basic residues (Lys42, 
Lys162, Arg163, and Arg218) form a positive patch at the entrance of the active site, 
highlighted in black in Figure 3.1A, consistent with the HA lyases of S. pneumoniae and 
S. agalactiae (6, 31). Additionally, a sequence alignment with 1QAZ (Figure 3.1B) 
revealed that the cleft contained a conserved tryptophan residue (Trp171) and several 
conserved polar/charged residues (Tyr115, His221, Tyr225, and Arg312) that undergo 
noncovalent interactions with the alginate substrate in A1-III lyase (4, 14). Thus, nine 
putative substrate-binding residues were identified based on homology modeling and 
sequence alignment with 1QAZ (Lys42, Tyr115, Lys162, Arg163, Trp171, Arg218, His221, Tyr225, 
and Arg312). The above amino acids were conservatively mutated in an effort to test specific 
properties of the given residue. For example, lysine and arginine were predicted to interact 
with the substrate via electrostatic attraction; therefore, these residues were mutated to 
leucine to remove the positive charge while minimizing side chain size variation. Tyrosine 
and histidine were predicted to interact with the substrate via hydrogen bonding; therefore, 
these residues were mutated to phenylalanine to remove the polar groups while maintaining 
side chain ring structure. Tryptophan was predicted to interact with the substrate via C–
H/π bonds and other hydrophobic interactions; therefore, this residue was mutated to 
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alanine to remove the aromatic ring and reduce its hydrophobicity. These mutations 
provide a structural basis for probing their effects on pH-dependent lyase activity against 
a broad range of polysaccharides, including poly-ManA, poly-GlcUA, and HA. 
 
Figure 3.1: Identification of putative substrate-binding residues in Smlt1473. (A) Surface homology model 
of Smlt1473 constructed with Swiss-Model and Protein Data Bank file 1QAZ as a template. A deep trench-
like cleft was identified (black arrow, inset). Catalytically active residues are highlighted in white. Positively 
charged residues are highlighted in black. A positive patch was identified at the entrance of the active site, 
immediately adjacent to the catalytically active residues. (B) Sequence alignment of Smlt1473 with 
Sphingomonas sp. A1-III lyase (PDB code 1QAZ) (11). Identical residues are highlighted in gray. Residues 
predicted to be located in the active site cleft and participate in substrate binding are highlighted in black. 
Residues predicted to participate in the catalytic mechanism of Smlt1473 are marked by asterisks. Residues 
located in positive patch are marked by daggers. 
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3.3.2 Enzymatic Activity Screening of Mutant Lyases Revealed Diverse Substrate 
Specificity 
The lyase activity of purified wild-type and mutant Smlt1473 was tested against the 
following 10 polyuronides: alginate (MP Biomedicals); poly-ManA, poly-GulA, poly-MG, 
poly-GlcUA, poly-GalA (Alfa Aesar); HA (MP Biomedicals); heparin (Sigma); heparan 
sulfate (Sagent Pharmaceuticals); and chondroitin sulfate (Alfa Aesar). Table 3.1 provides 
the specific activity of each mutant lyase against each substrate (1 mg/ml) at the optimal 
pH values determined previously for wild-type Smlt1473 (9). Note that no detectable 
activity was measured for any of the mutant lyases against poly-GalA, heparin, and heparan 
sulfate at pH 5, 7, and 9.  
Table 3.1: Substrate specificity of Smlt1473 mutants. Purified wild-type and mutant Smlt1473 was added 
to 1 mg/ml of each substrate in 30 mM buffer at indicated pH. Enzymatic activity was monitored by 
absorbance at 235 nm. One unit of activity was defined as an increase in absorbance at 235 nm of 1.0 per 
minute at 25oC. In addition to the substrates listed below, each enzyme was tested against poly-GalA, heparin, 
and heparan sulfate, with no detectable activity. All reactions were performed in triplicate and error is 
reported as standard deviation. 
 
 
Specific Activity (units/mg) 
WT K42L Y115F K162L R163L W171A R218L H221F Y225F R312L 
Alginate 
(pH 9) 
21.4 
±0.5 
22.5 
±1.9 
8.2 
±0.1 
21.9 
±2.1 
8.1 
±0.2 
33.1 
±0.7 
13.8 
±0.9 
27.1 
±0.3 
38.2 
±1.2 
1.0 
±0.1 
PolyManA 
(pH 9) 
85.0 
±1.7 
94.7 
±3.4 
37.5 
±1.1 
75.3 
±2.9 
33.7 
±0.9 
114.9 
±1.2 
75.0 
±4.5 
180.0 
±3.6 
203.2 
±5.2 
6.0 
±0.2 
PolyGulA 
(pH 9) 
2.3 
±0.3 
2.2 
±0.1 
2.5 
±0.2 
1.4 
±0.2 
1.0 
±0.1 
1.3 
±0.2 
1.7 
±0.5 
5.5 
±0.2 
3.4 
±0.1 
0.1 
±0.1 
PolyMG 
(pH 9) 
12.8 
±0.4 
16.5 
±0.6 
9.7 
±0.1 
16.0 
±0.5 
7.5 
±0.7 
15.6 
±0.2 
13.5 
±0.7 
25.0 
±0.6 
26.2 
±1.3 
1.3 
±0.1 
PolyGlcA 
(pH 7) 
898.2 
±3.2 
798.1 
±26.1 
1506.6 
±89.1 
571.8 
±31.7 
592.6 
±34.5 
1336.5 
±83.8 
478.4 
±14.3 
100.7 
±2.8 
1109.1 
±31.2 
1988.8 
±59.2 
Hyaluronan 
(pH 5) 
41.8 
±1.5 
31.8 
±1.0 
32.3 
±3.2 
39.1 
±0.9 
25.8 
±3.7 
0.4 
±0.1 
6.3 
±0.8 
1.8 
±1.4 
38.6 
±3.8 
23.2 
±2.2 
Chondroitin 
Sulfate 
(pH 5) 
1.0 
±0.2 
0.6 
±0.1 
0.6 
±0.1 
0.7 
±0.1 
0.4 
±0.1 
0.1 
±0.1 
0.2 
±0.1 
0.3 
±0.1 
1.0 
±0.1 
0.3 
±0.1 
 
Figure 3.2 displays the specific activity of each mutant against each of the three 
main substrates (poly-ManA, poly-GlcUA, and HA). All mutant lyases exhibited 
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diminished activity toward HA, the most inactive being the W171A mutant with a specific 
HA activity of 0.4 ± 0.1 units/mg, compared with wild-type at 41.8 ± 1.5 units/mg (Table 
3.1 and Figure 3.2).  
In contrast to HA, however, the Smlt1473 mutant lyases displayed significant 
changes in activity toward poly-GlcUA at pH 7 and poly-ManA at pH 9 and in some cases 
with specific mutants exhibiting opposite effects on activity for poly-ManA versus poly-
GlcUA (Table 3.1 and Figure 3.2). For example, the H221F mutant was 2.1 times more 
active than wild-type against poly-ManA, yet it retained only 11% activity toward poly-
GlcUA. Conversely, the R312L mutant was 2.2 times more active than wild-type against 
poly-GlcUA, yet it retained only 7% activity toward poly-ManA (Table 3.1 and Figure 
3.2).  
To better organize and understand the effect each mutation has on lyase activity, 
the mutants were subdivided into four groups as follows: mutation of residues located in 
the positive patch flanking the active site (K42L, K162L, R163L, and R218L; Figure 3.3A, 
E) mutations that exhibited increased activity and specificity toward poly-ManA (H221 
and Y225F; Figure 3.3B, F); mutations that exhibited increased activity and specificity 
toward poly-GlcUA (Y115F and R312L; Figure 3.3C, G), and mutations that exhibited 
increased activity and specificity toward poly-ManA and poly-GlcUA (W171A; Figure 
3.3D, H). 
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Figure 3.2: Specific activity of wild-type and mutant Smlt1473 against HA (A), poly-GlcUA (B), and poly-
ManA (C). Purified wild-type and mutant Smlt1473 (14 μg) was mixed with 1 mg/ml HA in 30 mM sodium 
acetate, pH 5, or poly-ManA in 30 mM Tris, pH 9, in a total reaction volume of 350 μl. For poly-GlcUA, the 
amount of enzyme added to 1 mg/ml poly-GlcUA in 30 mM Tris, pH 7, was reduced to 1.4 μg due to higher 
activity. Enzymatic activity was monitored by absorbance at 235 nm. One unit of activity was defined as an 
increase in absorbance at 235 nm of 1.0 per min at 25°C. Dashed lines indicate wild-type activity for 
comparison with other mutants. All reactions were performed in triplicate, and error is reported as standard 
deviation. 
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Figure 3.3: Location of putative substrate-binding residues in Smlt1473. (A-D) Homology model of 
Smlt1473 built with Swiss-Model and Protein Data Bank code 1QAZ. Images were generated in PyMOL. 
Predicted catalytic residues (Asn167, His168, Arg215, and Tyr222) are highlighted in white. Putative substrate 
binding residues of interest are highlighted in black. (E-H) Percent change in specific activity of mutant 
lyases from wild-type Smlt1473 for HA at pH 5, poly-GlcUA at pH 7, and poly-ManA at pH 9. Enzymatic 
activity was monitored by change in absorbance at 235 nm. All reactions were performed in triplicate and 
error is reported as standard deviation. Residues are organized into four groups as follows: residues located 
in the positive patch (Lys42, Lys162, Arg163, and Arg218; A and E) and residues whose mutation favors poly-
ManA cleavage (His221, Tyr225; B and F), poly-GlcUA cleavage (Tyr115, Arg312; C and G), and poly-
ManA/poly-GlcUA cleavage (Trp171; D and H).  
 
3.3.3 Mutation of Residues Located in Positive Patch 
 Homology modeling of Smlt1473 using 1QAZ (11) as a template revealed a cluster 
of basic residues (Lys42, Lys162, Arg163, and Arg218) located near the entrance of the active 
site and immediately adjacent to the catalytic residues (Figure 3.1A and 3.3A). Similar 
positive patches were observed in the crystal structures of HA lyases from S. pneumoniae 
and S. agalactiae. In both structures, the positive patch residues were predicted to play a 
role in the initial drawing of the negatively charged substrate into the active site via 
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electrostatic attraction (6, 31). Thus, we expected that mutation of the homologous basic 
residues located in the equivalent positive patch of Smlt1473 (Lys42, Lys162, Arg163, and 
Arg218) would also result in decreased lyase activity due to a diminished ability to attract 
the acidic polysaccharide to the active site. The loss of activity by removing positive 
charges from this patch is also expected to be substrate-independent due to each substrate 
containing the negatively charged C6 carboxylic acid groups. As shown in Figure 3.3E, 
mutation of each of the four basic residues to nonpolar leucine (K42L, K162L, R163L, and 
R218L) resulted in diminished activity toward HA at pH 5, poly-GlcUA at pH 7, and poly-
ManA at pH 9, with the exception of K42L, which exhibited a modest (11%) increase in 
activity toward poly-ManA compared with wild type. The K42L mutant also displays 
decreases of less than 25% in activity toward HA and poly-GlcUA (Figure 3.3E) and is 
located distal to the catalytic tetrad and other three basic residues (Figure 3.3A), indicating 
it may play a less significant role in substrate attraction. Overall, we see loss of activity 
against all three main substrates (poly-ManA, poly-GlcUA, and HA) when replacing 
positive charges in the predicted positive patch with hydrophobic residues (K42L, K162L, 
R163L, and R218L), which is consistent with our expected result that these play a general 
role in initial substrate binding due to the net negative charge of the polysaccharides. 
 
3.3.4 Mutations That Exhibited the Greatest Change in Activity with Respect to Wild Type 
for Poly-ManA 
In contrast to the cluster of positive residues involved in initial substrate binding, 
mutations to predicted substrate-binding residues within the active site cleft (H221F and 
Y225F; Figure 3.3B) resulted in significantly increased activity and specificity toward 
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poly-ManA (Figure 3.3F). The H221F mutant exhibited a 111% increase in poly-ManA 
activity, as well as a 96 and 89% decrease in HA and poly-GlcUA activity, respectively 
(Figure 3.3F), making it highly selective for poly-ManA. The specific activity ratios of 
poly-ManA/poly-GlcUA and poly-ManA/HA were shifted 10- and 50-fold relative to wild 
type, respectively, indicating a significant increase in poly-ManA specificity (Table 3.1 
and Figure 3.2). The Y225F mutant exhibited similar trends to H221F, with a 139% 
increase in poly-ManA activity, as well as a 23% increase and 7% decrease in poly-GlcUA 
and HA activity, respectively (Figure 3.3F). Likewise, the specific activity ratios of poly-
ManA/poly-GlcUA and poly-ManA/HA were both shifted by more than a factor of 2 in 
favor of poly-ManA (Table 3.1 and Figure 3.2). Taken together, the H221F and Y225F 
mutants both exhibited significant increases in both activity and specificity toward poly-
ManA (Figure 3.3F). Finally, whereas wild-type Smlt1473 exhibited the highest specific 
activity toward poly-GlcUA (898.2 ± 3.2 units/mg) versus poly-ManA (85.0 ± 1.7 
units/mg) and HA (41.8 ± 1.5 units/mg), the H221F mutant switched to having the highest 
specific activity toward poly-ManA (180.0 ± 3.6) versus poly-GlcUA (100.7 ± 2.8 
units/mg) and HA (1.8 ± 1.4 units/mg) (Table 3.1 and Figure 3.2). Thus, both predicted 
substrate-binding residues (His221 and Tyr225) play key roles in negative regulation of poly-
ManA specificity, with mutations to either causing a significant increase in selectivity and 
activity toward poly-ManA. 
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3.3.5 Mutations That Exhibited the Greatest Change in Activity with Respect to Wild Type 
for Poly-GlcUA 
As with poly-ManA-selective point mutations, point mutations to additional 
predicted substrate-binding residues (Y115F and R312L; Figure 3.3C) resulted in 
significantly increased activity and specificity toward poly-GlcUA (Figure 3.3G). The 
R312L mutant exhibited a 121% increase in poly-GlcUA activity, as well as a 45 and 93% 
decrease in HA and poly-ManA activity, respectively (Figure 3.3G), making it highly 
selective for poly-GlcUA. The specific activity ratios of poly-GlcUA/poly-ManA and 
poly-GlcUA/HA were shifted more than 30- and 4-fold in favor of poly-GlcUA, 
respectively (Table 3.1 and Figure 3.2). The Y115F mutant exhibited similar trends, with 
the specific activity ratios shifting nearly 4-fold in favor of poly-GlcUA versus poly-ManA 
and more than 2-fold in favor of poly-GlcUA versus HA (Table 3.1 and Figure 3.2). Taken 
together, the R312L and Y115F mutants exhibit increases in both activity and specificity 
toward poly-GlcUA (Figure 3.3G), indicating these residues play a key role in negative 
regulation of poly-GlcUA activity. 
 
3.3.6 Mutations That Exhibited the Greatest Change in Activity with Respect to Wild Type 
for Poly-GlcUA and Poly-ManA 
  Mutation of the highly conserved Trp171 located in the center of the active site cleft 
(Figure 3.3D) resulted in significantly increased activity and specificity toward poly-ManA 
and poly-GlcUA (Figure 3.3H). The W171A mutant exhibited a 49% increase in poly-
GlcUA activity, 35% increase in poly-ManA activity, and was almost inactive against HA, 
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shifting both the poly-GlcUA/HA and poly-ManA/HA specific activity ratios over 160-
fold in favor of poly-GlcUA and poly-ManA (Figure 3.3H). 
 
3.3.7 Changes in Michaelis Constant and Enzyme Efficiency 
To differentiate the effect each mutation had on substrate binding and product 
turnover, the Michaelis constant (Km), which reflects the substrate concentration necessary 
for catalysis to occur, and turnover number (kcat) were determined for each mutant against 
poly-GlcUA at pH 7 and poly-ManA at pH 9 (Table 3.2). Kinetic parameters were not 
determined for HA due to all nine mutants exhibiting a diminished activity toward that 
substrate. Given that required substrate concentration for catalysis and turnover rate are 
dependent on one another, the ratio of the two parameters (kcat/Km) is considered a measure 
of enzyme efficiency toward a given substrate (10, 14). Figure 3.4 depicts the percent 
change of enzyme efficiency with respect to wild type for either poly-GlcUA at pH 7 or 
poly-ManA at pH 9. Based on the equation derived by Kelly et al. (33) for polysaccharide 
lyase catalysis, a change in kcat/Km indicates the mutant enzyme is binding the substrate 
with a different affinity. Furthermore, although Km may approximate substrate affinity, it 
is also affected by other rate and equilibrium constants, and therefore kcat/Km is used as a 
descriptive parameter for substrate binding (33). 
In general, mutations of residues in the positive patch (K42L, K162L, R163L, and 
R218L) resulted in a decrease in enzyme efficiency for both substrates, due to either a 
decrease in kcat, an increase in Km, or in most cases both (Table 3.2 and Figure 3.4). The 
one exception was the K162L mutant against poly-GlcUA, which displayed a 10% increase 
in efficiency (Figure 3.4) due to the reduction in Km from 0.17 to 0.10 mM between wild-
94 
 
type and K162L (Table 3.2). Although this increase in efficiency is unexpected, it is 
important to recall that the positive patch is only partially disrupted by the removal of one 
of the charged groups, and other subtle changes in active site architecture may result in 
more efficient binding of a particular substrate (see section 3.4 Discussion). Overall, 
mutations to either arginine (R163L and R218L) appeared to have a greater detrimental 
effect on enzyme efficiency than lysine mutations (K42L and K162L) (Table 3.2 and 
Figure 3.4).  
Table 3.2: Kinetic parameters of Smlt1473 and mutants against poly-GlcUA and poly-ManA. Purified 
wild-type and mutant Smlt1473 was added to 16 different solutions containing 7.8 to 3000 μg/ml (22.2 to 
487.8 mM) of either poly-GlcUA at pH 7 or poly-ManA at pH 9. Enzymatic activity was monitored by 
absorbance at 235 nm. All reactions were performed in triplicate. Turnover rate (kcat) was calculated using 
an extinction coefficient of 6150 M-1 cm-1 for the unsaturated product (23). Km values are based upon an 
effective molecular weight of 352 for the disaccharide sugar unit, the smallest product formed by Smlt1473 
during catalysis (9, 44). 
 
Poly-GlcUA 
30 mM Tris, pH 7 
Poly-ManA 
30 mM Tris, pH 9 
kcat (s
-1) Km (mM) kcat (s
-1) Km (mM) 
Wild-type 31.9 0.17 3.3 0.35 
Positive Patch 
K42L 29.0 0.18 3.7 0.46 
K162L 20.3 0.10 2.8 0.33 
R163L 21.3 0.18 1.4 0.67 
R218L 17.8 0.19 2.8 0.36 
Favors ManA 
H221F 3.4 0.06 7.0 0.31 
Y225F 39.1 0.21 7.9 0.35 
Favors GlcA 
Y115F 59.6 0.38 1.3 0.15 
R312L 80.7 0.59 0.2 0.52 
Favors ManA/GlcA W171A 49.4 0.27 4.9 0.67 
 
For substrate-binding residues H221F and Y225F, both exhibited a 138% increase 
in enzyme efficiency toward poly-ManA, due to significant increases in kcat and decreases 
in Km values, indicating greater overall enzyme specificity for poly-ManA for both mutants. 
Additionally, the H221F mutant exhibited a 68% decrease in enzyme efficiency toward 
poly-GlcUA, emphasizing its significantly increased activity and specificity for poly-
ManA (Table 3.2 and Figure 3.4). Similarly, the substrate-binding residues Y115F, 
W171A, and R312L demonstrated increases in Km as well as kcat for poly-GlcUA compared 
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with wild type, and thus none of these mutants exhibited a significant increase in enzyme 
efficiency for poly-GlcUA. However, R312L, the most active mutant toward poly-GlcUA 
(kcat of 80.7 s
-1 versus 31.9 s-1 for wild type), displayed a 95% decrease in enzyme 
efficiency for poly-ManA, further indicating this mutant’s unique and significantly 
increased activity and specificity for poly-GlcUA (Table 3.2 and Figure 3.4). Overall, these 
results further reinforce the idea that the positive patch residues (Lys42, Lys162, Arg163, and 
Arg218) play a general role in substrate binding, as evidenced by uniform decreases in 
enzyme efficiency for mutations to any of these residues versus interior substrate-binding 
residues, where major increases in enzyme efficiency are observed for poly-ManA (H221F 
and Y225F). 
 
Figure 3.4: Percent change in enzyme efficiency (kcat/Km) of Smlt1473 mutants from wild type for poly-
GlcUA at pH 7 and poly-ManA at pH 9. 
 
96 
 
3.3.8 Heat Map of Changes in Substrate Specificity Caused by Mutation of Putative 
Substrate-binding Residues 
In an effort to summarize the effect of each mutation on substrate specificity, the 
putative substrate-binding residues were colored according to the effect of mutating each 
residue on activity toward HA, poly-GlcUA, and poly-ManA. More precisely, the specific 
activity of each mutant against poly-GlcUA was scaled to the color green with values 
ranging from 0, corresponding to the mutant with the lowest poly-GlcUA activity (H221F), 
to 255, corresponding to the mutant with the highest specific activity (R312L). A similar 
approach was taken for HA with red and poly-ManA with blue (Figure 3.5).  
 
Figure 3.5: Heat map of putative substrate-binding residues with respect to substrate specificity. Surface 
model (A) and stick model (B) of Smlt1473 built with Swiss-Model and Protein Data Bank code 1QAZ. 
Images were generated in PyMOL. Predicted catalytic residues (Asn167, His168, Arg215, and Tyr222) are 
highlighted in white. Each putative substrate-binding residue is colored according to the effect of mutating 
each residue on activity toward HA (red), poly-GlcUA (green), and poly-ManA (blue). The specific activity 
of the mutants against each substrate was scaled to the intensity of the corresponding color. The hydrogen 
bond between Tyr225 and Arg312 is highlighted by a yellow dashed line. 
 
Interestingly, mutations with similar effects on substrate specificity clustered 
together in the homology model. For example, H221F and Y225F both favored poly-ManA 
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cleavage and are localized to the left side of the active site, whereas Y115F and R312L 
both favored poly-GlcUA cleavage and are localized to the right side. Finally, W171A 
favored both poly-ManA and poly-GlcUA cleavage and is located in the middle of the 
active site (Figure 3.5). 
 
3.3.9 Changes in Optimal pH of R312L Mutant 
Our previous work concluded Smlt1473 was a multifunctional lyase that exhibited 
broad but pH-regulated substrate specificity, with optimal HA activity at pH 5, poly-
GlcUA activity at pH 7, and poly-ManA activity at pH 9 (9). Given the highly pH-sensitive 
nature of wild-type Smlt1473, it was important to differentiate whether the nine mutations 
changed the specific activity or the optimal pH of the enzyme against a given substrate. To 
that end, the pH optimum of each of the nine mutants was determined by measuring the 
activity at 1 pH unit above and below the optimal pH of wild-type Smlt1473 (pH 4-6 for 
HA, pH 6-8 for poly-GlcUA, and pH 8-10 poly-ManA). All mutants were found to exhibit 
optimal pH values identical to wild type with the exception of R312L against poly-GlcUA 
and poly-ManA, where the optimal pH was 1 unit less than that of wild-type Smlt1473 (pH 
6 for poly-GlcUA and pH 8 for poly-ManA) (Figure 3.6). Interactions between catalytic 
residues and nearby charged residues have been shown to significantly influence the 
apparent pKa value of the catalytic residues (34). Based on the homology model of 
Smlt1473, the side chain of Arg312 lies ~8 Å from the catalytic His168 and Tyr222 (Figure 
3.3C and 3.5), and it lies 3 Å from the hydroxyl group of Tyr225, which in turn lies 3 Å 
from the catalytic Tyr222 (Figure 3.3B and 3.5). Disruption of the interaction between Tyr225 
and Arg312 was estimated by PROPKA 3.1 (35–38) to increase the pKa of Tyr225 by 1.24. 
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A similar shift of 1.46 was estimated upon mutation of the corresponding arginine in 1QAZ 
(11). The hydrogen bond between the side chains of Tyr225 and Arg312 is highlighted in 
Figure 3.5 by a yellow dashed line. Given the close proximity of Tyr225 to Arg312 and the 
catalytic Tyr222, it is possible that Arg312 influences catalysis indirectly via Tyr225 (Figure 
3.5). 
 
Figure 3.6: Determination of shifted optimal pH of mutant Smlt1473 against poly-GlcUA (A) and poly-
ManA (B). Wild-type Smlt1473 and a R312L mutant were mixed with 1 mg/ml of either poly-GlcUA or 
poly-ManA in 30 mM buffers at indicated pH. Enzymatic activity was monitored by TBA method. 100% 
activity was taken as the activity of wild-type Smlt1473 at the optimal pH for a given substrate. All reactions 
were performed in triplicate and error is reported as standard deviation. 
 
3.4 DISCUSSION 
The homology model of Smlt1473 revealed a cluster of basic residues (Lys42, 
Lys162, Arg163, and Arg218) located at the entrance of the active site cleft immediately 
adjacent to the catalytic tetrad (Figure 3.1). Similar positive patches observed in the crystal 
structures of HA lyases from S. pneumoniae and S. agalactiae are thought to participate in 
substrate binding by drawing the negatively charged polysaccharide toward the active site 
via electrostatic attraction (6, 31). Therefore, we predicted that mutation of residues located 
in the positive patch of Smlt1473 would result in an overall reduction of enzymatic activity 
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regardless of substrate. As shown in Figure 3.3E, mutants K42L, K162L, R163L, and 
R218L resulted in diminished activity toward each substrate with the exception of K42L, 
which exhibited a modest (11%) increase in activity toward poly-ManA. Furthermore, each 
positive patch mutant displayed reduced enzymatic efficiency toward poly-GlcUA and 
poly-ManA, with the exception of K162L, which exhibited a modest (10%) increase in 
efficiency toward poly-GlcUA (Figure 3.4). In general, arginine mutations (R163L and 
R218L) appeared to have a greater detrimental effect on activity and enzyme efficiency 
than lysine mutations (K42L and K162L), implying the arginine residues play a more 
important role in substrate attraction and neutralization, perhaps due to the ability of the 
guanidinium group to interact with the C6 carboxylate of the substrate in three different 
orientations and form a larger number of electrostatic interactions, such as salt bridges and 
hydrogen bonds, compared with lysine (39, 40). 
Multiple sequence alignment of Smlt1473 with the PL-5 lyases listed in the CAZy 
database (2) revealed that Trp171 was conserved across all members of this family. Given 
the high degree of conservation and predicted location in the center of the active site cleft 
(Figure 3.3D), we anticipated a significant role for Trp171 in regulation of enzyme activity. 
Further evidence in favor of a role for conserved tryptophan in regulation of lyase activity 
comes from previous studies on the effect of mutating an analogous, conserved tryptophan 
residue (W292A) in the PL-8 HA lyase from S. pneumoniae, which retained 4% activity 
compared with wild type (10). Interestingly, crystal structures of the W292A mutant 
revealed that the HA substrate was still bound to the active site but was misaligned with 
respect to the catalytic residues (10). Consistent with the role of tryptophan aligning HA 
substrates within the active site, the analogous W171A in Smlt1473 resulted in essentially 
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complete elimination of HA activity (Figure 3.3H). However, in unexpected contrast, 
W171A exhibited increased activity toward poly-ManA and poly-GlcUA (Figure 3.3H), 
implying this residue was not essential for the optimal positioning of these additional 
substrates, but rather it was specific to HA. One possible explanation for this contrast in 
activities for different substrates is that HA is composed of repeating heterodisaccharide 
units of GlcUA and N-acetylglucosamine (GlcNAc), whereas poly-GlcUA and poly-ManA 
are both homopolysaccharides. The β-elimination mechanism of PLs requires that an 
uronic acid be present in the +1 subsite; therefore, the heterodisaccharide repeat of HA 
could require additional, unique positioning in the active site conferred by Trp171 (Figure 
3.7). Thus, Trp171 plays a key role in Smlt1473 in conferring activity for HA and is 
analogous to other tryptophan residues in related HA lyases where it is essential for activity 
by appropriately positioning the heterodisaccharide repeat within the active site for 
catalysis. 
 
Figure 3.7: Structural difference between HA and poly-GlcUA. HA is comprised of repeating disaccharide 
units of GlcUA and GlcNAc, whereas poly-GlcUA is a homopolymer of GlcUA. The β-elimination 
mechanism of PLs requires an uronic acid in the +1 subsite, therefore HA could require additional, unique 
positioning in the active site due to fewer cleavable bonds (designated by blue arrows) and compared to poly-
GlcUA and the presence of the bulky N-acetyl group (designated by red circle) absent in poly-GlcUA. 
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The remaining four substrate-binding mutants can be split into two groups with 
opposite effects on substrate specificity; H221F and Y225F exhibited increased activity 
and specificity for poly-ManA (Figure 3.33F), and Y115F and R312L exhibited increased 
activity and specificity for poly-GlcUA (Figure 3.3G). Based on the model proposed by 
Shaya et al. (8), it is interesting to consider the structural differences between poly-ManA 
and poly-GlcUA and how those differences dictate which residues in the active site 
undergo substrate binding and effect the overall positioning of the substrate with respect to 
the catalytic residues. In their model for heparinase II, the residue responsible for proton 
abstraction during the β-elimination mechanism is dependent on the structure of the 
substrate itself. For heparin cleavage, a histidine residue accepts the proton, whereas for 
heparan sulfate cleavage, a tyrosine located on the opposite side of the substrate accepts 
the proton. This model is based on the fact that heparin contains mostly GlcUA, whereas 
heparan sulfate contains mostly iduronic acid, the C5 epimer of GlcUA. The H5 proton 
abstracted during catalysis points in opposite directions for each substrate and therefore 
can only be abstracted by the catalytic residue it faces. Similarly, GlcUA and ManA are 
C2 epimers of each other, with the second hydroxyl group pointing down in the equatorial 
position for GlcUA and up in the axial position for ManA (Figure 3.8 top). Computational 
studies and x-ray crystallography have shown that this subtle difference has a dramatic 
effect on the polymeric structure (41, 42), namely poly-GlcUA favors a 21 helix (similar to 
cellulose) with 180° turns between each subsequent residue, whereas poly-ManA favors a 
32 helix with 120° turns between each residue. This results in poly-GlcUA having a planar 
shape with the substituents of every other residue pointing in the same direction (41). 
Alternatively, poly-ManA has a more rod-like shape with the sugar rings of three 
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subsequent residues lying in three separate planes (Figure 3.8 bottom) (42). Crystal 
structures of poly-ManA in complex with A1-III alginate lyase from Spingomonas sp. 
show that bound substrate retains the 32 confirmation with minor distortions between the 
-1 and +1 residues (4, 14). There is currently no crystal structure of a lyase in complex with 
poly-GlcUA, but because poly-ManA retains its native structure upon binding, one might 
consider that poly-GlcUA would do the same and therefore lead to dramatic changes in 
relative activity dependent on orientation of the substrates in the active site due to their 
unique structures (Figure 3.8). These structural differences likely account for the opposite 
effects of a single mutant on poly-ManA and poly-GlcUA activity and specificity. Further 
confirmation of this idea will require more detailed, high resolution structures of poly-
GlcUA-specific lyases with bound substrate to compare against poly-ManA-specific 
lyases. 
 
Figure 3.8: Structural differences between poly-ManA and poly-GlcUA. Top, chair diagram of GlcUA and 
ManA, which are C2 epimers of each other. The C2 hydroxyl group is pointing down in the equatorial 
position for GlcUA and pointing up in the axial position for ManA. Bottom, three-dimensional structure of 
poly-GlcUA in a 21 helix (41) and poly-ManA in 32 helix (42). Structures were downloaded from PolySac3Db 
and rendered in PyMOL. 
 
103 
 
To better understand the effect of mutations H221F, Y225F, Y115F, and R312L on 
substrate specificity, the corresponding residues were located in the solved crystal structure 
of A1-III alginate lyase in complex with poly-ManA tetrasaccharide (PDB code 4F13) (14) 
and analyzed for protein-protein and ligand/protein interactions (43) in an effort to explain 
the increased or decreased poly-ManA activity exhibited by the above mutants. However, 
these interactions must be evaluated with caution, because most mutations will lead to 
subtle structural changes that are difficult to predict. As stated previously, there are 
currently no solved crystal structures of a lyase in complex with poly-GlcUA; therefore, 
an equivalent analysis for poly-GlcUA activity could not be performed. The H221F mutant 
exhibited increased poly-ManA activity (Figure 3.3F) and substrate affinity (Table 3.2). 
The equivalent His245 forms a hydrogen bond with O3 of the +1 sugar ring. Although 
mutation to phenylalanine results in the loss of that hydrogen bond, the larger six-carbon 
ring was predicted to double the surface area between this residue and the +1 sugar ring 
(43), perhaps resulting in a stronger C–H/π interaction and therefore increased substrate 
binding. Interestingly, the Nϵ2 group of His245 lies 3.2 Å away from the C2 equatorial 
position of the -1 sugar ring, which is where the C2 hydroxyl group of poly-GlcUA would 
be located, implying the histidine would be capable of hydrogen bonding with both O3 and 
O2 of poly-GlcUA. The loss of this additional hydrogen bond may account for the decrease 
in poly-GlcUA activity observed for the H221F mutant. The Y225F mutant exhibited 
increased poly-ManA activity (Figure 3.3F) with little change in Km (Table 3.2), implying 
this mutation influences catalytic activity instead of substrate binding. The equivalent 
Tyr249 forms a partially stacked interaction with the -1 ManA sugar ring and a hydrogen 
bound with the side chain of Arg342 (equivalent to Arg312 in Smlt1473). Mutation to 
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phenylalanine would preserve the C–H/π interaction with the substrate but eliminate the 
hydrogen bond with arginine. Disruption of the interaction between Tyr225 and Arg312 in 
R312L also influenced the optimal pH of Smlt1473 (Figure 3.6), implying this bond plays 
an indirect role in catalysis. 
The Y115F mutant exhibited reduced poly-ManA activity (Figure 3.3G), yet 
increased substrate affinity (Table 3.2). The equivalent Tyr137 forms a partially stacked 
interaction with the +1 sugar ring. Mutation to phenylalanine may increase the C–H/π 
interaction between the residue and sugar ring and prevent release of the unsaturated 
product, therefore resulting in a decrease in overall activity but an increase in substrate 
affinity. The R312L mutant exhibited reduced poly-ManA activity (Figure 3.3G) and 
reduced substrate affinity (Table 3.2). The equivalent Arg342 forms a salt bridge with the 
carboxylic acid group of the -1 sugar ring. Electrostatic attraction between positively 
charged amino acids and the negatively charged substrate is a key factor in polysaccharide 
binding, and therefore it is not surprising that a mutation to leucine results in a decrease in 
substrate binding and activity. With regard to the increased poly-GlcUA activity of R312L, 
Arg312 may not be involved in neutralizing the carboxyl group of the -1 GlcUA sugar ring 
due to the structural differences between poly-ManA and poly-GlcUA (Figure 3.8). 
Removal of the arginine side chain may trigger a conformational change in the active site 
cleft that facilitates poly-GlcUA cleavage. Clearly, further structural analysis of Smlt1473 
is required to fully elucidate the effect of each mutation on enzymatic activity and substrate 
specificity. 
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3.5 CONCLUSION 
Overall, our results also point to the utility of a sequence structure guided approach 
in the identification of key residues responsible for regulating poly-ManA, poly-GlcUA, 
and HA activity in Smlt1473. By utilizing a homology model based on 1QAZ (Figure 3.1), 
we were able to identify nine key residues within the predicted active site, and we found 
point mutations that led to dramatic increases in activity as well as selectivity for poly-
GlcUA and poly-ManA. The ability to engineer a high degree of selectivity yet retain 
potent activity for a given substrate is of increasing interest in processing naturally 
occurring polysaccharides such as alginate and glucuronan for a diverse array of 
applications, including biomass pre-processing for fermentation-based biofuel production 
and generating defined chemical compositions and sizes of polysaccharides as drug 
delivery systems. Previous studies have used random mutagenesis coupled to selection to 
identify poly-α-L-guluronic (poly-GulA)-specific alginate lyases by randomly mutating 
AlyA from Klebsiella pneumoniae, which natively exhibited both high poly-MG and poly-
GulA activity. Although effective in identifying poly-GulA-specific lyases, the increase in 
selectivity came at the expense of significantly reduced overall activity (16). In contrast, 
our sequence-structure guided approach was able to focus our initial search to a narrow set 
of nine conserved residues, with point mutations giving rise to highly active and specific 
poly-ManA and poly-GlcUA lyases. Moreover, our results highlight the structural 
plasticity of the Smlt1473 active site, with key residues important for conferring activity 
to HA (Trp171), poly-GlcUA (His221 and Tyr225), and poly-ManA (Tyr115 and Arg312), 
enabling engineering of selectivity for a particular substrate. Future studies are focused on 
probing the structural specificity responsible for poly-GlcUA, which will enable 
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comparison of substrate structure with active site binding and catalysis to determine what 
role substrate structure plays in enzyme activity, selectivity, and catalysis. 
 
3.6 ABBREVIATIONS 
The abbreviations used in this chapter are as follows: PL, polysaccharide lyase; 
GlcUA, D-glucuronic acid; ManA, D-mannuronic acid; HA, hyaluronan; TBA, 
thiobarbituric acid; PL-5, polysaccharide lyase family 5; GlcNAc, N-acetylglucosamine; 
GulA, L-guluronic acid. 
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CHAPTER 4 
ENGINEERED GLUCURONAN ACTIVITY FROM AN EXOLYTIC 
POLYSACCHARIDE LYASE FROM STENOTROPHOMONAS MALTOPHILIA 
K279A 
Macroalgae represents a promising source of fermentable carbohydrates for use 
in the production of energy efficient biofuel. The primary carbohydrate in brown algae is 
the uronic acid-containing alginate, whereas green algae contains a significant amount of 
glucuronan. A necessary step in the conversion of these polyuronides to bioethanol is 
saccharification, which can be achieved by enzymatic or chemical degradation. 
Polysaccharide lyases are a class of enzymes which cleave uronic-acid containing glycans 
via a β-elimination mechanism, acting both endo- and exolytically on their substrates. In 
the present work, we characterize a putative alginate lyase from Stenotrophomonas 
maltophilia K279a (Smlt2602) and describe a H208F mutant that, in addition to cleaving 
alginate-based substrates, displays significant exolytic glucuronan activity. To our 
knowledge this is the first polysaccharide lyase to act exolytically on glucuronan and is an 
attractive candidate for the broad-spectrum digestion of polyuronides into fermentable 
monomers. 
 
4.1 INTRODUCTION 
Rising energy costs, diminishing fossil fuel resources, and increased greenhouse 
gas emissions have magnified the need to produce environmentally friendly biofuels via 
the microbial fermentation of readily available biomass. Macroalgae is a promising 
biomass source due to its cultivation requiring no arable land or fresh water, minimizing 
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any economical cost due to loss of farmland currently dedicated to food production (1). 
Algae is also capable of sequestering significant amounts of carbon from the atmosphere 
and metabolizing nutrients found in industrial effluents and municipal wastewater (2). 
Furthermore, the lack of lignin in algae allows for the simple and inexpensive extraction 
of polysaccharides (3). The primary carbohydrate in brown algae is alginate, whereas green 
algae contains significant amounts of glucuronan and its derivatives (3,4). Alginate is a 
linear copolymer comprised of repeating units of D-mannuronic acid (ManA) and L-
guluronic acid (GulA) arranged in three block types: repeating units of poly-β-D-ManA, 
repeating units of poly-α-L-GulA, and alternating units of ManA and GulA (poly-MG). 
Glucuronan is a homopolymer of D-glucuronic acid (GlcA), the C2 epimer of ManA (5). 
Saccharification of these uronic-acid containing polysaccharides is a necessary step in their 
conservation to bioethanol (6).  
Carbohydrate modifying enzymes offer a promising approach to produce 
fermentable monomers (7). Polysaccharide lyases (PLs) are a class of carbohydrate 
modifying enzymes which cleave uronic-acid containing polysaccharides via a β-
elimination mechanism, resulting in the formation of a double between C4 and C5 of the 
sugar group at the new nonreducing end (8). This unsaturated product can detected by 
monitoring absorbance at 235 nm (9). Successful high-yield recombinant expression and 
purification, ease of product detection, and selectively for uronic acid monomers, which 
are found in many difficult to ferment glycans, makes this class of enzymes advantageous 
for polysaccharide processing (5,10,11). Previously we reported an endolytic 
polysaccharide lyase (Smlt1473) from Stenotrophomonas maltophilia K279a that 
exhibited a unique pH-sensitive substrate specificity that could be significantly modified 
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through the mutation of residues located in the active site cleft but not directly involved in 
the catalytic process. We demonstrated that single point mutations H221F and R312L 
resulted in increased activity and specificity towards poly-ManA and poly-GlcA, 
respectively. These and other residues were selected on the basis of sequence alignment 
and homology modeling, and were hypothesized to participate in substrate-binding and the 
precise positioning of the cleavable glycosidic bond with respect to the catalytic tetrad 
(5,12).  
In the present work we characterize an exolytic polysaccharide lyase (Smlt2602) 
from S. maltophilia K279a and undertake a similar approach to that of Smlt1473. Wildtype 
Smlt2602 (WT) acts on alginate and each of its block structures, with highest activity 
towards poly-ManA. Mutation of putative catalytic residues reveals that Tyr264 and His418 
likely play the role of the general acid and base, respectively. Interestingly, we isolated a 
H208F mutant that exhibits significant exolytic activity towards poly-GlcA, a non-alginate 
based substrate that Smlt2602 is virtually inactive against. Thus, unlike Smlt1473 in which 
substrate specificity was only modified, we are able to engineer significant novel activity 
into Smlt2602 via a sequence and homology model based approach. To our knowledge, 
this is the first characterized bacterial lyase to demonstrate exolytic alginate and poly-GlcA 
activity and is another example of the structural plasticity in certain polysaccharide lyases 
which could be applied to the design of highly active and specific enzymes for use in glycan 
saccharification. 
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4.2 MATERIALS AND METHODS 
4.2.1 Homology modeling 
The exolytic alginate lyase Alg17c (Protein Data Bank 4OJZ) from 
Saccharophagus degradans 2-40 was chosen as a template for constructing a homology 
model of Smlt2602 due to having the highest sequence identity (50%) among 
polysaccharide lyases with solved crystal structures (18). The model was built in SWISS-
MODEL(42-44) and all images were generated in PyMOL (45). 
 
4.2.2 Subcloning, expression, and purification 
Unless otherwise stated, standard molecular biology techniques were used for 
subcloning and site-directed mutagenesis (46). An E. coli codon-optimized nucleotide 
sequence of smlt2602 (NCBI GeneID 6393623) was subcloned into pET28a(+) 
(Invitrogen) as a BamHI-XhoI insert. Mutagenic primers were designed via PrimerX 
(bioinformatics.org/primer) and point mutations were generated via QuikChange II Site-
directed Mutagenesis kit (Agilent Technologies). Mutations were confirmed by DNA 
sequencing (GeneWiz). Expression and purification were carried out in E. coli BL21(DE3) 
cells as described previously (5). Fractions were assayed for protein content via Bradford 
reagent (Bio-Rad), SDS-PAGE and immunoblotting as described previously (5). Samples 
containing purified Smlt2602 were pooled together and dialyzed against 4 L of 20 mM 
sodium phosphate buffer (pH 8.5), 100 mM NaCl, 5% v/v glycerol, 20 mM imidazole for 
20 hours at 4°C and then 20 mM sodium phosphate buffer (pH 8.5) for 40 hours at 4°C 
with one buffer exchange. Protein concentration was determined via absorbance 
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measurements at 280 nm and molar extinction coefficients estimated from primary amino 
acid sequences (13). 
 
4.2.3 Polysaccharide substrates 
Low viscosity sodium alginate and heparin were obtained from Sigma-Aldrich. 
Chondroitin sulfate and poly-GalA were obtained from Alfa Aesar. Hyaluronic acid, 
potassium salt from human umbilical cord, and heparin sulfate were obtained from MP 
Biomedicals and Sagent Pharmaceuticals, respectively. Poly-GlcA was prepared from 
Avicel PH-105 NF (FMC Biopolymer) and its structure confirmed by 1H NMR as 
described previously (5). Poly-ManA, poly-GulA and poly-MG were prepared via partial 
acid hydrolysis of sodium alginate and structure was confirmed by 1H NMR as described 
previously (5). All prepared polysaccharide samples were dialyzed against 4 L of ddH2O 
for 40 hours at 4°C with one buffer exchange, lyophilized, and stored as powders at 4°C 
until needed. 
 
4.2.4 Enzyme activity assays 
The β-elimination mechanism of polysaccharide lyases creates a double bond 
between C4 and C5 of the sugar ring at the newly formed nonreducing end whose 
accumulation can be monitored by measuring the change in absorbance at 235 nm (9). 
Absorbance measurements were taken in 1 second intervals over the course of at least 5 
minutes via an Ultrospec 3300 UV-Vis spectrophotometer with a detection limit of 0.001 
absorbance units at 235 nm per minute, as described previously (5). One unit of enzyme 
activity was defined as an increase in absorbance at 235 nm of 1.0 per minute at 25°C (1 
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unit = 1 ΔA235 nm min-1) (5,10). In general, 3.5 μg of purified wild-type and mutant 
Smlt2602 was added to a solution containing 1 mg/ml substrate in a final volume of 350 
μl. The pH of all reactions was controlled via specific buffers for a given pH range at a 
total ionic strength of 20 mM (acetate for pH 4-6, phosphate for pH 6-8.5, Tris for pH 7-9 
and glycine for pH 9-10).  
Additionally, the Michaelis constant (KM) and turnover number (kCAT) of wild-type 
Smlt2602 and H208F mutant against alginate, poly-ManA, poly-GulA, poly-MG and poly-
GlcA was determined by varying substrate concentration. An extinction coefficient of 6150 
M-1 cm-1 at 235 nm was used to convert absorbance values to product concentration (11,12). 
Initial rates (vi) were fit to the Michaelis-Menten equation, v = kCATE0S/(KM + S) with a 
generalized reduced gradient (GRG2) nonlinear optimization program (47). The R2 and 
correlation values for each enzymes against each substrate were greater than 0.989 and 
0.993, respectively. All reactions were carried out in triplicate and error is reported as 
standard deviation. Lyase activity was independently determined via the thiobarbituric acid 
(TBA) method as described previously (12,48). 
 
4.2.5 Circular dichroism 
Enzyme samples (300 μl) at 250 μg/ml in 20 mM sodium phosphate buffer (pH 8.5) 
were added to 1-mm path length quart cuvettes (Starna) and ellipticity was measured from 
190 to 260 nm in a J-815 circular dichroism spectrometer (JASCO) at a scan speed of 100 
nm/min with three accumulations per sample. 
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4.2.6 High-performance Liquid Chromatography (HPLC) of unsaturated sugar products 
Size-exclusion chromatography experiments were performed on an Agilent 1100 
series HPLC value system equipped with a 96-well autosampler and UV-visible detector. 
Wild-type and mutant Smlt2602 at a final concentration of 10 μg/ml was added to 
polyManA or polyGlcA at a final concentration of 1 mg/ml in 20 mM sodium phosphate 
buffer, pH 8.5, and incubated for 6 hours at room temperature. The reaction mixture (15 
μl) was injected into a TSKgel SuperOligoPW column (Tosoh) equipped with 
corresponding guard column. The mobile phase was 20 mM sodium phosphate buffer (pH 
8.5) plus 250 mM NaCl and the flow rate was 0.3 ml/min. Unsaturated uronic acid products 
were detected by absorbance at 235 nm. Polyethylene glycol (molecular weight 600, 1000 
and 2000; Alfa Aesar), D-glucuronic acid (Acros Organics) and xylose (Spectrum) were 
used as molecular weight standards to generated a calibration curve. 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Substrate Specificity Analysis Revealed that Smlt2602 is an Alginate-Specific Lyase 
 An E. coli codon-optimized nucleotide sequence of smlt2602 was subcloned into 
pET28a(+) as a BamHI-XhoI insert without a stop codon, resulting in the recombinant 
lyase containing a C-terminal His6 tag. Expression was carried out in E. coli BL21(DE3) 
cells at 18°C and Smlt2602-His6 was purified by passing soluble cell lysate over a Ni
2+-
bound chelating Sepharose column as described previously (5). Approximately 60 mg of 
enzyme was purified per liter of induced cultured. An SDS-PAGE and anti-His6 
immunoblot (Figure 4.1A) confirmed the presence of purified Smlt2602 at the expected 
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molecular weight of ~80.8 kDa, predicted from the primary amino acid sequence of 
Smlt2602-His6 without signaling peptide (13). 
 
Figure 4.1: Purification and substrate specificity of Smlt2602 WT. (A) SDS-PAGE and immunoblot of wild-
type Smlt2602. Lane L: Precision Blue Plus protein marker (Bio-Rad). Lane 1: SDS-PAGE of purified wild-
type Smlt2602. Lane 2: Anti-His6 immunoblot of purified wild-type Smlt2602. (B) Specific activity of 
Smlt2602 WT against 1 mg/ml of the indicated substrate in 20 mM sodium phosphate buffer, pH 8.5. 
Enzymatic activity was monitored by change in absorbance at 235 nm. All reactions were performed in 
triplicate and error is reported as standard deviation. 
 
The enzymatic activity of purified Smlt2602 was tested against the following ten 
polyuronides: alginate, poly-ManA, poly-GulA, poly-MG, poly-GlcA, poly-α-D-
galacturonic acid (poly-GalA), hyaluronan, heparin, heparan sulfate, and chondroitin 
sulfate. Of these substrates, significant activity was measured for alginate and each of its 
block structures (Figure 4.1B and Table 4.1) at an optimal pH of 8.5 (Figure 4.2). The 
highest overall specific activity (661.9 ± 29.1 units/mg) was for poly-ManA, which is 
among the highest reported for exolytic poly-ManA degradation (14-16). Smlt2602 
exhibited approximately half the activity towards alginate (328.3 ± 27.0 units/mg) and 
poly-MG (289.3 ± 9.8 units/mg) and the lowest activity towards poly-GulA (190.3 ± 8.3 
units/mg). No product formation was detected for the remaining substrates with the 
exception of poly-GlcA, towards which Smlt2602 displayed minimal yet measurable 
activity (2.8 ± 0.4 units/mg, less than 0.5% that of poly-ManA) (Figure 4.1B and Table 
4.1). 
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Table 4.1: Substrate specificity of Smlt2602 mutants. Purified wild-type and mutant Smlt2602 was added 
to 1 mg/ml of each substrate in 20 mM sodium phosphate buffer at pH 8.5 for alginate-based polysaccharides 
and pH 8 for poly-GlcA. Enzymatic activity was monitored by absorbance at 235 nm. In addition to the 
substrates listed below, each enzyme was tested against poly-GalA, heparin, heparan sulfate, and hyaluronic 
acid, with no detectable activity. All reactions were performed in triplicate and error is reported as standard 
deviation. 
 
Specific Activity (ΔA235nm min-1 mg-1) 
Alginate poly-ManA poly-GulA poly-MG poly-GlcA 
WT 328.3 ± 27.0 661.9 ± 29.1 190.3 ± 8.3 289.3 ± 9.8 2.8 ± 0.4 
Possible involvement in β-elimination mechanism 
Y455F 3.6 ± 0.3 4.0 ± 0.4 15.3 ± 1.4 11.5 ± 0.1 0.2 ± 0.1 
Enhanced poly-GlcA Activity 
H208A 48.2 ± 3.5 83.2 ± 4.2 6.3 ± 0.8 3.6 ± 0.4 3.1 ± 0.8 
H208W 185.3 ± 11.8 490.8 ± 4.1 48.5 ± 1.0 117.1 ± 7.8 7.1 ± 0.6 
H208F 88.4 ± 4.0 189.7 ± 4.1 9.5 ± 0.8 23.3 ± 1.0 77.2 ± 1.2 
Additional putative substrate-binding residues 
R143L 224.1 ± 13.9 245.4 ± 15.3 95.5 ± 2.5 159.0 ± 9.2 1.1 ± 0.3 
Q153A 129.0 ± 3.5 456.4 ± 26.4 30.3 ± 3.5 73.6 ± 4.4 0.2 ± 0.1 
Q153N 113.8 ± 9.9 323.7 ± 17.1 83.4 ± 2.6 108.7 ± 10.7 0.9 ± 0.2 
L155A 158.5 ± 9.5 597.6 ± 46.9 28.4 ± 0.9 89.6 ± 1.4 0.3 ± 0.1 
L155N 125.6 ± 12.6 512.7 ± 23.2 42.4 ± 2.9 131.9 ± 4.8 0.3 ± 0.2 
N201L 380.1 ± 9.2 915.8 ± 31.9 138.6 ± 12.9 255.3 ± 9.9 3.1 ± 0.7 
H206F 73.9 ± 2.3 147.8 ± 3.9 57.0 ± 2.9 73.2 ± 0.2 0.4 ± 0.1 
Y258F 173.4 ± 9.1 346.2 ± 16.1 88.7 ± 6.0 127.7 ± 9.5 0.5 ± 0.1 
Y263F 36.1 ± 0.4 83.5 ± 1.7 5.3 ± 0.6 13.5 ± 1.4 0.2 ± 0.1 
 
 
Figure 4.2: Optimal pH of Smlt2602 WT against alginate. The pH of each reaction was maintained by the 
indicated buffer at 20 mM total ionic strength. Enzyme activity was monitored by TBA method. All reactions 
were performed in triplicate and error is reported as standard deviation. 
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4.3.2 Identification of Putative Catalytic and Substrate-Binding Residues via Sequence 
Alignment and Homology Modeling  
 Polysaccharide lyases are divided into 22 families based on sequence, with the 
structure of at least one protein in each family determined. Comparison of solved crystal 
structures reveals that lyases from different families contain vastly different secondary 
structure content and thus overall fold (8). Smlt2602 is assigned to the PL-17 family, along 
with Alg17c from Saccharophagus degradans 2-40, whose structure has recently been 
solved and revealed to contain two domains: an N-terminal imperfect α-barrel and C-
terminal β-sheet domain (17,18). The circular dichroism spectrum of purified Smlt2602-
His6 is indicative of a protein containing both α-helices and β-sheets (Figure 4.3). 
Prediction of the secondary structure from the measured spectrum estimated that Smlt2602-
His6 is 30% α-helical and 25% β-sheet (19), in close agreement with the secondary 
structure content of Alg17c (39% α-helical and 26% β-sheet) (18). Furthermore, Smlt2602 
shares 50% sequence identity with Alg17c (Figure 4.4 top). Given that Smlt2602 contains 
the expected secondary structure content for a polysaccharide lyase belonging to the PL-
17 family and exhibits significant sequence homology with Alg17c, another member of the 
same family, the high-resolution crystal structure of Alg17c (Protein Data Bank 4OJZ) was 
selected as the template to construct a homology model of Smlt2602 (Figure 4.4 bottom). 
 In spite of diverse substrate specificity, secondary structure content, and tertiary 
folds, the β-elimination mechanism of PLs is remarkably conserved across the 22 families. 
The reaction proceeds via three chemical steps: (i) neutralization of the negatively charged 
C6 carboxylate group on the +1 sugar ring, reducing the pKa of H5, thereby facilitating its 
abstraction; (ii) removal of H5 by a general base; and (iii) electron transfer resulting in the 
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formation of a double bond between C4 and C5 of the +1 sugar ring and simultaneous 
protonation of O4 by a general acid resulting in the cleavage of the C4-O-C1 glycosidic 
bond (20). Biochemical and structural characterization of Alg17c identified a tyrosine 
residue (Tyr258) that is predicted to act as the general acid. This assertion is supported by 
the fact that the residue is in the correct orientation with respect to the glycosdic bond to 
donate a proton to O4 during the catalytic process and mutation of this tyrosine to 
phenylalanine abolished enzymatic activity (18). The corresponding tyrosine in Smlt2602 
(Tyr264) is highlighted in blue in Figure 4.4 and was utilized as an anchor point to 
approximate the location of the tunnel-like active site in Smlt2602. Park et al. proposed 
that Asn201 and His202 act as the neutralizing groups, whereas Tyr450 acts as the general 
base. All three of these residues were conserved in Smlt2602 (Asn207, His208, and Tyr455) 
and are highlighted in orange in Figure 4.4. 
 
Figure 4.3: Circular dichroism spectrum of wild-type and mutant Smlt2602. All proteins were measured at 
250 µg/ml in 20 mM sodium phosphate buffer, pH 8.5. 
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Figure 4.4: Identification of putative catalytic and substrate-binding residues in Smlt2602. Sequence 
alignment (top) and homology model (bottom) of Smlt2602 with S. degradans Alg17c lyase (Protein Data 
Bank 4OJZ) (18). Identical residues are highlighted in green. The tyrosine residue predicted to act as the 
general acid in the β-elimination mechanism is highlighted in blue (18). Residues predicted to be located near 
the active site cleft and to participate in either the catalytic mechanism or substrate-binding are highlighted 
in orange. 
 
Previous studies of PLs have revealed that polar and charged residues located in the 
active site cleft form hydrogen bonds and salt bridges with the hydroxyl and carboxyl 
groups of the substrate (8). In addition, aromatic side chains undergo C-H/π interactions 
with the sugar rings of the glycan substrate (21). The summation of these interactions 
results in the precise positioning of the polysaccharide substrate with respect to the 
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catalytically active residues for optimal enzymatic cleavage (22,23). Our own study of 
Smlt1473 confirmed that residues such as tyrosine, histidine, and arginine located in the 
active site cleft significantly influence substrate specificity and overall activity (12). To 
this end, we identified eight putative substrate-binding residues (Arg143, Gln153, Leu155, 
Asn201, His206, Tyr258, Tyr263, and His418) highlighted in orange in Figure 4.4, whose side 
chains are within 10 Å of the putative catalytic Tyr264 in the Smlt2602 homology model. 
Thus, a total of 12 residues were selected for analysis via site-directed mutagenesis in an 
effort to elucidate their role in Smlt2602, four of which are predicted to participate directly 
in the β-elimination mechanism (Asn207, His208, Tyr264 and Tyr455) and eight of which are 
predicted to bind and properly position the substrate in the active site (Arg143, Gln153, 
Leu155, Asn201, His206, Tyr258, Tyr263, and His418) (Figure 4.4). 
 
4.3.3 Site-directed Mutagenesis of Putative Catalytic Residues Indicates a Tyrosine and 
Histidine Act as Acid and Base 
 As stated previously, the β-elimination mechanism of PLs involves three steps: 
neutralization of the negatively charged substrate, proton abstraction by a general base, and 
proton donation by a general acid (20). Despite the significant structural diversity found 
among PLs, the residues responsible for each of the aforementioned steps appear to be 
highly conserved and fall into two general categories: (i) lyases that require a divalent 
cation (usually Ca2+) to act as the neutralizing group, and (ii) lyases that do not require a 
divalent cation and instead one or more polar or charged residues (usually arginine, 
asparagine, or glutamine) in close proximity to the C6 carboxylate group act as the 
neutralizing group. In the former category, a lysine or arginine acts as the base and water 
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as the acid. In the latter, a tyrosine or histidine acts as the base and tyrosine as the acid (8). 
For example, the crystal structure of Streptococcus pneumoniae hyaluronate lyase in 
complex with substrate revealed that the amide group of Asn239 fulfills the role of 
neutralization by interacting with the glycan carboxylate group in a bidentate fashion, and 
Tyr408 and His399 act as the acid and base, respectively (24). Similarly, the crystal structure 
of Sphingomonas sp. A1-III alginate lyase in complex with its substrate revealed that in 
addition to Asn191, the guanidinium group of Arg239 acts as the neutralizing group, with a 
single tyrosine residue (Tyr246) acting as both acid and base (25). As discussed above, Park 
et al. proposed a third mechanism for Alg17c in which Asn201 and His202 act as neutralizing 
groups, with Tyr258 acting as the acid and Tyr450 as the base. Given that Smlt2602 and 
Alg17c both belong to PL-17, we hypothesize that Smlt2602 has a catalytic mechanism 
most similar to Alg17c, in which two tyrosine residues, Tyr264 and Tyr455 in Smlt2602, play 
the role of general acid and base, respectively, and Asn207 and His208 neutralize the 
substrate (Figure 4.4). To test this hypothesis we prepared four inactivating mutants 
(N207L, H208F, Y264F, and Y455F) and measured their enzymatic activity against 
alginate and each of its block structures (Figure 4.5A). In order to confirm that any 
observed variations in activity are not due to an overall distortion of the active site 
architecture, the CD spectrum of each mutant lyase (N207L, H208F, Y264F, H419F, and 
Y455F) was collected and compared to WT (Figure 4.3). There was a less than 6% 
variation in the CD signal for each lyase, indicating that the overall secondary structure of 
Smlt2602 was not significantly perturbed by the point mutations. 
 The N207L and Y264F mutants are found to be completely inactive against alginate 
and all three block types (Figure 4.5A), whereas the H208F mutant exhibits reduced 
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activity towards each substrate tested, with approximately 30% WT activity against 
alginate and poly-ManA, and 5 and 8% WT activity  against poly-GulA and poly-MG, 
respectively (Figure 4.5A and Table 4.1). Our data is in close agreement with the kinetic 
parameters determined for mutants of the corresponding residues in Alg17c (18) and 
supports the hypothesis that Asn207 and His208 act as neutralizing groups and Tyr264 as the 
proton donor during the catalytic process. Given that N207L is a null mutant while H208F 
retains significant enzymatic activity, the Asn207 residue likely plays a more crucial role in 
the neutralization of the glycan carboxylate. Moreover, mutation of His208 to phenylalanine 
appears to have a significantly greater detrimental effect on poly-GulA and poly-MG 
activity compared to alginate and poly-ManA (Figure 4.5A and Table 4.1), implying this 
residue is more critical for the neutralization of the +1 sugar carboxylate group when that 
sugar is GulA. 
 
Figure 4.5: Mutagenesis of putative catalytic residues. (A) Specific activity of wild-type Smlt2602 and 
N207L, H208F, Y264F, H418F, and Y455F mutants against 1 mg/ml alginate-based substrates in 20 mM 
sodium phosphate buffer, pH 8.5. Enzyme activity was monitored by absorbance at 235 nm and confirmed 
via the TBA method (inset). For the TBA method, activity of Smlt2602 WT against each substrate was taken 
to be 100%. (B) Location of His418 and Tyr455 with respect to polysaccharide substrate, indicating each residue 
lies axial to the presumed location of the C5 proton (dashed black lines). Image generated from crystal 
structure of Alg17c from S. degradans 2-40 (Protein Data Bank 4OJZ) in complex with alginate trisaccharide 
(shown in purple). Residues in orange are His418 and Tyr450 of Alg17c which correspond to His418 and Tyr455 
of Smlt2602 (18). 
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The Y455F mutant exhibits significantly diminished yet measurable activity 
towards alginate and each of its block types (Figure 4.5A). More specificity, the mutant 
displays less than 1% alginate and poly-ManA activity compared to WT, yet approximately 
8 and 4% WT activity towards poly-GulA and poly-MG, with specific activities of 15.3 ± 
1.4 and 11.5 ± 0.1 units/mg, respectively (Figure 4.5A and Table 4.1). Y445F activity was 
confirmed via the TBA method (Figure 4.5A, inset). Although the measured enzymatic 
rates are minimal, the fact that the Y455F mutant demonstrates any residual activity 
suggests that Tyr455 may not act as the proton acceptor in the β-elimination mechanism of 
Smlt2602. To that end, we consulted the Smlt2602 homology model (Figure 4.4) and the 
Alg17c crystal structure (18) in search of an additional residue that could possibly act as 
the base. We located a nearby histidine in Smlt2602 (His418) whose corresponding histidine 
in Alg17c (His415) lies on the same side of the substrate and is within 4.3 Å of the C5 
position of the +1 sugar ring, implying it could abstract the C5 proton during catalysis 
(Figure 4.5B, dashed line). Therefore, we prepared a H418F mutant and tested its ability 
to cleave alginate-based substrates. We detected no increase in absorbance at 235 nm nor 
product formation via the TBA method, supporting the hypothesis that His418 is essential 
for catalysis (Figure 4.5A). 
 Given the above results, we propose that Tyr264 acts as the proton donor in 
Smlt2602 and one of two scenarios is taking place with regards to the general base: (1) 
His418 acts as the proton acceptor, resulting in a catalytic mechanism similar to the 
hyaluronate lyase of Streptococcus pneumoniae (24). In this regime, Tyr455 may stabilize 
an intermediate product of catalysis, explaining the diminished yet measurable activity of 
the Y455F mutant; or (2) Tyr455 acts as the proton donor, resulting in a catalytic mechanism 
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similar to Alg17c (18). In this regime, the His418 residue may act as a surrogate, yet less 
efficient, proton acceptor in the absence of Tyr264, also explaining the diminished yet 
measureable activity of the Y445F mutant. In an effort to elucidate which mechanism is 
more likely, we considered the fact that the ionizable residue acting as the general base 
must be deprotonated at the pH at which the enzymatic reaction occurs. Therefore we 
estimated the pKa of the phenolic ring of Tyr
455 and the imidazole ring of His418 using 
PROPKA (26-29), which predicts shifts in pKa resulting from interactions with the 
microenvironment surrounding the residue of interest (30). Based on the Smlt2602 
homology model (Figure 4.4), the pKa of Tyr
455 was predicted to be shifted to 17.6, whereas 
the pKa of His
418 was 5.1. Similarly, the model based on the Alg17c crystal structure in 
complex with the alginate trisaccharide (Protein Data Bank 4OJZ) predicted the pKa values 
of the corresponding tyrosine and histidine to be 15.4 and 3.84, respectively. Based on 
these estimations and given that Smlt2602 exhibited optimal activity at pH 8.5 (Figure 4.2), 
is unlikely that Tyr455 would be deprotonated and therefore cannot act as the general base 
during catalysis. Conversely, His418 would be deprotonated and able to fulfill the role of 
the catalytic base. Thus, we conclude the most likely catalytic mechanism for Smlt2602 is 
as follows: Asn207 and His208 act as neutralizing groups, His418 acts as the general base, and 
Tyr264 acts as the general acid.   
 
4.3.4 Isolation of an H208F Mutant that Exhibits Significant Poly-GlcA Acid Activity 
 
Mutation of His208 to phenylalanine resulted in an overall reduction in enzymatic 
activity towards alginate and each of its block structures (Figure 4.5A and Table 4.1). 
However, the ratio of poly-ManA to poly-GulA activity shifted from 3.5 for WT to 20 for 
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H208F, indicating that mutation of His208 significantly influenced the substrate specificity 
of Smlt2602 at the expense of overall enzymatic activity (Figure 4.5A and Table 4.1). The 
Nϵ2 of the corresponding histidine in Alg17c (His202) lies 2.7 Å from the carboxylic O6A, 
3.2 Å from O5, 3.9 Å from the hydroxyl O2, and 4.4 Å from the glycosidic O4 of the +1 
ManA sugar. Furthermore, the imidazole ring lies parallel to the +2 GulA ring at a distance 
of 3.8 Å (18). Given these multiple points of contact between the substrate and the side 
chain of His208, as well as the shift in substrate specificity with respect to poly-ManA, we 
postulate that His208 of Smlt2602 plays an important role in regulating substrate specificity 
and merits further evaluation.  
Remarkably, substrate specificity analysis of H208F revealed that the mutant lyase 
exhibited significant enzymatic activity towards poly-GlcA, a non-alginate based substrate 
(Figure 4.6 and Table 4.1). To our knowledge, no other characterized PL-17 lyase has been 
shown to cleave poly-GlcA (17). The specific activity of H208F against poly-GlcA (77.2 
± 1.2 units/mg) is a 28-fold increase over WT poly-GlcA activity (2.8 ± 0.4 units/mg) and 
is within an order of magnitude of WT alginate activity (328.3 ± 27.0) (Figure 4.6 and 
Table 4.1). Moreover the H208F poly-GlcA activity is on the same order of magnitude as 
other poly-GlcA specific lyases (5,31,32). Note that the optimal pH of activity was slightly 
shifted from pH 8.5 for alginate-based substrates to pH 8 for poly-GlcA (Figure 4.7). 
Substrate-dependent variations in optimal pH have been demonstrated before in PLs and 
may be indicative of slightly different binding of each substrate (5).  
In the interest of determining if the novel poly-GlcA activity was specific for the 
phenylalanine mutation or if any mutation of His208 would recapitulate the H208F result, 
we generated two other mutant lyases (H208A and H208W) and measured their ability to 
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digest poly-GlcA. H208A was indistinguishable from WT, whereas H208W demonstrated 
a minute 2-fold increase in activity (7.1 ± 0.6 units/mg) (Figure 4.6). Thus our results 
indicate that the novel poly-GlcA activity displayed by mutation of His208 is at least 
partially specific to the phenylalanine substitution (Figure 4.6 and Table 4.1). 
 
Figure 4.6: Enhanced polyGlcA activity via mutagenesis of His208 residue. Specific activity of WT and 
H208A, H208W, H208F mutants against 1 mg/ml poly-GlcA in 20 mM sodium phosphate buffer, pH 8. 
Enzymatic activity was monitored by change in absorbance at 235 nm. All reactions were performed in 
triplicate and error is reported as standard deviation. 
 
 
Figure 4.7: Optimal pH of H208F mutant against poly-GlcA. The pH of each reaction was maintained by 
the indicated buffer at 20 mM total ionic strength. Enzyme activity was monitored by TBA method. All 
reactions were performed in triplicate and error is reported as standard deviation. 
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4.3.5 Size-exclusion Chromatography Analysis of Carbohydrate Products formed by 
Smlt2602 and H208F Revealed an Exolytic Mode of Action 
PLs are known to act on polyuroides endolytically, exolytically, or a combination 
of both. Endolytic lyases bind to the polysaccharide substrate internally, cleave one 
glycosidic bond, and detach, resulting in the simultaneous accumulation of multiple 
unsaturated products of various sizes (31,33-35). Exolytic enzymes bind to the non-
reducing end of the polysaccharide substrate and cleave off mono-, di-, or trisaccharides 
until the entire macromolecule has been digested, resulting in the accumulation of 
predominantly one unsaturated product, with little to no accumulation of differently sized 
oligosaccharides (11,35-37). The hyaluronate lyases of Streptococcus sp. exhibit a hybrid 
mechanism in which hyaluronan is digested by an initial random endolytic cleavage and 
subsequent exolytic processing into disaccharides (24). Multiple PL-17 lyases, including 
Alg17c, have been shown to act exolytically on their alginate substrates, reducing the 
polysaccharide to unsaturated monomers (38-40). Due to Smlt2602 belonging to the same 
family and sharing 50% sequence identity with Alg17c, we predicted that Smlt2602 is an 
exolytic lyase.  
To test this hypothesis, the carbohydrate products formed during Smlt2602 
cleavage of both poly-ManA and poly-GlcA were analyzed by size-exclusion 
chromatography (Figure 4.8). Briefly, poly-ManA and poly-GlcA was digested with WT 
and H208F, respectively. After 6 hours the reaction mixture was separated on a TSKgel 
SuperOligoPW column and unsaturated products were detected by monitoring absorbance 
at 235 nm. A series of molecular weight standards were also run to assist in determining 
the molecular weight of the sugar products (Figure 4.8, dashed vertical lines). The most 
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prominent peak observed for poly-ManA and poly-GlcA eluted between the peaks of D-
glucuronic acid and xylose, which have molecular weights of 194 and 150 Da, respectively. 
A calibration curve was generated from the standards and the molecular weight of this most 
prominent species was estimated to be 166 Da, in close agreement with the molecular 
weight of ManA and GlcA unsaturated monomers (176 Da). This is consistent with the 
exolytic mode of action observed in other PL-17 lyases.  
 
Figure 4.8: Analysis of unsaturated sugar products formed by Smlt2602 WT against poly-ManA (top) and 
H208F mutant against poly-GlcA (bottom). HPLC chromatograms of products formed 6 hours after addition 
of enzyme. Dashed vertical lines indicate the elution time of molecular weight standards (PEG2000, 
PEG1000, PEG600, D-glucuronic acid and xylose from left to right), labeled with their respective molecular 
weights. 
 
As stated previously, exolytic cleavage usually results in the accumulation of a 
single sugar species. A single species was detected for the poly-GlcA run (Figure 4.8 
bottom), whereas an additional peak of lower abundance was detected for the poly-ManA 
run. This second species was estimated to have molecular weight of 378 Da, in close 
134 
 
agreement with the molecular weight of a disaccharide comprised of a saturated and 
unsaturated uronic acid (368 Da) (Figure 4.8 top). Given that WT demonstrates the lowest 
activity towards poly-G (Figure 4.1B and Table 4.1), it is possible this secondary product 
is a Δ-GulA dimer, where Δ represents the unsaturated sugar. Regardless, the accumulation 
of unsaturated monomers is indicative of an exolytic mode of action for Smlt2602 and 
H208F against poly-ManA and poly-GlcA, respectively. To our knowledge, this is the first 
characterized bacterial PL with exolytic alginate and poly-GlcA activity (17).  
 
4.3.6 Kinetic Parameters of Smlt2602 and H208F  
In order to evaluate the effect the His208 to phenylalanine mutation had on substrate 
binding and product conversion, the Michaelis constant (KM) and the turnover number 
(kCAT) of WT and H208F were determined for alginate, poly-ManA, poly-GulA, poly-MG, 
and poly-GlcA (Table 4.2). The two parameters are dependent on one another and their 
ratio (kCAT/KM) is considered a measure of enzyme efficiency (23,25). Note that although 
KM may approximate substrate affinity, it is also affected by other rate and equilibrium 
constants, and therefore kCAT/KM is used as a descriptive parameter for substrate binding 
(41). As can be seen is Table 4.2, the kCAT values for WT trend with the specific activity 
measured for each substrate (Figure 4.1B), with poly-ManA having the highest turnover 
rate (62.2 s-1) and alginate, poly-GulA, and poly-MG all having approximately half that 
rate (34.8, 34.6, and 22.2 s-1, respectively). WT also exhibited residual turnover of poly-
GlcA (0.4 s-1). The KM values of WT for the alginate-based substrates followed a similar 
trend, with poly-ManA having the lowest KM value (0.41 mM), reflective of the highest 
substrate affinity. Interestingly, the KM value of poly-GulA (5.99 mM) is at least 4-fold 
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higher than any other substrate, including poly-GlcA. Thus, the enzyme efficiency of WT 
towards poly-GulA (5.8 mM/s) was the lowest for all the alginate-based substrates and is 
indicative of poor poly-GulA binding. Overall, our results demonstrate that WT is an 
alginate-specific lyase, with highest substrate affinity and product turnover for poly-ManA 
(Table 4.2). 
Table 4.2: Kinetic parameters of WT and H208F mutant. Smlt2602 WT and H208F mutant were added 
to 10 different solutions containing 7.8 to 4000 µg/ml substrate in 20 mM sodium phosphate buffer at pH 8.5 
for alginate-based polysaccharides and pH 8 for poly-GlcA. Enzymatic activity was monitored by absorbance 
at 235 nm and all reactions were performed in triplicate. Turnover rate (kCAT) was calculated using an 
extinction coefficient of 6150 M-1 cm-1 for the unsaturated product (11,12). KM values are based upon an 
effective molecular weight of 176 for the monosaccharide unit, the smallest product formed by Smlt2602 
during catalysis (12,52). 
 WT H208F 
kCAT (s-1) KM (mM) kCAT/KM kCAT (s-1) KM (mM) kCAT/KM 
Alginate 34.8 0.67 52.2 14.6 1.35 10.8 
polyManA 62.2 0.41 151.8 21.3 0.41 51.5 
polyGulA 34.6 5.99 5.8 1.4 2.22 0.7 
polyMG 22.2 0.57 38.7 2.0 0.98 2.1 
polyGlcA 0.4 1.40 0.3 6.1 0.57 10.6 
 
The H208F mutant demonstrated decreases in kCAT for all alginate-based substrates 
relative to WT (Table 4.2), in agreement with the measured specific activities for each 
substrate (Figure 4.4A). Furthermore, H208F displayed a 15-fold increase in turnover rate 
for poly-GlcA (Table 4.2), reflective of the 28-fold increase in specific activity relative to 
WT (Figure 4.6). This increase in kCAT was coupled with a decrease in KM from 1.4 mM 
for WT to 0.57 for H208F, on pair with the binding of poly-ManA (0.41 mM) for each 
enzyme. The increase in turnover rate and decrease in Michaelis constant resulted in 35-
fold increase in enzyme efficiency towards poly-GlcA, from 0.3 for WT to 10.6 for H208F. 
This value for enzyme efficiency is on the same order of magnitude as WT efficiency 
towards alginate (Table 4.2) and within one order of magnitude of the value for Smlt1473, 
an endolytic lyase highly active against poly-GlcA (5). Overall, our results demonstrate 
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that H208F is multifunctional PL, with significant binding and exolytic turnover of both 
alginate- and glucuronan-based substrates (Table 4.2), which, to our knowledge, is 
unprecedented for PLs (17). 
It is interesting to consider the structural differences between the GlcA and ManA 
sugar residues in the context of explaining the increase in poly-GlcA activity observed for 
the H208F mutant. The only structural difference between the ManA and GlcA monomers 
is the positioning of the C2 hydroxyl group. In ManA the hydroxyl group points up, axial 
to the sugar ring, whereas in GlcA it points down, equatorial to the ring (8). As stated 
previously, the Nϵ2 of the histidine in Alg17c corresponding to His208 in Smlt2602 lies 3.9 
Å away from the C2 hydroxyl group of the +1 ManA sugar and the two atoms likely form 
a hydrogen bond. This bond would be disrupted upon mutation to phenylalanine and may 
account for the reduced enzymatic efficiency of the H208F mutant towards poly-ManA. 
Given that ManA and GlcA are C2 epimers, the Nϵ2 of His208 would be unlikely to form a 
hydrogen bond with the C2 hydroxyl of the +1 sugar due to the hydroxyl group pointing in 
the opposite direction relative to the sugar ring. Therefore the His208 mutation would not 
affect binding of poly-GlcA at this position. This, of course, does not explain the novel 
poly-GlcA activity of H208F, but it is an example of how the same point mutation can have 
divergent effects of two chemically related substrates. A high-resolution crystal structure 
of Smlt2602 and H208F in complex with poly-ManA and poly-GlcA would be required to 
fully elucidate the mechanism behind the enhanced poly-GlcA activity of H208F. 
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4.3.7 Substrate Analysis of Additional Putative Substrate-binding Mutants 
Residues located in the active site cleft but not directly involved in the β-elimination 
mechanism are thought to participate in substrate binding and alignment with respect to 
the catalytically active residues to allow for optimal cleavage of the glycosidic bond. 
Mutation of such residues in the endolytic lyase Smlt1473 resulted in significant changes 
in substrate specificity and overall enzyme activity and thus could be applied to designing 
highly active and specific endolyases (12). In an effort to explore whether the same 
principle applies for exolytic lyases and given that the H208F mutant exhibited significant 
poly-GlcA activity that was absent from WT, we mutated seven additional putative 
substrate-binding residues (Arg143, Gln153, Leu155, Asn201, His206, Tyr258, Tyr263, and 
His418), identified via homology modeling (Figure 4.4). A total of ten mutants were 
prepared (R143L, Q153A, Q153N, L155A, L155N, N201L, H206F, Y258F, Y263F, and 
H418F) with some residues being mutated to two different amino acids. Although all of 
the additional mutants, with the exception of N201L against poly-ManA, displayed an 
overall decrease in activity that was independent of substrate, a number of them did exhibit 
significant changes in substrate specificity towards alginate and its three block types (Table 
4.1).  
Given that WT is most active against poly-ManA, we analyzed the mutants by 
calculating the ratio of poly-ManA activity to poly-GulA activity or poly-MG, designated 
“RM/G” and “RM/MG”, respectively (Table 4.3). All RM/G and RM/MG values were greater than 
unity, therefore all mutant lyases remained most active towards poly-ManA compared to 
poly-GulA and poly-MG. The RM/G and RM/MG values for WT are 3.5 and 2.3, respectively. 
An increase in either value over WT represented a shift in substrate specificity towards 
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poly-ManA over the other substrate. Four of the mutants (R143L, Q153N, H206F, and 
Y258F) displayed minimal changes in RM/G and RM/MG relative to WT. The rest exhibited 
significant increases in both RM/G and RM/MG, indicating that the point mutations were 
causing the mutant lyases to favor ManA-ManA linkages, which are the predominant bond 
found in poly-ManA, over GulA-GulA, ManA-GulA, and GulA-ManA linkages found in 
the other two substrates (Table 4.3). Given that RM/G and RM/MG trended together, we 
focused our analysis on comparing the RM/G ratio to the overall poly-ManA activity (Figure 
4.9). 
Table 4.3: Substrate specificity ratios of mutant lyase. Ratios were calculated by dividing the poly-ManA 
activity of each mutant over the poly-GulA or poly-MG activity. 
 ManA/GulA ManA/MG 
WT 3.5 ± 0.1 2.3 ± 0.1 
R143L 2.6 ± 0.1 1.5 ± 0.1 
Q153A 15.1 ± 1.5 6.2 ± 0.3 
Q153N 3.9 ± 0.1 3.0 ± 0.3  
L155A 21.1 ± 0.6 6.7 ± 0.1 
L155N 12.1 ± 0.8 3.9 ± 0.1 
N201L 6.6 ± 0.6 3.6 ± 0.1 
H206F 2.6 ± 0.1 2.0 ± 0.1 
Y258F 3.9 ± 0.2 2.7 ± 0.2  
Y263F 15.7 ± 1.7 6.2 ± 0.6 
 
The mutant lyases were found to group into four general categories, colored coded 
in Figure 4.9. The first category comprised of R143L, Q153N, H206F, and Y258F (Figure 
4.9, red). These mutants displayed minute changes in substrate specificity compared to WT 
and exhibited ≤ 52% overall poly-ManA activity. Thus, mutation of these residues impedes 
either binding or catalysis, independent of substrate. The second category comprised of 
Q153A, L155A, and L155N (Figure 4.9, green). The overall poly-ManA of each of these 
mutants was ≥ 68% of WT and the RM/G values were ≥ 12, indicating these lyases were 
highly selective for poly-ManA with overall activity on pair with WT. The third category 
comprised of Y263F (Figure 4.9, purple) which displayed the lowest overall poly-ManA 
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activity (12.6%) and RM/G value of 15.7, indicating the mutant is highly selective for poly-
ManA, but catalysis is severely impeded. Given its close proximity to the catalytic acid 
(Tyr264) it is likely that Tyr263 plays an indirect role in catalysis (Figure 4.4). The fourth 
category comprised of N201L (Figure 4.9, blue), the only mutant to exhibit an increase in 
overall poly-ManA activity (138%). Furthermore, the RM/G value was 6.6, almost twice 
that of WT. Therefore this mutant is both highly active and specific for poly-ManA. Overall 
our results show that it is possible to modulate the substrate specificity of Smlt2602 through 
mutation of residues located near the catalytic core. 
 
Figure 4.9: Substrate specificity and overall activity of mutant lyases. The substrate specificity ratio 
(RM/G), defined as the ratio of poly-ManA activity over poly-GulA activity, with respect to overall poly-
ManA activity for each mutant lyase. Mutants were found to group in four general categories as discussed in 
the text. Note that 100% activity was taken as the activity of WT against poly-ManA. 
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4.4 CONCLUSIONS 
In summary, we describe the characterization of a PL-17 polysaccharide lyase from 
Stenotrophomonas maltophilia K279a which exolytically degrades alginate. Through 
homology modeling we identified a key residue (His208) thought to be involved in 
substrate-binding, and upon mutation we were able to introduce novel exolytic poly-GlcA 
activity into the lyase. Numerous exolytic polysaccharide lyases have been described 
which degrade alginate (15), poly-GalA (42), hyaluronan (24), heparan sulfate (43), and 
chondroitin sulfate (44). To our knowledge, no lyase has even been described that 
exolytically digests both alginate and poly-GlcA. Used in conjunction with the 
multifunctional endolytic lyase Smlt1473, which is also active against alginate and poly-
GlcA, Smlt2602 could be utilized to efficiency digest algae polysaccharides into 
fermentable monomers for biofuel production. Furthermore, our work demonstrates the 
possibility of engineering substrate specificity into lyases, which has applications not only 
in energy production, but in the design of glycan-based therapeutics as well. 
 
4.5 ABBREVIATIONS 
The abbreviations used in this chapter are as follows: ManA, D-mannuronic acid; 
GulA, L-guluronic acid; poly-MG, alternating units of ManA and GulA; GlcA, D-
glucuronic acid; PL, polysaccharide lyases; WT, wildtype Smlt2602; GalA, D-galacturonic 
acid. 
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CHAPTER 5 
A SECRETED ANKYRIN-REPEAT PROTEIN FROM CLINICAL 
STENOTROPHOMONAS MALTOPHILIA ISOLATES DISRUPTS ACTIN 
CYTOSKELETAL STRUCTURE 
 
In memory of Hanlon MacDonald, who we lost on August 22nd, 2013 
 
 
The work described in this chapter has been published in “A 
Secreted Ankyrin-repeat Protein from Clinical 
Stenotrophomonas maltophilia Isolates Disrupts Actin 
Cytoskeletal Structure” by Logan C. MacDonald, Sean 
O’Keefe, Mei-Fan Parnes, Hanlon MacDonald, Lindsey 
Stretz, Suzanne Templer, Emily L. Wong, and Bryan W. 
Berger, ACS Infectious Diseases (2015) 
 
 
Stenotrophomonas maltophilia is an emerging, multi-drug resistant pathogen of 
increasing importance for the immunocompromised, including cystic fibrosis patients. 
Despite its significance as an emerging pathogen, relatively little is known regarding the 
specific factors and mechanisms that contribute to its pathogenicity. We identify and 
characterize a putative ankyrin-repeat protein (Smlt3054) unique to clinical S. maltophilia 
isolates that binds F-actin in vitro and co-localizes with actin in transfected HEK293a 
cells. Smlt3054 is endogenously expressed and secreted from clinical S. maltophilia 
isolates, but not an environmental isolate (R551-3). The in vitro binding of Smlt3054 to F-
actin resulted in a thickening of the filaments as observed by TEM. Ectopic expression of 
Smlt3054-GFP exhibits strong co-localization with F-actin, with distinct, retrograde F-
actin waves specifically associated with Smlt3054 in individual cells as well as formation 
of dense, internal inclusions at the expense of retrograde F-actin waves. Collectively, our 
results point to an interaction between Smlt3054 and F-actin. Furthermore, as a potentially 
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secreted protein unique to clinical S. maltophilia isolates, Smlt3054 may serve as a starting 
point for understanding the mechanisms by which S. maltophilia has become an emergent 
pathogen. 
 
5.1 INTRODUCTION 
Stenotrophomonas maltophilia is a non-fermenting, Gram-negative, multidrug 
resistant bacilli that has gained significant attention as an emerging, opportunistic pathogen 
in immunocompromised patients (1,2). In particular, S. maltophilia is among the most 
prevalent bacteria responsible for ventilator-associated pneumonia, with longer treatment 
times and associated treatment costs required for S. maltophilia versus other prevalent 
pathogens (3). S. maltophilia is also increasingly found as part of chronic, multispecies 
bacterial infections in cystic fibrosis (CF) patients, with approximately 9% of CF patients 
in recent studies having co-infection of Pseudomonas aeruginosa and S. maltophilia (4). 
As a result, the attributed crude mortality of S. maltophilia infection was recently estimated 
to be as high as 37%, and S. maltophilia is among the 15 most prevalent pathogens isolated 
from pediatric patients in North America in the 2004 SENTRY Antimicrobial Surveillance 
Program (2). 
Although the significance of S. maltophilia as a nosocomial pathogen is clear, 
relatively few specific virulence factors that act directly on host cells have been identified. 
S. maltophilia clinical isolates test positive for extracellular protease and lipase activity, 
and recent studies have indicated that loss of extracellular protease activity associated with 
a type II secretion system (T2SS) reduces virulence in lung epithelial cell (A549) cultures 
(5-7). Several studies have focused on the role of biofilm formation in S. maltophilia 
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invasion and virulence, particularly in clinical isolates from CF patients. Of particular note, 
biofilm formation from both CF and non-CF isolates was associated with increased 
adhesion to epithelial respiratory cells, and clinical S. maltophilia isolates were observed 
to be capable of internalizing in both A549 and IB3-1 bronchial cells with rates ranging 
from 0.4 to 4.9% (8,9). Internalization provides one mechanism by which bacteria evade 
host detection, and in the case of S. maltophilia, the presence of internalized bacteria was 
consistent with its increased ability to persist during chronic lung infection (10). 
Interestingly, whereas adhesion to host cells was observed to correlate with biofilm 
formation, the rate of invasion was not correlated with biofilm formation. Thus, the specific 
factors responsible for S. maltophilia invasion and persistence, particularly in chronic lung 
infection, remain an active area of research. 
We describe the identification and characterization of a putative ankyrin-repeat 
containing protein unique to clinical isolates of S. maltophilia (Smlt3054, NCBI accession 
number SMLT_RS14540) that is secreted from clinical isolates of S. maltophilia, binds F-
actin in vitro, and affects cellular F-actin localization. Several bacterial pathogens, 
including Salmonella, Shigella, Rickettsia, and Listeria, are known to secrete effectors that 
disrupt F-actin structure and bundling in order to invade host cells during infection, with a 
steadily growing list of virulence factors that either act directly on actin or disrupt actin-
dependent signaling pathways (11,12). Furthermore, numerous bacterial pathogens secrete 
ankyrin-repeat containing proteins into their host to hijack various host functions (13). We 
find that Smlt3054 is endogenously expressed and secreted from S. maltophilia stains 
associated with infection and leads to disruption of cellular F-actin structure and 
localization when overexpressed in HEK293 cells. By tracking the fate of F-actin in 
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HEK293 cells overexpressing Smlt3054, we observe specific Smlt3054 binding to 
retrograde F-actin waves appearing at the leading edge of cells, which are regions of high 
membrane and F-actin turnover involved in cell motility. Purified Smlt3054 binds F-actin 
in vitro and TEM images reveal thickened, distorted F-actin fibers formed in the presence 
of added Smlt3054. Collectively, our results indicate Smlt3054 is a secreted protein from 
S. maltophilia clinical isolates that acts on F-actin in a manner consistent with a role in host 
cell cytoskeleton disruption, which may enhance invasion.  
 
5.2 MATERIALS AND METHODS 
5.2.1 Bacterial Strains and Genomic DNA Preparation 
Stenotrophomonas maltophilia K279a (TAX ID 522373) (14) was kindly provided 
by Robert Ryan (University College Cork). Clinical isolates of S. maltophilia were 
collected from patients as part of an IRB-approved study with the Lehigh Valley Health 
Network in Allentown, Pennsylvania, USA. All bacterial strains were cultured in 5 ml of 
LB broth at 37°C for 16 h before resuspension in 1 ml of LB broth containing 10% glycerol 
for long-term storage at -80°C. Genomic DNA was prepared from each isolate via standard 
molecular biology techniques (15). 
 
5.2.2 Cell Lines 
A549 (ATCC CRL-185), HEK293 (ATCC CRL-1573), and COS-7 (ATCC CRL-
1651) cells were cultivated in Dulbecco’s Modified Eagle Medium supplemented with 4.5 
g/l glucose and sodium pyruvate (Corning), 4 mM L-glutamine (Lonza), 10% fetal bovine 
serum (BioWest), and 1x Antibiotic Antimycotic solution (100 U/ml penicillin G, 100 
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μg/ml streptomycin, and 0.25 μg/ml amphotericin B) (Hyclone). Medium lacking phenol 
red was used for live cell imaging experiments.  
 
5.2.3 Genomic DNA Screening and Plasmid Preparation 
Gene specific oligonucleotide primers were designed on the basis of the nucleotide 
sequences of Smlt3054 (NCBI GeneID 6391502) with the necessary restriction enzymes 
added for cloning. Genomic DNA prepared from S. maltophilia K279a and the 20 clinical 
isolates of S. maltophilia were used as PCR templates. Smlt3054 was cloned into 
pMMB207 (ATCC 37809) as EcoRI/HindIII insert with a C-terminal HA epitope tag 
(YPYDVPDYA) for expression in S. maltophilia, pGFP2-N3 (BioSignal Packard) as a 
NheI/SacI insert with no stop codon for ectopic expression in HEK293, and pET28a(+) as 
a BamHI/XhoI insert with a stop codon for overexpression in Escherichia coli BL21(DE3) 
cells. Various fragments of Smlt3054 were cloned into pGL3 ctx-RFP ToxR for 
dimerization analysis. 
 
5.2.4 Expression of Smlt3054 in S. maltophilia and Cell Fractionation 
Either pMMB207-Smlt3054 or empty pMMB207 was electroporated into 
electrically competent S. maltophilia BB1 cells and plated on LB agar plates containing 10 
μg/ml chloramphenicol. All media were supplemented with 10 μg/ml chloramphenicol. 
Individual colonies were grown in 5 ml of LB broth for 16 h at 37°C, 200 rpm. The cultures 
were then diluted to an A600 of 0.8 in 5 ml of Brain-Heart Infusion broth and grown at 37°C, 
200 rpm for 1 h. After 1 h, protein expression was induced by the addition of 1 mM 
isopropyl 1-thio-β-D-galactopyranoside. Two 1 ml samples of cultures were harvested 16 
154 
 
h post induction by centrifugation at 17,000 x g for 30 min at 4°C. The medium supernatant 
was collected and filtered through a 0.2 μm syringe filter. One of the resulting pellets was 
resuspended in 200 μl of 4 M urea and designated the whole cell lysate sample. The 
periplasmic fraction of the second pellet was extracted as described previously (16). The 
whole cell lysate, periplasmic fraction, and medium supernatant were analyzed for the 
presence of HA-tagged Smlt3054 via immunoblotting as described below. For endogenous 
expression of Smlt3054, cells were processed as described above, and the media 
supernatant analyzed for the presence of Smlt3054 via immunoblotting as described below.  
 
5.2.5 Ectopic Expression in Mammalian Cells 
A549, HEK293, and COS-7 cells were suspended in ice-cold HEPES-buffered 
saline at a cell density of approximately 106 cells/ml and 200 μl of the cell suspension was 
mixed with vector DNA (15 μg per construct) in a total volume of 350 μl. The mixture was 
transferred to prechilled 2 mm electroporation cuvettes (USA Scientific) and 
electroporated via a Bio-Rad Gene Pulse XCell system using the preset parameters for the 
given cell type. Immediately after electroporation cells were transferred to 5 ml of media 
and placed in two 35 mm dishes containing gelatin-coated glass coverslips. After 24 to 36 
h the cells were fixed with 3.7% (w/v) paraformaldehyde in PBS. Coverslips were then 
washed twice with PBS and once with ddH2O before mounting onto microscope slides with 
fluoromount (Sigma-Aldrich).  
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5.2.6 Epifluorescence and Confocal Laser Scanning Microscopy 
Slides containing HEK293 cells were imaged via epifluorescence microscopy 
(Zeiss) at 20x and 40x magnification and via confocal laser scanning microscopy (Zeiss) 
at 63x magnification with an excitation wavelength of 488 nm for imaging GFP fused 
proteins and 543 nm for imaging tdTomato fused proteins. For live cell imaging, HEK293 
cells transfected with pGFP2-N3-Smlt3054 were cultivated on gelatin coated 30 mm round 
glass coverslips and mounted into a POCmini chamber heaters (PeCon GmbH, Erbach, 
Germany) containing phenol-red free medium and maintained at 37°C via stage and 
objective heaters (PeCon GmbH, Erbach, Germany). Images were collected on the Zeiss 
LSM confocal microscope every 20 s for 4 min.  
 
5.2.7 Expression and Purification of Recombinant Smlt3054 in E. coli 
The pET28a(+)-Smlt3054 vector was electroporated into E. coli BL21(DE3) cells 
and plated on LB agar plates containing 50 μg/ml kanamycin. For expression, all medium 
was supplemented with 50 μg/ml kanamycin. An individual colony was grown in 5 ml of 
LB broth for 16 h at 37°C, 200 rpm. Then 2 ml of saturated culture was added to 200 ml 
of LB broth and incubated for an additional 16 h at 37°C, 200 rpm. The culture was then 
diluted to an A600 of 0.8 in 800 ml LB broth and grown for 1 h at 18°C, 200 rpm. After 1 h, 
protein expression was induced by adding 1 mM isopropyl 1-thio-β-D-galactopyranoside 
and the culture was incubated at 18°C, 200 rpm for 20 h. Expression was confirmed via 
SDS-PAGE and immunoblotting as described below. 
For purification, cells were harvested at 8,000 x g for 15 min at 4°C, washed once 
in 20 ml of ice-cold PBS, resuspended in 20 ml PBS, and sonicated at 15 watts, 50% duty 
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for 30 min total processing time. The insoluble fraction containing recombinant His6-
tagged Smlt3054 was isolated by centrifugation at 17,000 x g for 30 min at 4°C and washed 
once in 20 ml PBS to remove any contaminating soluble proteins. The detergent 
concentration necessary for the extraction of Smlt3054 was determined by incubating the 
insoluble pellet in PBS containing various concentrations of sarkosyl, followed by 
centrifugation and analysis of the soluble fraction via SDS-PAGE (Figure 5.1).  
 
Figure 5.1: Extraction of Smlt3054 from insoluble fraction of E. coli lysate. Insoluble pellet containing His6-
tagged Smlt3054 was incubated via various concentrations of sarkosyl for 1 hour at room temperature. Then 
samples were clarified by centrifugation at 17,000 x g for 30 min at 4°C. Optimal extraction was observed at 
0.4% (w/v) sarkosyl, with minimal additional protein extracted at higher sarkosyl concentrations. 
 
Optimal Smlt3054 extraction was found to occur at sarkosyl concentrations of 0.4% 
(w/v) (Figure 5.1). Thus, Smlt3054 was extracted by incubating the insoluble pellet in 
Buffer A (1x PBS, 250 mM NaCl, 0.4% (w/v) sarkosyl) for 1 h at room temperature, 
followed by centrifugation at 17,000 x g for 30 min at 4°C. The solution was passed over 
a column containing 15 ml of Ni2+-bound Chelating Sepharose Fast Flow resin (GE 
Healthcare) pre-equilibrated in Buffer A at a flow rate of 2 ml/min via a BioLogic LP 
chromatography system (Bio-Rad) with a fraction collector. The column was washed for 
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80 min with Buffer A before applying a gradient from 0 to 30% Buffer B (1x PBS, 250 
mM NaCl, 0.4% (w/v) sarkosyl, 500 mM imidazole) over the course of 120 min to remove 
weakly bound contaminating proteins. Smlt3054 was eluted from the column by running 
100% Buffer B for 30 min. Fractions were analyzed via SDS-PAGE and samples 
containing purified Smlt3054 were pooled together and dialyzed against 4 liters of 20 mM 
sodium phosphate buffer, pH 7.5, plus 0.05% sarkosyl for 48 h with two buffer exchanges. 
  
5.2.8 SDS-PAGE and Immunoblotting 
Protein samples (40 μl) were mixed with 10 μl of 5x Lammeli sample buffer and 
heated for 10 min at 90°C before loading 25 μl onto 4% stacking, 12% separating 
acrylamide gels with MES running buffer. Precision Plus All Blue Standard (Bio-Rad) was 
used as a molecular weight standard. Samples were run at 150 V and transferred to a 
nitrocellulose membrane (Amersham Biosciences Hybond ECL) for 90 min at 200 mA at 
4°C. Transfer was confirmed by staining with 0.1% Ponceau S. The membrane was then 
blocked overnight at 4°C with 5% fat-free milk in TBST and incubated 1 h at room 
temperature with primary antibody. For expression of Smlt3054 in S. maltophilia via 
pMMB207-Smlt3054, the primary antibody was mouse monoclonal anti-HA.11 tag 
(BioLegend) diluted 1000-fold in 5% BSA in TBST. For endogenous expression of 
Smlt3054 from clinical S. maltophilia isolates, a rabbit polyclonal antibody was developed 
against purified Smlt3054 (Lampire) and used at 1:5000 dilution. For expression of 
Smlt3054 in E. coli via pET28a(+)-Smlt3054, the primary antibody was mouse monoclonal 
anti-His6 tag (Cell Signaling) diluted 5000-fold in 5% fat-free milk in TBST. Membranes 
were then washed five times with TBST and incubated for 1 h at room temperature with 
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horseradish peroxidase-conjugated anti-mouse IgG secondary antibody (Cell Signaling) 
diluted 1000-fold in 5% BSA in TBST for pMMB207-Smlt3054 expression and diluted 
5000-fold in 5% fat-free milk in TBST for pET28a(+)-Smlt3054 expression. Membranes 
were washed five times with TBST, twice with TBS, and developed with ECL plus 
Western blotting detection reagents (RPN2132, GE Healthcare), a chemiluminescent 
horseradish peroxidase substrate. 
  
5.2.9 Circular Dichroism and Tryptophan Fluorescence Measurements 
Smlt3054 protein samples (300 μl) at 320 μg/ml (9.6 μM) in 2 mM sodium 
phosphate buffer pH 7.5 plus sarkosyl ranging in concentration from 0.01 to 1% (w/v) were 
added to 1-mm path length quartz cuvettes (Starna) and ellipticity was measured from 190 
to 260 nm in a J-815 circular dichroism spectrometer (JASCO). The scan speed was 200 
nm/min with three accumulations per sample. The same Smlt3054 protein samples (100 
μl) were added to a 96 well half-area UV transparent plate (USA Scientific) along with 
equimolar tryptophan solutions in equivalent buffers. Fluorescence emission spectra was 
collected from 310 to 450 nm with an excitation wavelength of 295 nm via an Infinite 
M200 PRO plate reader (Tecan). 
  
5.2.10 Actin-Binding Protein Centrifugal Assay 
For F-actin experiments, F-actin was prepared from rabbit skeletal muscle actin and 
an F-actin binding assay (Cytoskeleton) was performed as described previously (17). 
Briefly, 10 μl of Smlt3054 (85 μM) in 20 mM sodium phosphate buffer pH 7.5 plus 0.2% 
sarkosyl was mixed with 40 μl of F-actin (21 μM) in Actin Polymerization Buffer (5 mM 
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Tris pH 8, 0.2 mM CaCl2, 50 mM KCl, 2 mM MgSO4, 1 mM ATP) for a final Smlt3054 
and F-actin concentration of 17 μM and sarkosyl concentration of 0.4% (w/v). Control 
samples were also prepared with F-actin only and Smlt3054 only at equivalent 
concentrations and buffers, as well as F-actin plus α-actinin and F-actin plus BSA as 
positive and negative controls for F-actin binding, respectively (Figure 5.2). After 
incubation at room temperature for 30 min, samples were fractionated via 
ultracentrifugation at 150,000 x g for 1.5 h in an Airfuge (Beckman) to sediment actin 
fibers. The resulting pellet and supernatant of each condition were analyzed via SDS-
PAGE. 
 
Figure 5.2: Control experiment for Actin-Binding Protein Centrifugal Assay. F-actin was pre-incubated with 
α-actinin and BSA before fractionating each sample via ultracentrifugation as described by section 5.2.10 
Actin-Binding Protein Centrifugal Assay. (P: pellet formed after centrifugation, S: supernatant after 
centrifugation). F-actin alone (lane 1) sediments at high centrifugal speeds (lane 1P) whereas α-actinin alone 
(lane 2) remains in the soluble fraction (lane 2S). When F-actin is pre-incubated with α-actinin (lane 3), a 
known actin-binding protein, approximately half of the α-actinin co-sediments with F-actin (lane 3P). 
However, when F-actin is pre-incubated with BSA (lane 4), a protein known to not interact with actin, all of 
the BSA remains in the soluble fraction (lane 4S). 
 
For actin polymerization experiments, 10 μl of Smlt3054 (85 μM) in 20 mM sodium 
phosphate buffer pH 7.5 plus 0.2% sarkosyl was mixed with of 40 μl G-actin (21 μM) in 
General Actin Buffer (5 mM Tris-HCl pH 8.0, 0.2 mM CaCl2) for a final Smlt3054 and G-
160 
 
actin concentration of 17 μM and sarkoysl concentration of 0.4% (w/v). After incubation 
at room temperature for 30 min, 2.5 μl of 10x Actin Polymerization Buffer was added to 
induce the polymerization of G-actin into F-actin. Actin polymerization was allowed to 
proceed for precisely 30 min before samples were fractionated via ultracentrifugation at 
150,000 x g for 1.5 h in an Airfuge (Beckman) to sediment actin fibers. The resulting pellet 
and supernatant of each condition was analyzed via SDS-PAGE. 
 
5.2.11 Transmission Electron Microscopy (TEM) 
Solutions containing F-actin alone and F-actin plus purified Smlt3054 were 
prepared as described above with the exception of a final sarkosyl concentration of 0.01% 
(w/v). Samples were incubated for 30 min at room temperature before adding 10 μl of each 
to 300 mesh gold TEM disks containing an ultrathin carbon film on a holey carbon support 
film (Ted Pella). After incubation for 30 s at room temperature, excess liquid was blotted 
off and samples were negatively stained with 1% uranyl acetate for 1 min. Excess liquid 
was blotted off again and samples were air dried for 30 min. Disks were imaged on a JEM-
2000FX scanning electron microscope (JEOL) at 100,000x and 300,000x magnification. 
 
5.2.12 ToxR Dimerization Assay 
 Oligomerization of full-length and fragmented Smlt3054 was analyzed via 
TOXRED, a transcription factor-based dimerization assay, as described previously (18). 
Briefly, the transmembrane domain of ToxR, a transcription factor from Vibrio cholera 
(19), is replaced with the protein of interest. Dimerization of the resulting fusion protein 
leads to the binding of ToxR to the ctx promoter, which in turn leads to the expression of 
a bacterial codon-optimized form of mCherry, a red fluorescent protein. Therefore, an 
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increase in red fluorescence signal over background is indicative of dimerization of the 
protein of interest fused to ToxR (18). In the case of Smlt3054, the signal from the full-
length protein was compared to the signal from various protein fragments to see if one 
particular domain is responsible for Smlt3054 oligomerization. Briefly, pGL3 ctx-RFP 
ToxR-Smlt3054 constructs were transformed into TB1 cells and plated onto LB agar plates 
supplemented with 100 μg/ml ampicillin. All subsequent media was also supplemented 
with 100 μg/ml ampicillin. Individual colonies were cultured for 20 hours in LB medium 
at 37°C, 200 rpm before 150 μl of saturated culture was diluted into 2 ml of fresh LB 
medium at 37°C, 200 rpm. After 2 hours, 400 μl of each culture was transferred to a black 
96 well, clear bottom plate and diluted two fold in the subsequent rows. Replicates of three 
were performed for each construct and pGEX was used as a negative control. Red 
fluorescence and absorbance were measured with a Tecan Infinite 2000 plate reader. 
 
5.3 RESULTS 
 
5.3.1 Expression and Purification of Smlt3054 Resulted in a Soluble, Folded Protein 
We originally identified Smlt3054 through a comparative analysis of published 
genomes from S. maltophilia clinical isolates (K279a, Ab55555) versus environmental 
isolates (R551-3, SKA14), where it was identified as a hypothetical protein present 
exclusively in a subset of clinical isolates (1,14). The Smlt3054 gene (NCBI GeneID 
6391502) was isolated from S. maltophilia K279a genomic DNA and subcloned into 
pET28a(+). The primary amino acid sequence of the resulting recombinant protein is 
presented in Figure 5.3, including the N-terminal His6-tag added by pET28a(+) for IMAC 
purification (shown in bold, underlined) and three predicted ankyrin-repeat domains 
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(ANKs) located near the C-terminal of Smlt3054 (highlighted in purple, green, and blue). 
The 33-residue ANK is one of the most common amino acid motifs observed in nature and 
frequently appears in tandem repeats which cooperatively fold into structures that undergo 
protein-protein interactions, including interactions between host and microbial proteins 
(13). In addition to interacting with other target proteins, ankyrin-repeat containing proteins 
are also known to interact with themselves to form homomultimers (20-22). 
 
Figure 5.3: Primary amino acid sequence of recombinant His6-Smlt3054. The primary amino acid sequence 
of His6-Smlt3054 contains 308 amino acids, including the His6-tag added by pET28a(+) (highlighted in bold 
and underlined) used for IMAC purification and three predicted ANKs (highlighted in purple, green, and 
blue). The secondary structure of recombinant His6-Smlt3054 is 44.5% α-helical, as shown by the residues 
designated with a red “H” (24). The alignment of each ANK with the consensus sequence for ankyrin-repeats 
is also shown. Whereas overall sequence identity of each ANK is ≤ 58%, the most frequently conserved 
amino acids in the 33-residue motif are conserved for each ANK in Smlt3054 (39). 
 
Recombinant Smlt3054 was expressed and purified from E. coli (Figure 5.4A, B). 
The predicted molecular weight of His6-tagged Smlt3054 is 33.4 kDa, consistent with the 
most prominent band in Figure 5.4A, B (23). However, higher molecular weight species 
were detected by the anti-His6 antibody as well (Figure 5.4B), at approximately twice the 
molecular weight of monomeric His6-Smlt3054. Thus, our results imply that Smlt3054 
forms SDS-PAGE resistant multimers, consistent with other ankyrin-repeat containing 
proteins (20-22). Prediction of secondary structure using JPred4 (24) indicates that 
Smlt3054 is 44.5% α-helical (Figure 5.3) and is therefore consistent with the α-helical 
signal measured by circular dichroism (Figure 5.4C). Likewise, tryptophan fluorescence 
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emission spectra show a blue-shift as compared to free tryptophan (Figure 5.4D), indicative 
of partial burial of tryptophan side chains. Thus, we conclude that Smlt3054 is expressed 
and purified in a soluble form, with secondary and tertiary structures consistent with those 
of a folded protein. 
 
Figure 5.4: Expression and purification of recombinant Smlt3054. (A) SDS-PAGE gel of IMAC-purified, 
His6-tagged Smlt3054 expressed recombinantly from E. coli BL21 (DE3) cells. The molecular weight of 
Smlt3054 based on primary sequence plus the N-terminal His6-tag is 33.4 kDa. (B) Immunoblot using anti-
His6 monoclonal antibody confirming the presence of His6-tagged Smlt3054 in purified protein sample. (C) 
Circular dichroism spectra of purified Smlt3054 revealing an α-helical secondary structure, consistent with 
the predicted 44.5% α-helical structure for Smlt3054 from Jpred4 (24). (D) Tryptophan emission spectra for 
purified Smlt3054 blue-shifted relative to free tryptophan, consistent with burial of tryptophan residues 
present in Smlt3054.  
 
5.3.2 S. maltophilia Clinical Isolates Endogenously Express and Secrete Smlt3054 
Given that S. maltophilia is noteworthy in terms of its genetic diversity (25), we 
were interested in determining whether the Smlt3054 gene was prevalent in clinical isolates 
and how well conserved the primary amino acid sequence was between the various strains. 
Of the 20 clinical strains tested, 10 screened positive for the Smlt3054 gene. Sequencing 
of the Smlt3054 PCR products from each positive clinical strain revealed seven unique 
primary amino acid sequences, one of which was identical to Smlt3054 from S. maltophilia 
K279a, and six that shared between 93 and 95% sequence identity with Smlt3054 from S. 
maltophilia K279a (Figure 5.5).  
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Figure 5.5: Sequence alignment of Smlt3054 from S. maltophilia clinical isolates. Multiple sequence 
alignment of Smlt3054 from S. maltophilia K279a with the seven unique sequences of Smlt3054 found 
through translation of sequenced Smlt3054 PCR products obtained from the genomic DNA of S. maltophilia 
clinical strains containing the Smlt3054 gene. Mutations are highlighted in black with their positions in the 
sequence designated by asterisks. Three predicted ANKs are highlighted in purple, green, and blue. Note 
that dashes indicate a lack of DNA sequence information for that portion of the protein. Strain BB34 
contained sequence 1, strains BB01 and BB12 contained sequence 2, strains BB03, BB16, and BB22 
contained sequence 3, strain BB17 contained sequence 4, strain BB18 contained sequence 5, strain BB20 
contained sequence 6, and strain BB09 contained sequence 7. 
 
Each of the six divergent sequences contained between 11 and 17 point mutations 
distributed throughout the entirety of the protein (Figure 5.5). There were 35 positions in 
the Smlt3054 sequence where at least one of the divergent sequences contained a point 
mutation, marked by asterisks in Figure 5.5 and summarized in Table 5.1. Each of the six 
divergent sequences contained three identical point mutations (L88F, N111D, and F206A), 
a mutation at position 92 (S92M, S92T, or S92K), an insertion at position 126 (S126inL), 
and a series of mutations unique to each particular sequence (Figure 5.5 and Table 5.1). 
Notably, a number of mutations introduced charged residues (G17D, G33D, and G73D) or 
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reversed the type of charge present at that position (E70K). Our results provide further 
evidence that S. maltophilia exhibits an exceptional degree of genetic diversity even in 
strains isolated from the same hospital (25). 
Table 5.1: Mutations in Smlt3054 sequences. The position of each mutation is listed along with what 
residue is present in Smlt3504 from S. maltophilia K279a and what residue is present in each of the divergent 
Smlt3054 sequences. Hydrophobic residues are highlighted in green, polar in purple, positively charged in 
blue, and negatively charged in red. 
Position K279a 
Sequence Number 
1 2 3 4 5 6 7 
17 G  D  D D   
25 A   T     
26 G  A  A A   
32 A    P P   
33 G   D    D 
70 E   K     
71 H  Q      
73 G   D D D  D 
74 A   V     
84 H    Y Y   
86 L      M  
88 L  F F F F F F 
92 S  M T T T K T 
96 T  R      
97 R   Q     
98 D   N     
111 N  D D D D D D 
124 A      G  
126 insertion  L L L L L L 
130 H  D      
131 T  A V A A  A 
148 R   Q K K   
162 G  A    A A 
172 H  E      
202 R      G  
205 H     R   
206 F  A A A A A A 
207 S   L   L  
214 E   Q   Q  
217 A    S S   
224 A   G   G T 
225 H  L      
237 K  R     R 
261 T    P    
 
We were also interested in whether the Smlt3054 protein was endogenously 
expressed from the clinical isolates. Using purified Smlt3054 (Figure 5.4), a polyclonal 
antibody against Smlt3054 was raised and tested against eight clinical S. maltophilia strains 
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which screened positive for the gene. An anti-Smlt3054 immunoblot revealed expression 
of Smlt3054 for two out of eight strains under standard growth conditions as well as the 
reference strain K279a that contains Smlt3054, whereas no expressed protein was detected 
for the environmental isolate R551-3 which lacks Smlt3054. A representative immunoblot 
using anti-Smlt3054 for one of the clinical isolates (BB3) is provided in Figure 5.6A, 
illustrating positive endogenous expression in strains K279a and BB3, both of which 
contain the gene product for Smlt3054, but not in the environmental strain R551-3. 
Furthermore, Smlt3054 was detected by anti-Smlt3054 immunoblotting in the perisplasm 
and culture supernatant of BB3 cultures (Figure 5.6B). Additionally, Smlt3054 was 
subcloned with a C-terminal HA tag into plasmid pMMB207, which contains a tac 
expression promoter and has been used previously for protein overexpression in S. 
maltophilia as well as in demonstrating secretion of actin-binding proteins from Vibrio 
parahaemolyticus (26,27). When transformed into the clinical strain BB1, we find that 
Smlt3054 overexpressed from plasmid pMMB207 is present in the periplasm as well as 
the culture supernatant as detected by immunoblotting with an anti-HA antibody, whereas 
no expression is detected in the absence of pMMB207- Smlt3054 (Figure 5.6C). Thus, we 
conclude that Smlt3054 is endogenously expressed and secreted from S. maltophilia 
clinical isolates grown under standard conditions.  
It should be noted that on each anti-Smlt3054 immunoblot (Figure 5.6A, B) 
endogenously expressed Smlt3054 is detected at a molecular weight of approximately 
twice that of the predicted molecular weight of Smlt3054 (29.8 kDa). As stated previously, 
purified recombinant Smlt3054 samples contained higher order oligomers as observed by 
anti-His6 (Figure 5.4B) and anti-Smlt3054 (Figure 5.6A, B) immunoblots, and numerous 
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ankyrin-repeat containing proteins have been shown to form multimers (20-22). Thus, our 
results are consistent with Smlt3054 existing as a dimer as well as higher order oligomer 
when expressed endogenously as well as overexpressed recombinantly.  
 
Figure 5.6: Smlt3054 is secreted from clinical S. maltophilia isolates. (A) Immunoblot using a rabbit 
polyclonal antibody raised against purified Smlt3054 indicates expression of Smlt3054 in S. maltophilia 
clinical isolates K279a and BB3 but not environmental isolate R551-3. (B) Immunoblot using anti-Smlt3054 
antibody indicates the presence of Smlt3054 in the periplasmic space and culture supernatant of BB3 cultures. 
(WC: whole cell extract, P: periplasmic space, S: culture supernatant) (C) Immunoblot for HA-tagged 
Smlt3054 overexpressed in clinical strain BB1 indicates Smlt3054 is expressed and present in culture 
supernatants. Note that the genotype for strain BB1 includes Smlt3054. 
 
5.3.3 Smlt3054 is Associated with Actin in Mammalian Cells 
To determine a possible role for Smlt3054 as a host effector, we overexpressed 
Smlt3054 with a C-terminal GFP fusion in transfected HEK293 cells and compared its 
intracellular distribution to that of actin, which was overexpressed with an N-terminal 
tdTomato fusion, via multichannel confocal microscopy. Similar approaches have been 
used previously in determining intracellular localization and function for secreted ankyrin-
repeat effectors from Coxiella (AnkJ) as well as for actin-specific effectors from 
Salmonella (SopB, SopE) (28,29). We observe essentially complete overlap (yellow) 
between the Smlt3054 (green) and actin (red) channels (Figure 5.7, left), with a nonuniform 
distribution of actin-Smlt3054 overlap throughout the cell; in particular, internal dense 
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regions of locally higher actin-Smlt3054 concentration and co-localization are observed 
throughout the transfected cells. Transfection into A549 and COS-7 cells revealed a similar 
pattern of internal dense regions of Smlt3054-GFP, implying the effect is not cell specific 
(Figure 5.8). This same pattern is not observed in cells co-expressing GFP alone with 
tdTomato-actin, with regions of high actin (red) concentration observed within cells 
distinct from GFP, and no significant overlap between the two proteins (Figure 5.7, right). 
Thus, the nonuniform, co-localized regions of acitn-Smlt3054 are consistent with a specific 
actin-Smlt3054 interaction. 
 
Figure 5.7: Ectopically expressed Smlt3054-GFP co-localizes with tdTomato-actin in transfected HEK293 
cells. The left nine panels (A-I) correspond to co-expression of pEGFP2-Smlt3054 and ptdTomato-Actin-7, 
whereas the right six panels (J-O) correspond to co-expression of pEGFP2 and ptdTomato-Actin-7. The first 
row (panels A, D, G, J, M) are the green (Smlt3054-GFP or GFP) channel alone, the second row (panels B, 
E, H, K, N) are the red (tdTomato-actin) channel alone, and the third row (panels C, F, I, L, O) are merged 
images. Note the lack of co-localization between GFP and tdTomato-actin in the right six panels (J-O) as 
indicated by the lack of overlap (yellow) in panels L and O, whereas the left nine panels (A-I) exhibit strong 
co-localization between Smlt3054-eGFP and tdTomato-actin as indicated by the overlap (yellow) in panels 
C, F and I. 
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Figure 5.8: Ectopically expressed Smlt3054-GFP in HEK293, A549, and COS-7 cells exhibits a similar of 
pattern of internal dense regions of GFP signal, indicating the effect is not cell specific. 
 
Using time-lapse confocal microscopy, we tracked the fate of Smlt3054-GFP 
expressed within individual cells. Snapshots from the time-lapse images (Figure 5.9) and 
videos based on these images (Video S1) reveal the presence of Smlt3054-GFP (white) at 
prominent, retrograde F-actin ‘waves’ propagating from the leading edges of individual 
cells (Figure 5.9 and Video S1). Dense, intracellular inclusions consistent with the co-
localization images (Figure 5.7) are also observed in individual cells overexpressing 
Smlt3054-GFP, and considerably diminished retrograde F-actin waves are observed in 
cells containing internal inclusions (Figure 5.10 and Video S2). Retrograde F-actin waves 
are known to occur in the leading edges of lamellapodia and fillipodia during cell 
movement, and F-actin-driven cell motility is associated with a wide range of cell types 
and biological processes (30). The distinctness of the observed retrograde F-actin waves 
(Figure 5.9 and Video S1), as well as the accumulation of dense, internal inclusions at the 
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expense of these waves (Figure 5.10 and Video S2), provides further evidence in support 
of a specific Smlt3054-actin interaction. 
 
Figure 5.9: Ectopically expressed Smlt3054-GFP associates with retrograde F-actin waves. Each panel 
indicates individual images from time-lapse confocal microscopy images of HEK293 cells overexpressing 
Smlt3054-GFP taken 20 s apart for 4 min. The white signal indicates expression of Smlt3054-GFP. Smlt3054 
is associated with transient waves at the edge of individual cells as indicated by the white arrows. Videos S1 
assembled from time-lapse confocal microscopy images are also provided to illustrate the retrograde F-actin 
waves observed in individual cells overexpressing Smlt3054-GFP.  
 
 
 
Figure 5.10: Ectopically expressed Smlt3054-GFP forms dense internal inclusions co-localized with F-actin, 
at the expense of retrograde F-actin waves. Each panel indicates individual images from time-lapse confocal 
microscopy images of HEK293 cells overexpressing Smlt3054-GFP taken 20 s apart for 4 min. The white 
signal indicates expression of Smlt3054-GFP. Videos S2 assembled from time-lapse confocal microscopy 
images are also provided. 
 
5.3.4 Smlt3054 Binds in F-actin in Vitro 
To demonstrate a specific interaction between F-actin and Smlt3054 we used a 
centrifugal assay based on the density difference between G-actin, F-actin, and Smlt3054. 
171 
 
In this assay, purified Smlt3054 (Figure 5.4) is co-incubated with F-actin, and mixtures are 
ultracentrifuged to sediment F-actin and associated proteins from solution; proteins that do 
not associate with F-actin remain in solution. As expected, F-actin filaments alone 
sediment when centrifuged (Figure 5.11A, lane 1), whereas Smlt3054 alone does not 
(Figure 5.11A, lane 2). However, when Smlt3054 is pre-incubated with F-actin, Smlt3054 
is observed to co-sediment with F-actin (Figure 5.11A, lane 3). Additionally, we repeated 
this experiment with G-actin to test if Smlt3054 influenced the polymerization of G-actin 
into F-actin (Figure 5.11B). Briefly, Smlt3054 is pre-incubated with G-actin in a low salt 
buffer, then actin polymerization is induced by increasing the salt concentration and 
allowed to proceed for precisely 30 min at room temperature. Mixtures are then 
ultracentrifuged and the resulting supernatant and pellet are analyzed for protein content 
via SDS-PAGE. The ultracentrifugation causes F-actin to sediment, however G-actin will 
remain in solution. Therefore if Smlt3054 either sequesters G-actin, preventing it from 
polymerizing into F-actin, or promotes the polymerization of G-actin into F-actin, the 
relative amount of actin protein in the supernatant and pellet lanes containing both actin 
and Smlt3054 will be significantly different than the actin alone lanes. As shown in Figure 
5.11B, the majority of the actin alone sample sediments (lane 4) and Smlt3054 alone does 
not (lane 5). While we did observe Smlt3054 co-sedimentation with the F-actin (lane 6P), 
there is no significant difference between the amount of F-actin that sediments when pre-
incubated with Smlt3054 (lane 6) and the amount of F-actin that sediments in the absence 
of Smlt3054 (lane 4). Thus, our results indicate that Smlt3054 interacts directly with F-
actin in vitro and does not significantly influence actin polymerization, providing evidence 
in favor of a specific, direct Smlt3054 interaction with F-actin filaments. 
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Figure 5.11: Purified Smlt3054 co-sediments with F-actin in vitro. Association of purified Smlt3054 with 
F-actin (A) and the effect of Smlt3054 on actin polymerization (B) in vitro was tested using a centrifugal 
assay as described in section 5.2.10 Actin-Binding Protein Centrifugal Assay. (P: pellet formed after 
centrifugation, S: supernatant after centrifugation). Purified Smlt3054 does not sediment at high centrifugal 
speeds (lane 2 and 5), remaining in the soluble fraction (lane 2S and 5S), whereas purified F-actin does 
sediment at high centrifugal speeds (lane 1 and 4), accumulating in the insoluble fraction (lane 1P and 4P). 
(A) F-actin binding experiment: When F-actin is pre-incubated with Smlt3054 (lane 3), Smlt3054 is observed 
in the insoluble fraction (lane 3P), indicative of association with F-actin. (B) Polymerization test: G-actin 
was incubated with Smlt3054 for 30 min before inducing polymerization for 30 min. Any remaining G-actin 
will stay in the supernatant while polymerized F-actin will sediment upon ultracentrifugation. While 
Smlt3054 does co-sediment with F-actin (lane 6P) there is no significant change in the amount of actin that 
sediments when pre-incubated with Smlt3054 (lane 6) and the amount of actin that sediments in the absence 
of Smlt3054 (lane 4) indicating that Smlt3054 does not alter the rate of actin polymerization. 
 
To investigate further what specific effects bound Smlt3054 may have on F-actin, 
purified F-actin samples incubated with Smlt3054 were imaged via TEM. Preparation of 
F-actin and Smlt3054/F-actin was performed using previously described techniques for 
TEM imaging of F-actin (31). As expected, F-actin samples exhibit long, straight filaments 
consistent with previous results for TEM imaging of F-actin (31). However, in the presence 
of Smlt3054 distinct changes in F-actin filament structure are observed. First, individual 
filaments are thicker in the presence of Smlt3054 (Figure 5.12C, D) versus F-actin 
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filaments alone (Figure 5.12A, B), with darkened regions of increased electron density 
observable throughout the Smlt3054-treated samples. Second, at 100 nm scale, regions of 
increased local electron density are observed on individual filaments in the presence of 
Smlt3054 (Figure 5.12D), with rounded protrusions observable along individual filaments 
(highlighted by arrows in Figure 5.12D). Collectively, these results support the 
observations in cells and in vitro indicating Smlt3054 binds F-actin, and provide further 
insight into the specific effects of Smlt3054 on F-actin bundle structure. 
 
Figure 5.12: Smlt3054 causes thickening of F-actin filaments. F-actin filaments were negatively stained and 
imaged using TEM as described previously, comparing F-actin alone (panel A and B) to F-actin treated with 
Smlt3054 (panel C and D) (31). Regions of higher electron density and thicker F-actin filaments are observed 
for Smlt3054-treated F-actin filaments (panel C and D) versus F-actin alone (panel A and B). Rounded 
protrusions with higher electron density are also observed on individual, thickened filaments (highlighted by 
arrows in panel D). 
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5.3.5 Domain Analysis of Smlt3054 via ToxR Dimerization Assay 
 As stated previously, ankyrin-repeat containing proteins are known to form 
multimers (20-22) and immunoblotting of recombinant and endogenous Smlt3054 detected 
higher molecular weight species consistent with Smlt3054 homodimers (Figure 5.4 and 
5.6). Furthermore, domain analysis revealed that Smlt3054 contains three C-terminal 
ANKs (Figure 5.3 and 5.5). The N-terminal domain of Smlt3054 contains no putative 
conserved domains and little sequence homology with any protein in the NCBI reference 
sequences database (40). In an effort to decipher which portion of Smlt3054 may be 
responsible for oligomerization, we implemented a ToxR-based dimerization assay (18). 
 ToxR is a single pass transmembrane transcription factor which activates the ctx 
promoter through its N-terminal DNA binding domain. Gene activation only occurs upon 
ToxR dimerization, which is driven by the transmembrane domain (19). In the TOXRED 
assay, the transmembrane domain of ToxR is removed, resulting in a soluble ToxR protein 
still capable of binding the ctx promoter upon dimerization, but lacking the drive to 
dimerize due to the absence of the transmembrane domain. The protein of interest, in our 
case various fragments of Smlt3054, is fused to the C-terminal of the truncated ToxR 
protein. Thus, dimerization of the protein of interest results in activation of the ctx 
promoter. In order to monitor the degree of ctx promoter activation, a bacterial codon-
optimized version of the red fluorescent protein (RFP) mCherry is ligated in frame with 
the ctx promoter, therefore promoter activation results in expression of mCherry and an 
increase in red fluorescence whose magnitude is directly related to the tendency of the 
protein of interest to dimerize. Both the ctx-RFP and the constitutively active ToxR-
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Smlt3054 constructs were ligated into the pGL3 plasmid for ease of transfection into E. 
coli TB1 cells. 
 In order to determine which domains of Smlt3054 contributed to dimerization, we 
ligated full-length Smlt3054 and four fragments into the pGL3 ctx-RFP ToxR plasmid. The 
fragments were as follows: (1) M1 to S192, containing the entire N-terminal non-
homologous region of Smlt3054 and ANK1; (2) H39 to S192, containing a portion of the 
N-terminal non-homologous region of Smlt3054 and ANK1; (3) H39 to N223, containing 
a portion of the N-terminal non-homologous region of Smlt3054, ANK1, and ANK2; (4) 
H39 to L274, containing a portion of the N-terminal non-homologous region, ANK1, 
ANK2, and ANK3 (Figure 5.13A). 
 A control experiment was performed with pGEX, pGL3 ctx-RFP, pGL3 ctx-RFP 
ToxR, and pGL3 ctx-RFP ToxR-Smlt3054 (Figure 5.13B). The fluorescence intensity of 
each sample is plotted against absorbance at 600 nm to compensate for variations in 
fluorescence signal due to cell density. A linear trend line was applied to the raw data from 
each sample. The slope of this line was termed normalized fluorescence intensity (NFI) 
and used to compare samples (Figure 5.13C). A 95% confidence interval was calculated 
for each sample to ensure any differences in NFI were statistically significant. The pGEX 
vector contains no fluorescent protein gene and therefore acts as a baseline for background 
fluorescence due to the sample itself. The pGL3 ctx-RFP lacks the ToxR gene and therefore 
acts as a baseline for nonspecific ctx promoter activation. The pGL3 ctx-RFP ToxR 
expresses only the truncated form of ToxR with no fusion protein and therefore acts as a 
baseline for specific ctx promoter activation due to the random stochastic collision of ToxR 
proteins in solution. As expected, the NFI of the pGEX is significantly lower than pGL3 
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ctx-RFP, which in turn is lower than pGL3 ctx-RFP ToxR (Figure 5.13B, C). The signal 
from pGL3 ctx-RFP ToxR was taken as a minimum value to compare to the signal from 
ToxR-Smlt3054 fusions. Any fusion exhibiting a NFI greater than that of pGL3 ctx-RFP 
ToxR is indicative of an oligomerization tendency greater than that due to Brownian 
motion. Full-length Smlt3054 consistently exhibited a NFI greater than pGL3 ctx-RFP 
ToxR (8520 ± 409 versus 3766 ± 119), providing further evidence that Smlt3054 forms 
higher order multimers (Figure 5.13B, C). This data is in agreement with anti-Smlt3054 
immunoblots (Figure 5.4 and 5.6). 
 Interestingly, all four fragments of Smlt3054 exhibited a NFI significantly lower 
than full-length Smlt3054 yet higher than pGL3 ctx-RFP ToxR, implying that Smlt3054 
oligomerization is not due to one specific domain, but instead each domain working in 
conjunction (Figure 5.13C).  More specifically, the Smlt3054 H39 to L274 fragment, which 
lacks the first 38 residues (Met1 to Leu38) of Smlt3054, exhibited 60 ± 1.6% of full-length 
NFI, implying those first 38 residues play an important role in dimerization (Figure 5.13C, 
light blue bar). The stepwise removal of each C-terminal ANK resulted in a moderate but 
significant decrease in NFI as well, with the Smlt3054 H39 to N223 fragment exhibiting 
56 ± 1.5% NFI (Figure 5.13C, orange bar) and the Smlt3054 H39 to S192 fragment 
exhibiting 51 ± 2.1% NFI (Figure 5.13C, green bar) when compared to full-length 
Smlt3054. Interestingly, the Smlt3054 M1 to S192 fragment, which reintroduces the first 
38 residues, exhibited 69 ± 2.2% NFI (Figure 5.13C, red bar), an 18% increase compared 
to Smlt3054 H39 to S129. Overall, our results indicate that each ANK contributes to 
Smlt3054 dimerization in an additive fashion, as well as the first 38 residues (Met1 to Leu38) 
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(Figure 5.13C). These results do not rule out the possibility of other regions of Smlt3054 
that are critical for dimerization and the assay needs to be repeated for more fragments. 
 
Figure 5.13: Dimerization analysis of Smlt3054 via ToxR assay. (A) Schematic of Smlt3054 depicting the 
location of each ANK and the N-terminal non-homologous region. (B) Fluorescence intensity of mCherry 
versus absorbance at 600 nm for pGL3 ctx-RFP ToxR constructs. Data was fitted to a trend line, the slope of 
which was defined as the normalized fluorescence intensity for that particular construct. pGEX (white) acted 
as a negative control. The increased fluorescence of pGL3 ctx-RFP (pink) over pGEX is due to nonspecific 
activation of the ctx promoter. The increase fluorescence of pGL3 ctx-RFP ToxR (dark blue) over pGL3 ctx-
RFP is due to random collisions of ToxR and subsequent binding and activation of ctx promoter. The 
increases fluorescence of pGL3 ctx-RFP ToxR Smlt3054 (purple) over pGL3 ctx-RFP ToxR is indicative of 
dimerization of ToxR-Smlt3054 fusion due to Smlt3054. (C) Normalized fluorescence intensity for all pGL3 
ctx-RFP ToxR Smlt3054 constructs. Each condition was run in triplicate and error is reported as standard 
deviation. The NFI due to pGL3 ctx-RFP ToxR is indicated by a dashed line for comparison. 
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5.4 DISCUSSION 
Bacterial pathogens have evolved a wide range of effector types and mechanisms 
to deliver them to host cells to manipulate actin cytoskeletal structure. In the case of 
Smlt3054, we provide evidence in favor of it being a specific actin-binding protein in 
transfected cells (Figures 5.7, 5.8, 5.9, and 5.10) as well as in vitro (Figures 5.11 and 5.12). 
Bacterial actin-binding proteins have been identified in a wide range of pathogens, where 
they contribute directly to bacterial internalization, cell movement and intracellular 
replication (11). Among the most well-studied of these is SipA from Salmonella 
typhimurium, which decreases the critical concentration of actin required for F-actin 
polymerization, stabilizes F-actin filaments by preventing depolymerization and enhances 
F-actin bundling, thereby promoting extension of membrane ruffles and filipodia to 
facilitate invasion (12,17,32). For Smlt3054, we do not observe a reduction in the 
concentration of G-actin required for F-actin polymerization (Figure 5.11B), but when 
overexpressed in transfected mammalian cells, we observe Smlt3054 co-localization with 
overexpressed actin (Figure 5.7) and Smlt3054 bound specifically to retrograde F-actin 
waves associated with lamellapodia and fillipodia (Figure 5.9). We also observe 
significant, morphological changes in F-actin filaments in the presence of Smlt3054: F-
actin filaments are thicker and contain rounded, dense protrusions from individual 
filaments (Figure 5.12). In the case of SipA, addition of SipA to F-actin filaments resulted 
in an increase in electron density around the fibers when observed by TEM. This increase 
was interpreted as SipA binding laterally to individual F-actin filaments, and the resulting 
TEM images were used to build a 3D predictive model of the SipA/F-actin structure 
(12,32). In the case of Smlt3054, we observe a similar increase in electron density around 
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individual F-actin filaments, implying that Smlt3054 also binds laterally to F-actin, 
essentially “coating” the filament. However, unlike SipA, we also observed nodules of 
electron density protruding from individual filaments in Smlt3054-treated F-actin 
filaments (Figure 5.12C, D white arrows). A recent study of T2SS in S. maltophilia K279a 
indicates significant changes in A549 actin cytoskeletal structure for cells treated with 
K279a culture supernatants, and these changes were dependent on expression of specific 
proteins associated with assembly of the identified T2SS (5). Another recent study 
demonstrated two serine proteases (StmPr1 and StmPr2) secreted by S. maltophilia via a 
T2SS contributed either directly or indirectly to the actin rearrangement associated with 
the co-culturing of S. maltophilia K279a with A549 cells which ultimately resulted in cell 
rounding, detachment and death (33). In the current study, secretion of Smlt3054 from 
clinical S. maltophilia isolates (Figure 5.6) occurred under the same growth conditions as 
those used in identification of type II secreted effectors from strain K279a. In the case of 
S. typhimurium, several other effectors are secreted to independently affect microtubule 
structure and other aspects of cytoskeletal structure, and in the case of S. maltophilia, it 
will be interesting to identify what, if any, other effectors work in concert with Smlt3054 
to modulate host cytoskeletal structure (29). 
Analysis of Smlt3054 oligomerization via a ToxR-based dimerization assay 
revealed that each ANK contributed to Smlt3054 dimerization in an additive manner 
(Figure 5.13). Furthermore, we identified an additional segment (Met1 to Leu38) critical for 
dimerization. Although the domain analysis is far from complete and requires additional 
Smlt3054 fragments be analyzed, it would be informative to overexpress and purify 
identical fragments via pET28a(+) and test their ability to bind F-actin through ectopic 
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expression (section 5.2.5 Ectopic Expression in Mammalian Cells) and in vitro actin 
binding experiments (section 5.2.10 Actin-Binding Protein Centrifugal Assay and 5.2.11 
Transmission Electron Microscopy). The above analysis would shed light on whether 
Smlt3054 oligomerization is critical for actin binding. 
Although Smlt3054 is a hypothetical protein, we demonstrate that it is 
endogenously expressed and secreted from S. maltophilia clinical isolates containing the 
gene product for Smlt3054 versus reference strains lacking the gene product for Smlt3054 
(Figure 5.6) and exhibits a well-defined secondary and tertiary structure (Figure 5.4), 
providing further evidence in favor of it being a specific S. maltophilia actin-binding 
effector protein. Using the sequence-specific domain prediction tool PFAM, Smlt3054 is 
predicted to contain three C-terminal ANKs (Figure 5.3 and 5.5) (34).  Interestingly, 
bacterial ANKs have previously been identified in other intracellular bacterial pathogens 
as host effectors, including Anaplasma phagocytophilum, Ehrlichia chaffeensis, Legionella 
pneumophila and Coxiella burnetii, where in each case, the ANK is secreted via a type II 
secretion system (T2SS) to modulate host cell behavior, facilitate bacterial internalization 
and promote intracellular replication during infection (13). For Ehrlichia chaffeensis, the 
effector AnkA has been shown to interfere with dissociation of the host IκB/NF-κB 
complex necessary to activate host cytokine production and pro-inflammatory response; 
specifically, it is though the ANKs present in AnkA act as mimics of IκB, thereby 
sequestering NF-κB and preventing its transcriptional activation (35). For L. pneumophila, 
AnkX has been shown to interfere with microtubule-dependent transport of vesicles from 
the ER to the Golgi, whereas AnkB contains an additional F-box domain that interacts with 
host ubiquitination machinery; loss of AnkB severely reduced intracellular replication of 
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L. pneumophila in a mouse model of infection (36,37). Thus, our results add to the growing 
list of specific, virulence-associated functions attributable to ANKs as secreted effectors 
from bacterial pathogens; to date, no bacterial ANKs have been reported whose function is 
to disrupt host actin cytoskeletal structure (Figures 5.7, 5.8, 5.9, and 5.10) and directly bind 
F-actin (Figures 5.11 and 5.12) as is observed for Smlt3054 (13). Given that previous 
studies of S. maltophilia virulence have indicated actin rearrangement in A549 cells occurs 
in a T2SS-dependent manner, it is interesting to speculate whether Smlt3054 is secreted 
via a T2SS or instead via a type I or type IV system as has been described for other secreted 
bacterial ankyrin-repeat effectors (5,13,38). 
 
5.5 CONCLUSIONS 
In summary, we provide evidence that the hypothetical protein Smlt3054 is 
expressed and secreted in clinical S. maltophilia isolates and acts directly on F-actin 
filaments to disrupt cytoskeletal structure and bind retrograde F-actin waves. Our work 
provides the first study of a specific, secreted protein from S. maltophilia having function 
linked to actin cytoskeletal disruption, and suggests a role as a possible effector involved 
in facilitating S. maltophilia internalization during infection. Clinical S. maltophilia 
isolates from cystic fibrosis patients with chronic, drug-resistant infections were capable 
of internalization in cell culture studies using bronchial epithelial cells, and internalization 
was thought to contribute to both drug-resistance and persistence. Thus, our work serves 
as a useful starting point for understanding mechanisms that may contribute to multi-drug 
resistance and persistence of this important, emerging bacterial pathogen (2). 
 
182 
 
5.6 ABBREVIATIONS 
The abbreviations used in this chapter are as follows: CF, cystic fibrosis; T2SS, 
type II secretion system; TEM, transmission electron microscopy; ANK, ankyrin repeat 
domain; RFP, red fluorescent protein; normalized fluorescence intensity, NFI. 
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CHAPTER 6 
RELATED PROJECTS AND FUTURE PERSPECTIVES 
 The focus of this thesis is the biochemical characterization of novel polysaccharide 
lyases (PLs) from Stenotrophomonas maltophilia K279a (Smlt1473 and Smlt2602) in an 
effort to gain a basic understanding on how these enzymes achieve substrate specificity 
and their potential utility in combatting multidrug resistant infections, as well as generating 
glycans of interest for therapeutic and industrial applications (Chapters 2-4). We 
successfully identified key residues located in the active site cleft of PLs that significantly 
influence substrate specificity and activity, which led to the engineering of mutant lyases 
with unique specificity. However, a plethora of research remains in understanding how 
minor changes in active site architecture give way to such drastic changes in enzyme 
activity and specificity. Understanding the laws that govern specificity will allow for the 
design of highly specialized enzymes, fine-tuned to the problem at hand. In addition to our 
analysis of these enzymes, we identified and characterized an ankyrin-repeat containing 
protein (Smlt3054) that is secreted by medically relevant S. maltophilia isolates and found 
to bind F-actin in vitro and disrupt the actin cytoskeletal structure in transfected 
mammalian cells (Chapter 5). However the mechanism by which Smlt3054 binds actin and 
the consequence of this binding in the context of bacterial invasion and infection remains 
unanswered. Thus, there are an abundance of research opportunities and related projects 
that are applicable to the work presented in the preceding chapters, some of which are 
addressed below. 
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6.1 ANTIBIOTIC SCREENING OF S. MALTOPHILIA CLINICAL ISOLATES 
Antibiotic resistance is a growing concern in the healthcare industry and a central 
theme of this thesis. The rate of new antibiotic development is vastly overwhelmed by the 
remarkably efficient ability of bacteria to evolve or acquire new resistance mechanisms 
(1). This is evident in the opportunistic pathogens as well, including S. maltophilia, an 
emerging, multidrug resistant (MDR), Gram-negative bacilli of particular concern for 
patients suffering from cystic fibrosis (CF), and those with indwelling medical devices (2). 
The bacterium is heavily guarded by resistance mechanisms, including enzymes involved 
in antibiotic inactivation, broad-spectrum efflux pumps, and pili and fimbriae involved in 
adhesion to surfaces and biofilm development (3). As a result, S. maltophilia is reported to 
exhibit intrinsic resistance to the β-lactams, aminoglycosides, macrolides, and many 
quinolones (2,3). Of greater concern, strains have demonstrated resistance to trimethoprim-
sulfamethoxazole, the therapeutic of choice to treat S. maltophilia infections (4), as well as 
drugs of last resort such as carbapenems, tetracyclines, chloramphenicol, and polymyxins 
(5). Wide-spread resistance towards these drugs would result in no viable antibiotic 
treatment for S. maltophilia infections.  
In an effort to collaborate the above results, we screened the 32 clinical S. 
maltophilia strains we obtained from Lehigh Valley Health Network, Allentown, 
Pennsylvania, USA as part of an IRB-approved study. Briefly, strains where grown 
overnight in LB medium at 37°C, 200 rpm and then diluted to an A600 of 0.1 in fresh LB 
medium containing the antibiotic of interest at typical working concentrations and grown 
overnight at 37°C, 200 rpm. Finally the A600 of each culture was measured and compared 
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to cultures containing no antibiotics. Strains were considered resistance to the antibiotic if 
the A600 was ≥ 50% that of the cultures with no antibiotic.  
As expected, the isolates exhibited complete resistance to the β-lactams and 
aminoglycosides tested, with the exception of one strain being sensitive to gentamicin at 
the concentration tested. More alarmingly, between 10 to 25% of the strains were resistant 
to one or more second and third line of defense antibiotics, including polymyxin B (25%) 
and chloramphenicol (9.3%) (Table 6.1). Collectively, these result confirm what other 
researchers have observed in that a significant percentage of clinical S. maltophilia isolates 
exhibit extensive drug resistance (4). A logical next step in this study would be to determine 
the minimum inhibitory concentration for the more potent and clinically relevant 
antibiotics like polymyxin B, nalidixic acid, tetracycline, and chloramphenicol, as well as 
test additional antibiotics like trimethoprim-sulfamethoxazole. Ultimately this data could 
be correlated with the clinical presentation and genetic makeup of each isolate in an effort 
to decipher any trends. 
Table 6.1 Drug Resistance in S. maltophilia clinical isolates. Strains were obtained as part of an IRB-
approved study with Lehigh Valley Health Network in Allentown, Pennsylvania, USA. 
Class Name 
Concentration 
(μg/ml) 
Number of 
Resistant 
Strains (n=32) 
Percentage 
of Resistant 
Strains (%) 
β-lactam Ampicillin 100 32 100 
Aminoglycoside 
Streptomycin 50 32 100 
Spectinomycin 50 32 100 
Kanamycin 50 32 100 
Gentamicin 15 31 96.8 
Glycopeptide Zeocin 50 32 100 
Quinolone Nalidixic acid 30 7 21.9 
Cationic peptide Polymyxin B 20 8 25 
Broad-spectrum 
Tetracyline 15 5 15.6 
Chloramphenicol 30 3 9.3 
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6.2 CHARACTERIZATION OF RELATED POLYSACCHARIDE LYASES FROM 
ACHROMOBACTER INSUAVIS AXX-A AND BORDETELLA AVIUM 197N 
As stated previously, Smlt1473 shares greater than 90% sequence homology with 
a subset of putative alginate lyases found exclusively in medically relevant strains of S. 
maltophilia. Smlt1473 also shares greater than 60% sequence identity with predicted 
alginate lyases from two other opportunistic pathogens, Axxa07160 from Achromobacter 
insuavis AXX-A and Bav2839 from Bordetella avium 197N (Figure 6.1). A. insuavis is a 
MDR opportunistic pathogen known to cause persistent respiratory tract infections in CF 
patients (6). B. avium was once thought to be solely an animal pathogen that causes 
tracheobronchitis in wild and domesticated birds. However, recently B. avium been isolated 
from the lungs of CF patients, as well as those suffering from pneumonia, indicating it is 
also an opportunistic human pathogen (7). Given the clinical similarities between S. 
maltophilia, A. insuavis, and B. avium, and that Axxa07160 and Bav2839 share such high 
sequence identity with Smlt1473, we were interested in determining whether Axxa07160 
and Bav2389 exhibit the same pH-regulated activity towards poly-β-D-mannuronic acid 
(poly-ManA), poly-β-D-glucuronic (poly-GlcA), and hyaluronic acid (HA). 
Escherichia coli codon-optimized nucleotide sequences of axxa07160 and bav2389 
(corresponding to GenBankTM protein accession numbers EGP47054 and CAJ50449, 
respectively) were subcloned into pET28a(+) (Invitrogen) as a NcoI-XhoI inserts with no 
stop codons, resulting in each protein containing a C-terminal His6 tag. Expression, 
purification, and enzymatic characterization were carried out in manners similar to 
Smlt1473, as described in section 2.2 MATERIALS AND METHODS. Axxa07160 was 
successfully expressed in LB at 18°C and purified via immobilized metal ion 
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chromatography (Figure 6.2A). However, we were unable to express Bav2839, despite 
attempting various expression media, temperature, and induction times (Figure 6.2B). 
Attempting to express Bav2839 as a fusion to a stabilizing protein such as maltose-binding 
protein or glutathione S-transferase would be a logical next step in the attempt to express 
this lyase.  
 
Figure 6.1: Sequence alignment of Smlt1473 from S. maltophilia K279a (black letters) with Axxa07160 
from A. insuavis AXX-A (blue letters) and Bav2839 from B. avium 197N (green letters). The predicted 
catalytic tetrad is highlighted in black. Residues predicted to reside in the positive patch near the entrance of 
the active site are marked by daggers (see Chapter 3). Residues predicted to bind and align the substrate in 
active site are marked by asterisks (see Chapter 3). 
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Figure 6.2: Expression and purification of Axxa07160 and attempted expression of Bav2839. (A) SDS-
PAGE of purified Axxa07160 at the expected molecule weight of approximately ~35 kDa. (B) SDS-PAGE 
of expression conditions attempted for Bav2839. Expression parameters are listed in table below. The 
predicted molecular weight of Bav2839 is ~37 kDa. Note no prominent band at that size that does not also 
appear in the negative control sample (Lane 1). 
 
The enzymatic activity of purified Axxa07160 was tested against the following six 
polyuronides: poly-ManA, poly-GlcA, HA, chondroitin sulfate, heparin, and heparin 
sulfate at pH 5 through pH 10. Of these substrates, significant activity in terms of increased 
absorbance at 235 nm was measured for poly-ManA and poly-GlcA at pH 6 and minimal 
but measurable activity for HA at pH 5 (Table 6.2). Interestingly, this is a vastly different 
substrate specificity profile compared to Smlt1473 (Figure 6.3). Although both enzymes 
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exhibited activity towards HA at pH 5, Axxa07160 demonstrated only approximately 10% 
the activity of Smlt1473 (4.8  0.5 units/mg versus 42.3  1.3 units/mg) (Table 6.2 and 
Figure 6.3A). Unlike Smlt1473, which exhibited significant poly-GlcA activity only in 
neutral solutions and poly-ManA activity only in alkaline solutions, Axxa07160 displayed 
optimal activity for both substrates in slightly acidic solutions (pH 6) (Figure 6.3B, C). 
Furthermore, Axxa07160 exhibited 128% the poly-GlcA activity and 305% the poly-
ManA activity of Smlt1473 (Table 6.2). Thus, the specific activity of Axxa07160 for poly-
GlcA (1084.5  20.5 units/mg) is among the highest reported for polyGlcA-specific lyases 
(8-11) (Table 6.2). 
Table 6.2: Substrate specificity of Axxa07160 compared to Smlt1473. Enzyme (17.5 μg for poly-ManA 
and HA, 1.7 μg for poly-GlcA) was added to 1 mg/ml of each substrate in 20 mM buffer at various pH. 
Enzymatic activity was monitored by absorbance at 235 nm. One unit of activity was defined as an increase 
in absorbance at 235 nm of 1.0 per minute at 25oC. 
Substrate 
Axxa07160 Smlt1473 
Optimal 
pH 
Specific Activity 
(units/mg) 
Optimal 
pH 
Specific Activity 
(units/mg) 
poly-ManA 6 209.3  4.1 9 68.5  2.9 
poly-GlcA 6 1084.5  20.5 7 848.3  6.3 
Hyaluornan 5 4.8  0.5 5 42.3  1.3 
 
 The fact that Smlt1473 and Axxa07160 exhibit such vastly different substrate 
specificity profiles with respect to optimal pH and overall activity (Table 6.2 and Figure 
6.3) and yet share a high degree of sequence conservation (61% identical), including the 
same catalytic tetrad (Figure 6.1), begs the question of what residues are responsible for 
the unique pH-sensitive activity of Smlt1473. Given their highly conserved nature it can 
be assumed that both lyases have the same overall fold, implying that the differences in 
their modes of action are due to the chemical nature of individual amino acids. Identifying 
those residues in Smlt1473 and their counterparts in Axxa07160 would further our basic 
understanding on how PLs, and enzymes in general, achieve substrate specificity and 
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would assist in the engineering of mutant lyases with highly-tuned specificity for 
therapeutic and industrial applications.  
 
Figure 6.3: Comparison of optimal pH of activity for Smlt1473 (red) and Axxa07160 (blue). Note that 
Axxa07160 exhibited optimal poly-GlcA and poly-ManA at pH 6, unlike Smlt1473 which exhibits optimal 
activity at pH 7 and 9, respectively. 1 unit of activity was taken as the change in absorbance at 235 nm over 
the course of 1 min. 
 
 To that end, we constructed a heat map of differences between Axxa07160 and 
Smlt1473 using the Smlt1473 homology model described in section 2.2.12 Homology 
Modeling (Figure 6.4). Residues which appear in both Axxa07160 and Smlt1473 are 
colored green, with the conserved catalytic tetrad in orange. Residues which are not 
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conserved are colored red. As can be seen by the surface representation of this model 
(Figure 6.4A), the nonconserved residues are distributed throughout the three dimensional 
structure of the protein, with no one area appearing significantly more divergent than 
another. However we were able to identify residues of interest located in or near the active 
site, highlighted in the cartoon representation of our model (Figure 6.4B). Note that the 
model is of Smlt1473 and therefore the residue numbers listed correspond to Smlt1473. 
Charged residues are known to play an important role in PL activity (12,13). 
Hyaluronidases, including Smlt1473, are known to contain a positive patch located near 
the active site that is involved the initial attraction of the anionic substrate (12). One of the 
residues we identified is an arginine located in this positive patch (Arg163) that is a histidine 
in Axxa07160 (Figure 6.4B). Lack of this charged residue may influence initial substrate 
attraction and may account for some of the reduced HA activity seen in Axxa07160. 
Furthermore, the cyclical histidine has a distinctly different shape than the more rod-like 
arginine. Given that Arg163 is located near the active site opening, this shape difference 
may alter the size of the opening and account for the differences in substrate binding. 
Another residue we identified is a glutamine (Gln118) that is a glutamic acid in 
Axx07160 (Figure 6.4B). This residue is located ~4 Å from the catalytic His168 residue in 
Smlt1473, which is postulated to act as the general base in the degradation of alginate-
based substrates (Chapter 2) (11). Interaction between catalytic residues and nearby 
charged residues is known to significantly influence the apparent pKa of the catalytic 
residues and thus the optimal pH of enzymatic activity (14). Given the close proximity of 
Gln118 to His168 and the structural similarities between glutamine and glutamic acid, it is 
likely that the glutamic acid in Axxa07160 is also in close proximity to the corresponding 
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catalytic histidine and therefore may be influencing catalysis indirectly, accounting in part 
for the different optimal pH values observed for Axxa07160 and Smlt1473. A similar effect 
was observed for the R312L mutant of Smlt1473, which shifted the optimal pH of poly-
GlcA activity from 7 to 6 (Chapter 3) (12). 
Aromatic and cyclic residues located in the active site cleft of PLs are known to 
form C-H/π interactions with the sugar rings of the substrate. These interactions are thought 
to assist in the positioning of substrate and the cleavable O-glycosidic bond with respect to 
the catalytic tetrad (15). The third and fourth residues we identified are a leucine (Leu283) 
and alanine (Ala285) which are a histidine and phenylalanine in Axxa07160 (Figure 6.4B). 
These additional aromatic and cyclic residues may form interactions with the carbohydrate 
substrate that are not present in Smlt1473, and may account in part for the differences 
observed between the enzymes in terms of activity and specificity. 
In addition to the four individual residues discussed above, we observed that the 
outward facing side of an α-helix located near the active site was comprised completely of 
nonconserved residues, whereas the inward facing side was conserved (boxed in Figure 
6.4B). It may be interesting to analyze a number of these residues, given that the outward 
face of the helix is most likely to interface with the substrate. 
Our proposed plan of action in elucidating whether any of the aforementioned 
residues influence the variations seen between Axxa07160 and Smlt1473 is to mutate the 
corresponding residues in each enzyme and test activity and specificity. For example, 
create a R163H mutant of Smlt1473 and the corresponding H181R mutant of Axxa07160 
to see what effect that has on optimal pH of activity and if we can modify Axxa07160 to 
exhibit a pH-sensitive substrate specificity similar to Smlt1473.  
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Figure 6.4: Heat map of Smlt1473 versus Axxa07160. The homology model of Smlt1473 built from PDB 
1QAZ (16) was used to map out the difference between Smlt1473 and Axxa07160. Identical residues are 
shown in green, the conserved catalytic tetrad in orange, and nonconserved residues in red. (A) Surface 
model shown at four different angle. Note that the nonconserved residues are distributed throughout the 
enzyme. (B) Cartoon model highlighting nonconserved residues located in or near the active site that may 
account for the different substrate specificity seen in Axxa07160 versus Smlt1473. 
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6.3 EFFECT OF ADDING SMLT3054 DIRECTLY TO A549A CELLS 
Chapter 5 of this thesis describes a secreted ankyrin-repeat containing protein that 
binds F-actin in vitro and disrupts the actin cytoskeleton of transfected mammalian cells 
(17). We hypothesize that Smlt3054 is a virulence factor that is secreted by S. maltophilia 
during infection and disrupts the host actin cytoskeleton in a way that assists invasion. 
Similar modes of action have been observed in other bacterial pathogen (18). For example, 
Salmonella internalization and infection requires the reorganization of host cytoskeleton 
and is induced by several virulence factors secreted into the host cytosol via a bacterial 
type III secretion system (T3SS). At least five Salmonella effector proteins have been 
identified to be involved in host cytoskeleton rearrangement either by signal transduction 
manipulation (SopE, SopE2, SopB) or direct binding of actin (SipC and SipA). SopE and 
SopE2 bind the RhoGTPases Rac1 and CDC42, and act as potent nucleotide exchange 
factors for these G-proteins, thereby activating their signal transduction pathways which 
ultimately leads to actin polymerization and lamellipodia and filopodia formation. SopB 
has a similar effect by activating Rac1 and CDC42 in an indirect fashion. SipC nucleates 
actin polymerization and bundles F-actin fibers together. SipA promotes the 
polymerization of G-actin into F-actin at the site of bacteria-host contact. Altogether these 
five effector proteins promote the formation of filopodia and lamellipodia at the site of 
bacterial contact, which induces localized membrane ruffling and accelerates the 
internalization of Salmonella by macropinocytosis (18,19). 
As stated previously, Salmonella secretes its virulence factors via a T3SS, which 
are multi-protein structures comprised of a needle complex that spans both the inner and 
outer bacterial membranes as well as the host membrane, resulting in the direct secretion 
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of toxins into the host cytosol (20). Type II secretion systems (T2SS) are known to also be 
involved in secretion of toxins into the extracellular environment (21). Type II secretion 
factors include proteases, cellulases, pectinases, phospholipases, lipases, and toxins that 
act on host tissue, causing cell damage and disease (21). Interestingly, a recent study links 
T2SS in S. maltophilia with significant changes in A549 actin cytoskeletal structure (22). 
Given the effect Smlt3054 has on HEK293 and A549 cells upon ectopic expression, we 
speculate that Smlt3054 may be secreted in a T2SS-depedent manner (17). If that is the 
case, Smlt3054 would need to act extracellularly on the host cells, instead of internally as 
is the case with type III secretion. 
In an effort to begin to elucidate possible mechanisms by which S. maltophilia 
delivers Smlt3054 to the host, we added recombinant purified Smlt3054 directly to A549 
cells to see if we could observe any morphological changes linked to actin structure. 
Briefly, A549 cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 4.5 g/l glucose and sodium pyruvate, 4 mM L-gluatmine, 10% fetal 
bovine serum, and 1 x antibiotic/antimycotic solution to approximately 50% confluency. 
Then the media was exchanged with fresh DMEM further supplemented with either Protein 
Buffer (670 μM sodium phosphate, pH 8, plus 0.002% sarkosyl) (Figure 6.5A), 1 μM 
Smlt3054 in Protein Buffer (Figure 6.5B), or 1 μM Smlt3054 treated with Proteinase K in 
Protein Buffer (Figure 6.5C). As can been seen in Figure 6.5A, the cells treated with Protein 
Buffer appeared well attached and spread out, similar to untreated cells. The same is true 
for cells treated with Smlt3054 degraded by Proteinase K (Figure 6.5C). However, A549 
cells treated with Smlt3054 appeared rounded and detached from the dish surface (Figure 
6.5B and Figure 6.6 green arrow). Furthermore, the membranes of cells treated with 
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Smlt3054 were coated in small round granules, giving a “hairy” appearance (Figure 6.5B 
and 6.6 blue arrow), and in some cases the membranes had seemingly been dissolved 
completely (Figure 6.5B and Figure 6.6 red arrow).  
 
Figure 6.5: Light microscopy images of A549 cells treated with Smlt3054. (A) A549 cells treated with 
Protein Buffer (670 μM sodium phosphate, pH 8, plus 0.002% sarkosyl). (B) A549 cells treated with 1 μM 
Smlt3054 in Protein Buffer. (C) A549 cells treated with 1 μM Smlt3054 treaded with Proteinase K in Protein 
Buffer. 
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Figure 6.6: Light microscopy of A549 cells treated with 1 μM Smlt1473. Note that cells appear rounded 
and detached from cell surface (green arrow), or the membranes are coated in small round granules, giving 
a “hairy” appearance (blue arrow), or have seemingly been dissolved complete (red arrow). 
 
 The phenotype observed for cells treated with 1 μM Smlt3054 in Protein Buffer 
was not seen in cells treated with Protein Buffer only (Figure 6.5A), therefore we conclude 
that the effect on the cell membranes is not due to the sarkosyl present in the buffer. 
Furthermore, cells treated with 1 μM Smlt3054 that had been digested by Proteinase K 
(Figure 6.5C) were indistinguishable from cells treated with Protein Buffer only (Figure 
6.5A). Therefore, we conclude that the cell rounding, detachment, and dissolving effect 
seen by cells treated with 1 μM Smlt3054 was due to the intact protein (Figure 6.5B and 
Figure 6.6).  The actin cytoskeleton plays a key role in maintaining the shape and structure 
of cells, as well as cell attachment (23), therefore we hypothesize that the Smlt3054 added 
directly to A549 cells is disrupting the F-actin network at the membrane, leading to the 
phenotypes observed. Our results also imply that Smlt3054 is able to act on the cells 
extracellularly, providing indirect evidence that it may be delivered to the host 
extracellularly, perhaps via a T2SS. Obviously this is a preliminary result that needs to be 
further verified. A logical next step is to repeat the above experiment, then fix and stain the 
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cells with an F-actin specific stain, such as FITC-phalloidin, and compare the actin 
cytoskeletal network in A549 cells plus or minus Smlt3054. 
  
 
6.4 HIGH RESOLUTION CRYSTAL STRUCTURE OF SMLT1473 IN COMPLEX 
WITH SUBSTRATES 
 In order to elucidate the mechanism by which Smlt1473 achieves pH-sensitive 
substrate specificity and clarify the roles of the catalytic histidine and tyrosine, a high 
resolution structure of the enzyme alone and in complex with its three most active 
substrates (HA, poly-ManA, and poly-GlcA) is necessary and can be acquired by X-ray 
crystallography. X-ray crystallography is based upon the fact that X-rays are diffracted by 
electrons and have wavelengths on the order of bond lengths, allowing for atomic 
resolution. An electron density map of the protein is generated by collected a series of two 
dimensional diffraction patterns created by beaming X-rays through a protein crystal at 
different angles, followed by converting the two dimensional diffraction patterns into a 
three dimensional structure via a Fourier transform. From the electron density map a 
starting model can be generated, however determining the phase of each data point requires 
the use of molecular replacement, which involves starting with a homologous protein 
structure (24). In the case of Smlt1473, the closest homolog is with a solved crystal 
structure is Spingomonas sp. A1-III alginate lyase (PDB 1QAZ) used to generate the 
homology model of Smlt1473 (Chapter 2) (11,16). Given that the Smlt1473 homology 
model was accurate enough to allow for the selection of putative catalytic and substrate-
binding residues (Chapters 2 and 3), it should provide a sufficient enough first 
approximation to successfully solve the crystal structure. Once a crystal structure of 
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Smlt1473 is solved, it can be used as a more precise starting model for subsequent 
structures. 
 Solving the structure of Smlt1473 in complex with HA, poly-GlcA, and poly-ManA 
under acidic, neutral, and alkaline conditions, respectively, will allow for the identification 
of non-catalytic active site residues that interact with each substrate via hydrogen bonding 
and π-stacking. Similar types of observations have been made for numerous PLs crystal 
structures in complex with corresponding substrates (16,25-28). Additionally by 
determining the distance and orientation of each catalytic residue with respect to the 
cleavable O-glycosidic bond, the role of the catalytic histidine and tyrosine can be further 
clarified. Due to Smlt1473 having optimal HA activity at pH 5 and pKa predictions of the 
catalytic histidine and tyrosine, the histidine will be in close enough proximity and correct 
orientation to act as the general base in HA cleavage under acidic conditions, whereas its 
position will be altered and suboptimal to act as the general base under neutral and alkaline 
conditions (Chapter 2) (11). The shift in position may be due to slightly different binding 
of each substrate in the active site cleft, similar to the ScPL8Hyal enzyme crystallized in 
complex with HA and chondroitin (29) and caused by chemical differences between the 
substrates themselves. For example, all three of the most active substrates contain GlcA 
(poly-GlcA and HA) or its C2 epimer ManA (poly-ManA), however only HA contains N-
acetyl-D-glucosamine (GlcNAc). GlcNAc contains a C2 acetylamino group and lacks the 
negatively charged C6 carboxyl indicative of uronic acids. Also, only HA contains both 
(1→4) and (1→3) O-glycosidic bonds, resulting in a distinct macromolecular 
conformation. Therefore the structural and chemical differences between HA and poly-
GlcA/poly-ManA could result in a unique binding site for HA in the active site cleft of 
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Smlt1473 and thus a unique positioning of the catalytic His168 and Tyr222 with respect to 
C5 proton of the +1 GlcA residue in HA. All of the above questions can be addressed with 
a solved crystal structure of Smlt1473 in complex with its substrates.  
Protein crystallization is a time and material intensive process that requires 
screening hundreds of buffer conditions including pH, ionic strength, and concentration of 
various precipitates in an effort to create well-ordered crystals (30). However, Smlt1473 
can be expressed and purified in large quantities (>75 mg/L culture), providing plenty of 
material for crystal screens (Chapter 2) (11). Also, the structure of at least 48 unique PLs 
has been solved by X-ray crystallography, including another PL-5 lyase (PDB 1QAZ), 
implying that crystallization of PLs is feasible (16,31). Furthermore, to our knowledge, a 
high-resolution crystal structure of Smlt1473 will be the first structure of a poly-GlcA 
specific enzyme, as well as an enzyme capable of cleaving both amino containing 
polysaccharides such as HA and non-amino polysaccharides such as poly-GlcA and poly-
ManA. To that end, we are currently in the process of attempting to solve the crystal 
structure of Smlt1473 in collaboration with Dr. Rudresh Acharya of the National Institute 
of Science Education and Research in Bhubaneswar, India. 
 
6.5 EFFICACY OF SMLT1473 AGAINST CLINICAL RELEVANT BIOFILMS 
Understanding the biological and potentially virulent role that Smlt1473 plays 
during the course of S. maltophilia infection is a critical step in developing a therapy that 
circumvents the inherit drug resistance exhibited by S. maltophilia, including its ability to 
form biofilm on respiratory cells (32).  One possibility is that Smlt1473 has a similar 
function to that of AlgL from Pseudomonas aeruginosa and acts to regulate 
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exopolysaccharide chain length during biofilm secretion (33). A recently study identified 
GlcA residues in two S. maltophilia biofilms isolated from CF patients (34). Given the high 
activity of Smlt1473 against poly-GlcA, it is possible that the lyase is involved in biofilm 
processing and formation. Therefore we propose to compare the biofilm forming 
capabilities of smlt1473 positive and negative S. maltophilia clinical strains, test what 
effect treating biofilm-associated cultures with Smlt1473 has on antibiotic resistance, and 
test the ability of Smlt1473 to degrade biofilm isolated from various S. maltophilia strains. 
A second possibility is that S. maltophilia secretes Smlt1473 as part of a spite mechanism 
against P. aeruginosa in an effort to break down the biofilm of P. aeruginosa and render 
the competitor vulnerable to antibiotic treatment (35). We therefore also propose to isolate 
biofilm from P. aeruginosa and test the enzymatic activity of Smlt1473 towards the foreign 
biofilm.  
 Given that biofilm-associated strains exhibit up to 1,000-fold greater antibiotic 
resistance than their planktonic counterparts, one potential mechanism to combat biofilms 
is to break down the extracellular polymeric substance (EPS), which would release encased 
bacteria and re-sensitize them to antibiotic treatment (36). Alkawash, et al. tested this 
hypothesis in vitro using two mucoid CF strains of P. aeruginosa and treating biofilm with 
alginate lyase and gentamicin. Mucoid bacteria treated only with gentamicin survived 
while mucoid bacteria treated with both enzyme and antibiotics were killed, validating PLs 
potential use in breaking down biofilm during inhaled antibiotic treatment of CF patients 
(36). The broad substrate specificity of Smlt1473 makes it an attractive candidate for 
similar adjuvant treatments due to its potential to be active against a wide variety of 
microbial biofilms. A more detailed experimental plan is provided below. 
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 S. maltophilia strains isolated from patients at Lehigh Valley Hospital were 
collected under the supervision of Dr. Emily Wong. LB agar slants containing cultured 
strains were received from Health Network Laboratories and subsequently cultured in LB 
at 37°C, 200 rpm before being stored long term in 10% glycerol at -80oC. Genomic DNA 
from each strain was isolated according to standard techniques and PCR primers were 
designed to amplify genes of interest from the clinical strains, including Smlt1473. Out of 
a total of 26 strains, 21 were found to contain smlt1473 (Figure 2.7). We propose isolating 
biofilm from both smlt1473 positive and negative strains and testing Smlt1473's ability to 
degrade the biofilm in vitro. Biofilm can be isolated from bacteria via centrifugation and 
precipitation with cetylpyridinium chloride (34). Additionally we propose isolating biofilm 
from P. aeruginosa to test as well. 
In order to test the feasibility of utilizing Smlt1473 as an adjuvant to antibiotic 
treatment we propose growing biofilms on plastic or glass cover slips, as seen in Figure 
6.7, and then determining a concentration of gentamicin sufficient to kill planktonic but 
not mucoid bacteria. Biofilm-associated samples would then be treated with antibiotic plus 
or minus lyase. Biofilm content would be determined via crystal violet or Alcian blue 
staining and a killing efficiency would be determined via optimal density measurements or 
cell counting (37). The process would then be repeated with biofilms grown on IB3-1 
epithelial cells (a CF mimic) for a more biologically relevant system (32) and with the 
mutant lyases described in Chapter 3 of this thesis. 
209 
 
 
Figure 6.7: Biofilm development by S. maltophilia clinical strain BB3 on glass cover slip. EPS is stained 
by Alcian blue and appears as a haze surrounding the bacteria. 
 
6.6 IDENTIFICATION OF ACTIN-BINDING DOMAIN IN SMLT3054 
 Although Chapter 5 of this thesis identified Smlt3054 as a secreted ankyrin-repeat 
containing protein that binds F-actin, the portion of the protein responsible for ankyrin-
binding is as of yet unknown (17). Identifying the actin-binding domain of Smlt3054 would 
further our understanding of the mechanism behind Smlt3054 binding, by comparing with 
other bacterial actin-binding domains, and would assist in the development of a therapeutic, 
such as a small peptide or molecule, that competitively binds Smlt3054 and prevents it 
from binding host actin. To that end, we propose fragmenting Smlt3054 in a manner similar 
to the fragments generated for the ToxR dimerization assay (section 5.3.5 Domain Analysis 
of Smlt3054 via ToxR Dimerization Assay) and repeating the actin binding assay (section 
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5.2.10 Actin-Binding Protein Centrifugal Assay). A similar approach was taken in the 
identification of the SipA actin-binding domain (38). 
 
6.7 FINAL REMARKS 
 In summary, the work presented in this thesis contributes to the field of 
carbohydrate-modifying enzymes and their potential therapeutic and industrial 
applications, as well as the field of multidrug resistance. More specifically, the 
polysaccharide lyases (Smlt1473 and Smlt2602) described in Chapters 2-4 exhibit unique 
and exceptional structural plasticity, adding to our understanding of how this class of 
enzymes achieves substrate specificity. They also serve as an excellent platform for the 
design of highly active and specific mutant lyases, fine-tuned to the industrial or medical 
problem at hand. Their applications range from the saccharification of algae 
polysaccharides for use in biofuel production to the degrading of the extracellular 
polymeric substance found in biofilm-associated infections. Furthermore, the secreted 
ankyrin-repeat protein (Smlt3054) characterized in Chapter 5 adds to our understanding of 
how S. maltophilia infects and persists in its host. Given that little in known regarding the 
pathogenicity of S. maltophilia, identification of potential virulence factors, like those 
described in this work, is incredibly important in the treatment of this emergent, multidrug 
resistant, opportunistic pathogen. My hope for this work is that it informs and inspires 
individuals to tackle the numerous unanswered questions remaining regarding enzyme 
specificity and bacteria virulence and apply that knowledge towards the betterment of 
humankind. 
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6.8 ABBREVIATIONS 
The abbreviations used in this chapter are as follows: PL, polysaccharide lyase; 
MDR, multidrug resistant; CF, cystic fibrosis; poly-ManA, poly-beta-D-mannuronic acid; 
poly-GlcA, poly-beta-D-glucuronic acid; HA, hyaluronic acid; T3SS, type III secretion 
system; T2SS type II secretion system; GlcNAc, N-acetyl-D-glucosamine; EPS, 
extracellular polymeric substance. 
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